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Abstract

PROVISION OF HOSPITAL-BASED PALLIATIVE CARE AND THE IMPACT ON
ORGANIZATIONAL AND PATIENT OUTCOMES

By Marisa L. Roczen, Ph.D., M.A.
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of
Philosophy at Virginia Commonwealth University.
Virginia Commonwealth University, 2016
Director: Dolores G. Clement, Dr.P.H.
Sentara Professor, Department of Health Administration

Hospital-based palliative care services aim to streamline medical care for patients with
chronic and potentially life-limiting illnesses by focusing on individual patient needs, efficient
use of hospital resources, and providing guidance for patients, patients’ families and clinical
providers toward making optimal decisions concerning a patient’s care. This study examined the
nature of palliative care provision in U.S. hospitals and its impact on selected organizational and
patient outcomes, including hospital costs, length of stay, in-hospital mortality, and transfer to
hospice. Hospital costs and length of stay are viewed as important economic indicators.
Specifically, lower hospital costs may increase a hospital’s profit margin and shorter lengths of
stay can enable patient turnover and efficiency of care. Higher rates of hospice transfers and
lower in-hospital mortality may be considered positive outcomes from a patient perspective, as
the majority of patients prefer to die at home or outside of the hospital setting.
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Several data sources were utilized to obtain information about patient, hospital, and
county characteristics; patterns of hospitals’ palliative care provision; and patients’ hospital
costs, length of stay, in-hospital mortality, and transfer to hospice (if a patient survived
hospitalization). The study sample consisted of 3,763,339 patients; 348 urban, general, shortterm, acute care, non-federal hospitals; and 111 counties located in six states over a 5-year study
(2007-2011). Hospital-based palliative care provision was measured by the presence of three
palliative care services, including inpatient palliative care consultation services (PAL), inpatient
palliative care units (IPAL), and hospice programs (HOSPC). Derived from Institutional Theory,
Resource Dependence Theory, and Donabedian’s Structure Process-Outcome framework, 13
hypotheses were tested using a hierarchical (generalized) linear modeling approach.
The study findings suggested that hospital size was associated with a higher probability
of hospital-based palliative care provision. Conversely, the presence of palliative care services
through a hospital’s health system, network, or joint venture was associated with a lower
probability of hospital-based palliative care provision. The study findings also indicated that
hospitals with an IPAL or HOSPC incurred lower hospital costs, whereas hospitals with PAL
incurred higher hospital costs. The presence of PAL, IPAL, and HOSPC was generally
associated with a lower probability of in-hospital mortality and transfer to hospice. Finally, the
effects of hospital-based palliative care services on length of stay were mixed, and further
research is needed to understand this relationship.

Chapter 1: Introduction

This chapter is divided into six sections. The first two sections summarize the study
problem and research questions examined in this study. The third section provides an overview
of the theoretical framework used to address the research questions, followed by a description of
the analytical approach applied to test the study hypotheses. The significance of the study is
highlighted in the fifth section. The chapter concludes with a summary of the remaining chapters.
The Study Problem
The chronically ill population with serious, potentially life-limiting diseases has been
growing rapidly over the last two decades. In 2010, seven of the top ten leading causes of death
in the United States were chronic diseases, with cancer and heart disease accounting for almost
50% of all deaths (Murphy, Xu, & Kochanek, 2013). While 37% of U.S. adults had at least one
chronic illness in 1987, this number rose to about 60% in 2005 (Hoffman, Rice, & Sung, 1996;
Machlin, Cohen, & Beauregard, 2008). This percentage is significantly higher for older adults,
with the fraction ranging from 36.4% of persons aged between 18 and 34 to 91.5% of adults aged
65 and over (Machlin et al., 2008). These numbers are alarming considering the aging U.S.
population. According to the Administration on Aging (AoA), Americans aged 65 and over
constituted 13.3% of the overall population in 2011 (Administration on Aging, n.d.). This
percentage is expected to increase to 21% in 2040. Similarly, the 85+ population is projected to
nearly triple between 2011 and 2040, from 5.7 million in 2011 to a projected 14.1 million in
2040. With a population that currently has a life expectancy of 78.7 years, the U.S. health care
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system must prepare to serve an aging population that lives longer but most likely with serious,
chronic illnesses or conditions that require long-term, often costly specialized care (Center to
Advance Palliative Care, 2008).
One service explicitly tailored toward caring for individuals with serious, chronic, and
potentially life-limiting illnesses is palliative care. Palliative care has the potential to help
clinicians address the needs of such patients and generate cost savings. This study’s focus is on
exploring the associations between hospital and environmental factors and the provision of
hospital-based palliative care services and on examining how hospital-based palliative care
services and hospitals’ experience in providing such services are associated with hospital costs,
hospital length of stay, in-hospital mortality, and care transition to hospice.
Palliative care is a specialized, interdisciplinary, and holistic approach to medical care
tailored toward patients with a serious, chronic and/or worsening illness. This type of care
emphasizes the identification, prevention, assessment, alleviation, and management of suffering
caused by a life-limiting disease or condition (Adolph, Frier, Stawicki, Gerlach, & Papadimos,
2011). Suffering can include physical pain and symptoms or other psychological, psychosocial,
emotional, and spiritual distress (White & Coyne, 2011). Palliative care is typically provided by
an interdisciplinary health care team, including specialist physicians, nurses, social workers, and
chaplains, who focus on the complex needs of patients and their families with the goal to
optimize quality of life across the continuum of a patient’s disease (National Quality Forum,
2011; World Health Organization, 2016). This type of care is appropriate at any age or stage of
illness and can be provided along with life-prolonging or curative treatments.
The hospice and palliative care movement is rooted in Europe, where Dame Cicely
Saunders first started to raise awareness of inadequate pain and symptom management at the end
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of life and advocate for better care for terminally-ill patients in the mid-20th century. Her efforts
to establish the first modern hospice in 1967 in London is considered a vital milestone in the
history of palliative care. Seven years later, the first U.S. hospice was founded in Connecticut
preceded by rigorous collaborative efforts of Dame Cicely Saunders and hospice and palliative
care advocates in the United States. However, it was not until the early to mid-1980s that U.S.
policy makers began taking tangible action to facilitate access to palliative care for individuals at
the end of life, including the establishment of the Medicare Hospice Benefit in 1983. During that
time, hospice and palliative care was primarily considered most appropriate for terminal patients
subsequent to curative treatment. But over the succeeding decades, this type of care started to be
acknowledged as a fundamental part of medical care for all patients suffering from a serious and
life-limiting illness.
While palliative care is provided in a variety of health care settings (e.g., long-term care
facilities, hospitals, hospice, at home), the hospital setting remains a central source of end-of-life
or palliative care for a large proportion of seriously ill patients. That is, while most patients with
serious illnesses prefer to die at home, almost one in three Medicare beneficiaries with a cancer
diagnosis or a chronic disease died in the hospital in 2007 (Goodman, Esty, Fisher, & Chang,
2011). The importance of hospital-based palliative care has been recognized since the late 1980s
when concerns about patients’ extended periods of suffering before death first started to take
shape. A substantial misalignment between patient preferences and actual care provided at the
end of life was first demonstrated in the mid-1990s, when the Study to Understand Prognoses
and Preferences for Outcomes and Risks of Treatment (SUPPORT) documented a lack of
communication about end-of-life preferences between physicians and their patients. The twoyear observational study of 4,301 patients revealed that 47% of physicians were unaware of their
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patients’ preference to withhold cardiopulmonary resuscitation (CPR). Further, according to
family members, 50% of patients who died in the hospital experienced moderate to severe pain at
least 50% of the time during their last three days of life (The SUPPORT Principal Investigators,
1995). The second phase of the study was a two-year controlled clinical trial with 4,804 patients
designed to improve end-of-life decision-making by facilitating information sharing between
patients and their physicians. The results of this study phase revealed that patient preferences for
end-of-life care did not have a significant effect on care processes, costs, or patient outcomes. A
follow-up study showed that almost 82% of patients who had expressed a preference for dying at
home, in fact, died in the hospital (Pritchard et al., 2008). In 1997, the Institute of Medicine
(IOM) published its report “Approaching death: Improving care at the end-of-life,” in which the
need for action to improve care at the end of life was stressed (Institute of Medicine, 1997).
Since the turn of the 21st century, palliative care has been one of the fastest growing
health care trends in the United States. The number of inpatient palliative care consultation
services in hospitals increased from 24.5% in 2000 to 65.7% of hospitals with at least 50 beds in
2010 (Center to Advance Palliative Care, 2012). These numbers include inpatient palliative care
consultation services provided by the hospital, health system, network, or a joint venture within
the local community. Moreover, various palliative care initiatives, such as the National
Consensus Project for Quality Palliative Care (NCP), the Center to Advance Palliative Care
(CAPC), and the National Hospice and Palliative Care Organization (NHPCO) have been
established, which focus on increasing the quality and availability of palliative care for
individuals with serious, life-limiting health conditions.
As quality of life for critically ill patients has received greater attention and palliative
care options have expanded, some research suggests that patients’ preferences and end-of-life
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care have become more closely aligned (Cosgriff, Pisani, Bradley, O'Leary, & Fried, 2007;
Wright et al., 2010). Numerous studies conducted in critical care settings have identified
successful palliative care interventions with significant improvements in quality of care through
the reduction of ineffective curative treatments when death is inevitable (Mosenthal et al., 2012).
Untreated suffering has been shown to be associated with low patient and family satisfaction,
amplified symptoms of post-traumatic stress disorder (PTSD) among family members, extended
time in the intensive care unit (ICU) without observable patient benefits, decreased quality of
life, and increased risk of mortality (Adolph, 2011; Andersson, 2009; Katz, 2002). Palliative care
consultations have been found to improve symptoms of ICU cancer patients, such as pain,
fatigue, nausea, constipation, dyspnea, sleep, depression, loss of appetite, drowsiness, and
anxiety (Delgado-Guay, Parsons, Li, Palmer, & Bruera, 2009). Another study revealed that
symptoms of PTSD, anxiety, and depression among family members of ICU patients were
significantly improved following the implementation of a palliative care communication
conference and bereavement brochure (Lautrette et al., 2007).
Hospital-based palliative care services aim to streamline patient care at the end of life
with a specific focus on individual patient needs and efficient use of hospital resources. Access
to palliative care in the hospital setting has the potential to guide patients, patients’ families and
clinical providers toward making optimal decisions concerning a patient’s care, such as timely
transitioning to other health care settings if appropriate. Avoiding prolonged hospital stays may
be more in line with patients’ preferences for end-of-life care and may reduce the cost of patient
care if medically unnecessary. The proposed study thus aims to explore the nature of palliative
care provision in the hospital setting and the capability of palliative care services to facilitate
care transitions to hospice, shorten length of stay, and reduce hospital costs and risk of mortality.
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Research Questions
This research study has two main objectives. The first is to evaluate organizational and
environmental factors associated with the likelihood of providing palliative care services among
urban, non-federal, short-term, and acute care hospitals in the United States. The second
objective is to examine potential associations between hospital-based palliative care services and
subsequent organizational and patient outcomes in urban, non-federal, short-term, and acute care
hospitals for patients who are most likely to benefit from and utilize palliative care services. The
outcomes of interest are hospital costs per patient, hospital length of stay per patient, in-hospital
mortality, and care transition to hospice. The following research questions are examined to
explore the nature of hospital-based palliative care services and the association of hospital-based
palliative care services with organizational and patient outcomes.
1) Which organizational and environmental forces are associated with the provision of
hospital-based palliative care services?
2) Do hospitals that provide palliative care services have improved organizational and
patient outcomes compared to those not providing such services?
3) Is a hospital’s experience in providing palliative care services associated with improved
organizational and patient outcomes?
Theoretical Framework
The underlying theoretical framework for this study is based on organizational theories
and frameworks that have been used by other health services researchers to explain the nature of
hospital service adoption and how such adoption potentially influences hospital performance.
Five propositions and hypotheses that correspond to research question one are derived from
Resource Dependence Theory (Pfeffer & Salancik, 1978) and Institutional Theory (DiMaggio &
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Powell, 1983; Meyer & Rowan, 1977). Donabedian’s Structure-Process-Outcome (SPO)
framework for quality assessment (Donabedian, 1980) is applied to derive one proposition and
four hypotheses corresponding to research questions two and three, respectively. Besides the key
explanatory variables to test the study’s 13 hypotheses, additional patient, hospital, and country
control variables are included to account for factors potentially affecting the association between
the key explanatory variables and the dependent variables.
Analytical Approach
To test the study’s hypotheses, longitudinal data between 2007 and 2011 from six states,
namely Arizona, California, Florida, Maryland, New Jersey, and New York are used. This study
utilizes data from the following databases: Healthcare Cost and Utilization Project (HCUP) state
inpatient databases, American Hospital Association (AHA) Annual Survey of Hospitals, Area
Health Resources Files (AHRF), the Centers for Medicare & Medicaid Services (CMS)
Healthcare Cost Report Information System (HCRIS), the HealthLeader-Interstudy databases,
and the website of the American Nurses Credentialing Center (ANCC). A two-level hierarchical
generalized linear model (HGLM) is used to analyze the proposed hypotheses under research
question one, where hospitals are nested within markets (i.e., counties). Four three-level HGLM
and hierarchical linear models (HLM) are employed to test the proposed hypotheses under
research questions two and three, with patients nested within hospitals nested within markets.
Significance of the Study
This study is significant for several reasons. First, the U.S. health care system serves an
aging population with increasing life expectancy and serious chronic or terminal illnesses that
require specialized care (Center to Advance Palliative Care, 2008). Palliative care services are
uniquely equipped to care for this type of patient population.
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Second, hospital settings remain the primary source of palliative care for the majority of
seriously ill patients. Thus, it is important to gain a broader understanding of the nature and
effects of hospital-based palliative care.
Third, palliative care may play a significant role in implementing goals articulated by the
Affordable Care Act (2010). Specifically, Fletcher and Panke (2012) reviewed the opportunities
and challenges of palliative care in light of the Affordable Care Act and highlighted that
palliative care may be the answer to rising healthcare costs and deficiencies in quality of care.
The authors concluded with a call for evidence-based research efforts linking palliative care to
improvement in quality of care and cost reduction. Despite the increased prevalence of hospitalbased palliative care services, the necessity to improve care for patients with serious medical
conditions remains (Weissmann & Meier, 2011). Existing studies primarily focus on evaluating
the effects of palliative care provision on patient and organizational outcomes in single hospitals
or a small number of hospitals within a hospital system. However, these effects are potentially
hospital- or hospital system-specific and may therefore not be generalizable to all U.S. hospitals.
An examination of palliative care services in a larger set of hospitals, as conducted in this study,
may provide the basis for more generalizable conclusions regarding the impact of palliative care
services on selected patient and organizational outcomes.
Summary of Remaining Chapters
This manuscript is divided into six chapters. This chapter introduced the study’s thematic
focus; defined the study problem, research questions, significance of this study; and summarized
the theoretical framework and the analytical methodology applied in this study.
Chapter 2 provides detailed background information and reviews relevant literature
related to the study’s research questions. Chapter 3 describes the Structure-Process-Outcome
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framework, Institutional Theory, and Resource Dependence Theory to derive seven propositions
and the corresponding 13 testable hypotheses. A detailed description of the study’s data,
methodology, research design, and empirical implementation is provided in Chapter 4. Chapter 5
summarizes the study findings, including descriptive statistics, regression models, and
supplemental sensitivity analyses. Finally, Chapter 6 discusses and reflects on the study’s
findings with regard to the propositions and hypotheses and closes with outlining the study’s
limitations and implications for theory, health care policy, and practice.
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Chapter 2: Literature Review

This chapter is divided into eight sections. The first section sets the stage by defining
palliative care and related concepts. The second section outlines the evolution of palliative care
in the U.S. health care system, including the historical development of conceptual models of
palliative care. The third and fourth sections present the major delivery models of palliative care
and their diffusion across hospitals nationwide and in the study sample. The fifth section
discusses the study’s dependent variables and why they are important from a hospital
performance perspective. The sixth and seventh sections illustrate how studies have empirically
explored the provision of hospital-based palliative care and hospital performance in regard to the
study’s selected organizational and patient outcomes. The last section concludes this chapter by
summarizing the potential contribution of this study to the current literature exploring similar
research questions.
Defining Palliative Care
Several terminologies exist to describe palliative care and related concepts, such as endof-life care, palliative care, and hospice care. Recognizing their differences and commonalities is
necessary to understand the evolution, nature, and goals of palliative care. The term “hospice”
originates from the Latin word for hospitality (i.e., hospitium); the term “palliative” is derived
from the Latin word for cloaked or covered (i.e., palliativus) and refers to the act of “relieving
pain or alleviating a problem without dealing with the underlying cause” (Oxford Dictionaries,
2015). While palliative care is appropriate for seriously ill patients at the time of diagnosis and
10

concurrent with curative treatment, hospice care typically starts after or independent of lifeprolonging treatments and when the patient is not expected to live longer than six months.
Consequently, hospice care may be viewed as a specific subset of palliative care, which is
provided at the end of life when death is inevitable. Finally, end-of-life (EOL) care is often used
as a synonym for palliative care despite its deceptive and limited view of palliative care. Rather,
EOL care is more closely aligned with hospice care, as it focuses on providing care to patients
with terminal diagnoses. Several leading health care initiatives have developed definitions of
palliative care. Table 1 provides an overview of these definitions.
Table 1
Organizational Definitions of Palliative Care

1

Organization

WHO

NQF

CAPC

NCP

Definition
Palliative care is an approach that improves the quality of life of patients and
their families facing the problem associated with life-threatening illness,
through the prevention and relief of suffering by means of early identification
and impeccable assessment and treatment of pain and other problems, physical,
psychosocial and spiritual. (WHO, 2016)
Palliative care refers to patient- and family-centered care that optimizes quality
of life by anticipating, preventing, and treating suffering. Palliative care
throughout the continuum of illness involves addressing physical, intellectual,
emotional, social, and spiritual needs and facilitating patient autonomy, access
to information, and choice. (NQF, 2006)
Palliative care, also known as palliative medicine, is specialized medical care
for people living with serious illness. It focuses on providing relief from the
symptoms and stress of a serious illness – whatever the diagnosis. The goal is
to improve quality of life for both the patient and the family. (CAPC, n.d.)
The goal of palliative care is to prevent and relieve suffering and to support the
best possible quality of life for patients and their families, regardless of the
stage of the disease or the need for other therapies. Palliative care is both a
philosophy of care and an organized, highly structured system for delivering
care. Palliative care expands traditional disease-model medical treatments to
include the goals of enhancing quality of life for patient and family, optimizing
function, helping with decision making, and providing opportunities for
personal growth. As such, it can be delivered concurrently with life-prolonging
care or as the main focus of care. (NCP, 2013)

Note. CAPC=Center to Advance Palliative Care. NCP=National Consensus Project for Quality Palliative Care.
NQF=National Quality Forum. WHO=World Health Organization.
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The NQF’s definition is among the most widely used description of palliative care in the
United States. Both the National Hospice and Palliative Care Organization (NHPCO) and the
Centers for Medicare and Medicaid Services (CMS) officially refer to this definition in the
context of palliative care. There are several notable commonalities between the definitions
presented in Table 1, including the focus on quality of life, relief of disease-related suffering, and
care that is centered on the patient and their families. Several definitions mention the multidimensionality of palliative care, including addressing physical, psychological, social, and
spiritual needs of patients and their families.
In 2004, the NCP developed a set of eight domains covering the full spectrum of
palliative care services. Each domain is associated with guidelines, which outline best palliative
care practices, as presented in Table 2.
A review of the guidelines in Table 2 illustrates that high-quality palliative care should be
provided by an interdisciplinary team that carefully assesses and manages various aspects of
patients’ and families’ needs from the time of diagnosis to bereavement support after the
patient’s death. The domains and corresponding guidelines also highlight the importance of carethat emphasizes quality of life and is based on goals of care that reflect patients’ and families’
preferences and values. To assure that patients’ and families’ needs are met, palliative care draws
from the expertise of a wide spectrum of clinical specialists, including physicians, nurses,
chaplains, social workers, psychologists, and other disciplines. Finally, palliative care
distinguishes itself from other types of medical care by not only attending to medical needs (i.e.,
pain and symptom management), but also addressing other aspects of life affected by the
patient’s illness, including bereavement support for family members after the patient’s death.
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Table 2
Palliative Care Domains and Corresponding Guidelines
Table 2 (continued)
Domain
Guideline
1. A comprehensive and timely interdisciplinary assessment of patient and family forms the
basis of the plan of care.
2. The care plan is based on the identified and expressed preferences, values, goals, and needs
of the patient and family and is developed with professional guidance and support for
patient-family decision making. Family is defined by the patient.
2

3. An interdisciplinary team (IDT) provides services to the patient and family consistent with
the care plan. In addition to chaplains, nurses, physicians, and social workers, other
therapeutic disciplines who provide palliative care services to patients and families may
include: child-life specialists, nursing assistants, nutritionists, occupational therapists,
recreational therapists, respiratory therapists, pharmacists, physical therapists, massage, art,
and music therapists, psychologists, and speech and language pathologists.
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1. Structure/Processes

4. The palliative care program is encouraged to use appropriately trained and supervised
volunteers to the extent feasible.
5. Support for education, training, and professional development is available to the
interdisciplinary team.
6. In its commitment to quality assessment and performance improvement, the palliative care
program develops, implements, and maintains an ongoing data driven process that reflects
the complexity of the organization and focuses on palliative care outcomes.
7. The palliative care program recognizes the emotional impact of the provision of palliative
care on the team providing care to patients with serious or life-threatening illnesses and their
families.
8. Community resources ensure continuity of the highest quality palliative care across the care
continuum.
9. The physical environment in which care is provided meets the preferences, needs and
circumstances of the patient and family, to the extent possible.

Table 2 (continued)
Domain
2. Physical

Guideline
1. The interdisciplinary team assesses and manages pain and/or other symptoms and their
subsequent effects based upon the best available evidence.

3. Psychological/Psychiatric

2. The assessment and management of symptoms and side effects are contextualized to the
disease status.
1. The interdisciplinary team assesses and addresses psychological and psychiatric aspects of
care based upon the best available evidence to maximize patient and family coping and
quality of life.

4. Social

2. A core component of the palliative care program is a grief and bereavement program
available to patients and families, based on assessment of need.
1. The interdisciplinary team assesses and addresses the social aspects of care to meet patientfamily needs, promote patient-family goals, and maximize patient-family strengths and
well-being.
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2. A comprehensive, person-centered interdisciplinary assessment (as described in Domain 1,
Guideline 1.1) identifies the social strengths, needs, and goals of each patient and family.
1. The interdisciplinary team assesses and addresses spiritual, religious, and existential
dimensions of care.
2. A spiritual assessment process, including a spiritual screening, history questions, and a full
spiritual assessment as indicated, is performed, The assessment identifies religious or
5. Spiritual/Religious/Existential
spiritual/existential background, preferences, and related beliefs, rituals, and practices of the
patient and family; as well as symptoms, such as spiritual distress and/or pain, guilt,
resentment, despair, and hopelessness.

6. Cultural

3. The palliative care service facilitates religious, spiritual, and cultural rituals or practices as
desired by patient and family, especially at and after the time of death.
1. The palliative care program serves each patient, family, and community in a culturally and
linguistically appropriate manner.
2. The palliative care program strives to enhance its cultural and linguistic competence.

Table 2 (continued)
Domain

7. End-of-Life

Guideline
1. The interdisciplinary team identifies, communicates, and manages the signs and symptoms
of patients at the end of life to meet the physical, psychosocial, spiritual, social, and cultural
needs of patients and families.
2. The interdisciplinary team assesses and, in collaboration with the patient and family,
develops, documents, and implements a care plan to address preventative and immediate
treatment of actual or potential symptoms, patient and family preferences for site of care,
attendance of family and/or community members at the bedside, and desire for other
treatments and procedures.
3. Respectful postdeath care is delivered in a respectful manner that honors the patient and
family culture and religious practices.
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4. An immediate bereavement plan is activated postdeath.
1. The patient or surrogate’s goals, preferences, and choices are respected within the limits of
applicable state and federal law, current accepted standards of medical care, and
professional standards of practice. Person-centered goals, preferences, and choices form the
basis for the plan of care.
8. Ethical/Legal

2. The palliative care program identifies, acknowledges, and addresses the complex ethical
issues arising in the care of people with serious or life-threatening illness.
3. The provision of palliative care occurs in accordance with professional, state and federal
laws, regulations and current accepted standards of care.

Note. Adapted from “National Consensus Project for Quality Palliative Care. C. Dahlin, Ed. Clinical Practice Guidelines for Quality Palliative Care. 3rd ed.
Pittsburgh, PA: National Consensus Project for Quality Palliative Care; 2013.” Copyright 2013 by the National Consensus Project for Quality Palliative Care.
Adapted with permission.

Evolution of Palliative Care
The evolution of palliative care in the U.S. healthcare system was highly influenced by
historical changes in defining and conceptualizing the role of death and dying. This can be
illustrated by the changing role of curative treatment and palliative care along the continuum of
care or illness trajectory spanning from the time of diagnosis to death.
In Western societies, including the United States, changes in perceptions of death and
dying have been accompanied and influenced by scientific, medical, pharmacological, and
technological advancements. Until the mid-19th century, there was little medicine could do to
prolong life or cure diseases. Dying often occurred with minimal medical involvement and was
largely considered the responsibility of the family, community or religious institutions (Institute
of Medicine, 1997). In addition, life expectancy was relatively low and most deaths occurred at
home in the care of family members. While the first U.S. hospitals established in the 18th century
functioned like hospices to provide care for the sick and dying and shelter for the poor, the
preferred place of care for the upper and middle class was at home throughout most of the 19th
century (Starr, 1982).
As medical practice advanced steadily and industrialization continued to evolve, health
care became increasingly professionalized and institutionalized. By the early-20th century,
hospitals had transformed into modern health care facilities with a focus on recovery and cure
employing professional staff and medical technology and techniques, such as aseptic surgery and
x-rays (Starr, 1982). In 1946, the Hospital Survey and Construction Act (or Hill-Burton Act),
initiated considerable hospital growth by providing substantial financial support to expand
community hospitals in the United States. In addition, the Public Health Service Act of 1944
shaped medical research in the post-World War II era by providing federal funds that triggered
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the expansion of the National Institutes of Health (NIH) and facilitated growth of medical
knowledge and fostered scientific discovery. Scientific breakthroughs, particularly in medicine,
generated a universal confidence and hopefulness toward medicine’s ability to prolong life and
conceivably defeat death (Byock, 2014). As more Americans died in institutional settings than in
their own homes, the role of medicine and medical institutions at the end of life became
increasingly prominent. The focus of medicine was primarily on curing diseases and postponing
death in the early to mid-20th century. Death was largely viewed as the inability to cure a disease,
which commonly led to inattention to patients’ suffering, including pain at the end of life
(Wheat, 2009). In addition, patients were typically not included in the medical decision-making
process and little attention was paid to patients’ preferences and values (Byock, 2014).
Medical advances also led to a steep decrease in infant mortality and a gradual increase in
life expectancy (Institute of Medicine, 1997). Concerns about how to care for the elderly and
terminally-ill arose among health care professionals and the public. During the early 1950s,
Europeans began focusing their attention on end-of-life or hospice care. In particular, the modern
use of the term hospice can be traced back to England (Clark, 2014). Considered among the most
important landmarks of the modern hospice and palliative care movement is the establishment of
the first modern hospice, St. Christopher’s Hospice in 1967 in London, UK, by nurse, medical
social worker, and physician Dame Cicely Saunders (Wheat, 2009). Saunders is considered one
of the movement’s pioneers, as she was among the first to identify and focus on the special needs
of patients at the end of life (Richmond, 2005). The decade preceding the foundation of St.
Christopher’s played a crucial role in shaping and developing the modern idea of hospice and
palliative care (Buck, 2011; Clark, 1998).
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Saunders first discussed the idea of creating a home for the dying with one of her
terminally-ill patients, a Polish Jewish refugee named David Tasma, during Saunders’s work as a
medical social worker at Archway Hospital in Northern London in 1948 (Richmond, 2005).
Hoping to expand her nursing work with terminally-ill patients, she was advised to become a
physician to better influence the care provided to the dying. She started her medical training at
St. Thomas Hospital shortly after, followed by a research scholarship to study pain management
at St. Mary’s Hospital in London (Richmond, 2005). During that time, she also volunteered at St.
Joseph’s Hospice between 1958 and 1965, a home for the dying poor run by nuns located in
London, where she used her medical knowledge and research findings to improve quality of care
(Saunders, 2001). Extensive anecdotal and empirical evidence of the use of pain and symptom
management were collected at St. Joseph’s Hospice to reveal the inadequacies of care for the
dying in the British welfare state and raise awareness for the idea of specialized care for the
dying (Saunders, 2001).
In 1959, Saunders had prepared a 10-page proposal outlining her concept for a terminalcare home, which she shared and later refined with support from key constituents in the clinical
field in Britain and the United States (Clark, 1998; Saunders, 2001). Publishing papers became
an important and effective medium for disseminating her ideas and connecting with constituents
around the world (Clark, 1998). Her first paper in 1957, entitled “Dying of Cancer,” in which
Saunders discussed many of the elements comprising the core elements of modern idea of
hospice care, generated affirmative feedback and valuable connections with supporters and
associates dedicated to her cause. But it took several years to evoke serious interest among
professionals in the medical field (Clark, 1998).
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As her professional network grew, Saunders developed an interest in exploring terminal
care in the United States. She began lecturing about her work and research with terminally-ill
patients at St. Joseph’s Hospice in medical institutions in the United States in 1963 (Buck, 2011).
Her approach to medical care was in stark contrast to the then pre-dominant emphasis on using
medicine to cure diseases, such as cancer, rather than alleviate suffering caused by such diseases
(Wheat, 2009). Her lectures made a profound impression on Florence Wald, then Dean of the
School of Nursing at Yale University, who eventually invited her to become a visiting faculty
member in the school in 1965 (National Hospice and Palliative Care Organization, 2015).
As awareness of the need for specialized care for terminally-ill patients rose steadily,
numerous studies demonstrating inadequate pain management and lack of emotional,
psychosocial, spiritual and psychological support for patients with terminal illnesses and their
families in the United States were published (Buck, 2011). Specifically, several studies published
in the 1950s and early 1960s played an important role in shifting the attention to suffering and
poor care conditions among patients dying of cancer at home and in charitable homes (Clark,
2014; Saunders, 2001). For example, Elisabeth Kübler-Ross’ book “On Death and Dying”
published in 1969 became an international bestseller, in which the author introduced the five
stages of grief based on numerous interviews with dying patients and emphasized the patient’s
right to participate in the end-of-life decision-making process (National Hospice and Palliative
Care Organization, 2015).
While the medical mainstream remained largely reluctant, nursing educators began
proposing and teaching alternative approaches to care for the dying, including strategies to
address ethical, spiritual, and emotional issues related to end-of-life care (Buck, 2011). After the
establishment of St. Christopher’s Hospice in 1967 and sabbatical visits to study that hospice’s
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care for terminally-ill patients, Wald founded the first modern hospice in North America, the
Connecticut Hospice in Branford, Connecticut in 1974 (National Hospice and Palliative Care
Organization, 2015; Saunders, 2001), shortly followed by the establishment of the International
Work Group in Death, Dying, and Bereavement (IWG) (Buck, 2011).
In 1978, following a series of meetings of hospice advocates during the prior three years,
the National Hospice Organization (NHO) was founded. This organization published the first
Standards of a Hospice Program of Care in the following year (Connor, 2007). Concurrently,
the IWG published the document Assumptions and Principles Underlying Standards for
Terminal Care (1979). Both organizations were actively involved in developing and advocating
for a guiding framework for hospice and palliative care (Buck, 2011).
National policy makers became increasingly aware of the potential benefits of hospice
care for the elderly population. The Centers for Medicare and Medicaid Services (CMS),
formerly known as the Health Care Financing Administration (HCFA), initiated 26
demonstration programs in hospices nationwide to assess their care delivery models, structure,
and cost effectiveness in an effort to facilitate a federal reimbursement system for hospice care.
As a result, the Medicare Hospice Benefit (MHB), established in 1983 and made permanent in
1985, was included in the Tax Equity and Fiscal Responsibility Act (TEFRA) of 1982 to cover
end-of-life services to eligible individuals aged 65 and older. During this time, The Joint
Commission (TJC), formerly known as the Joint Commission on Accreditation of Healthcare
Organizations (JCAHO), started developing standards for hospice accreditation. While the
nursing profession had long accepted and promoted hospice and palliative care for terminal
patients, the medical profession began to follow suit (Connor, 2007). Although palliative care
began to be recognized as a critical part of health care delivery, it remained largely separate from
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curative and life-prolonging therapies. Palliative care was primarily considered end-of-life care
and thus largely provided through hospice programs to actively dying patients after lifeprolonging or curative treatments had been exhausted, as displayed in Figure 1 (Meier &
McCormick, 2015).

Curative Treatment
Diagnosis

CONTINUUM OF CARE

HOSPICE
Death

Figure 1. Paradigm of Medical Care with Hospice Care
Adapted from “Living Well at the End of Life: Adapting Health Care to Serious Chronic Illness in Old Age,” by J.
Lynn, D. M. Adamson, 2003, RAND Health White Paper WP-137, p. 10. Copyright 2003 by RAND Corporation.
Adapted with permission.

The definition and application of palliative care began to broaden in the 1990s, when the
focus was on the integration of palliative care and curative treatment. The 1995 SUPPORT study
jump-started this paradigm shift by demonstrating a substantial lack of such integration.
Specifically, the study revealed that the majority of hospital patients experienced untreated
physical pain at the end of life, that physicians lacked awareness of patients’ preferences of care
and that patients’ preferences (when known) did not significantly impact processes of care.
Additionally, two reports published by the Institute of Medicine (IOM) reports, Approaching
Death (1997) and Crossing the Quality Chasm (2001), emphasized the need to combine the
traditional model of medical care and palliative care into a comprehensive approach to care
focused on increasing the quality of life for patients with serious illnesses and regardless of
disease progression. Sepulveda et al. (2002) suggested that “this change in thinking emerged
from a new understanding that problems at the end of life have their origins at an earlier time of
the trajectory of disease” (p. 92)
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Palliative care became increasingly recognized as an integral part of high-quality health
care delivery appropriate and potentially beneficial to patients at the time of diagnosis, not only
to patients at the end of life through the channel of hospice care. This paradigm shift was evident
through a variety of developments in health care delivery, practice and research. For example, in
2000, the NHO changed its name to the National Hospice and Palliative Care Organization
(NHPCO) in recognition of the need to expand the application of palliative care. Also, the World
Health Organization’s (WHO) definition of palliative care was considerably modified in 2002.
The WHO initially regarded palliative care as an approach to care that is focused on pain relief
and targeted toward cancer patients who do not respond to curative or life-prolonging treatments.
The updated definition, however, emphasized that palliative care may not be limited to patients
at the end of life, but instead, may be appropriate and beneficial for all patients with serious or
life-threatening illnesses and at any stage of the illness trajectory (World Health Organization,
2002). The new definition broadened its focus to consider the treatment of all disease-related
symptoms, such as physical, social, psychological, and spiritual needs, and attend to the patient’s
family members’ well-being and health both during the patient’s illness and after the patient’s
death by means of bereavement support (Sepulveda et al., 2002).
In 2001, palliative care leaders met at a conference organized by the Center to Advance
Palliative Care (CAPC) to discuss the current state of palliative care in the United States, which
eventually led to the foundation of the National Consensus Project for Quality Palliative Care
(NCP) (NCP, 2013). The NCP first published its Clinical Guidelines for Quality Palliative Care
in 2004, which included the core concepts and structures of quality palliative care and eight
domains of practice, as presented in the previous section. In the 2006 report A National
Framework and Preferred Practices for Palliative and Hospice Care Quality, the National
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Quality Forum (NQF) endorsed and included NCP’s clinical guidelines and domains of practice,
which were used as a foundation to develop a set of preferred practices developed to improve
palliative care. The guidelines have been updated in 2009 and 2013 to reflect the current state of
research and practice. The modern paradigm of medical care that recognized the need to
integrate palliative care early in the illness trajectory is presented in Figure 2.
Hospice Bereavement
Curative Treatment

Diagnosis

Palliative Care
CONTINUUM OF CARE

Death

Figure 2. Paradigm of Medical Care with Palliative Care, Hospice Care, and Bereavement
Adapted from “Living Well at the End of Life: Adapting Health Care to Serious Chronic Illness in Old Age,” by J.
Lynn, D. M. Adamson, 2003, RAND Health White Paper WP-137, p. 10. Copyright 2003 by RAND Corporation.
Adapted with permission.

Recognizing the need to provide access to palliative care to patients regardless of age,
stage of illness, and health care setting has translated into a wide-variety of quality-improvement
projects, which are concerned with improving palliative care in hospital settings (e.g., ICUs,
emergency rooms), in other health care settings (e.g., ambulatory clinics, home health), and for
certain patient populations (e.g., neonatal/pediatric patients, AIDS/HIV patients). The following
section defines and describes the different delivery models of palliative care relevant to this
study’s research focus.
Delivery Models of Palliative Care
Palliative care is provided in a range of health care settings, including hospitals, the
patient’s home (e.g., the patient’s residence, nursing homes, or assisted-living facilities),
hospices, and ambulatory or outpatient clinics (e.g., physician’s offices, transitional care
facilities, or cancer centers). In the United States, palliative care is predominately delivered at

23

home, in hospices, and in the hospital setting. This study centers on the provision of palliative
care in the hospital setting.
There are four major delivery models for hospital-based palliative care, including
integrative models, inpatient palliative care consultation services, inpatient palliative care units,
and hospice programs. Integrative models, or primary palliative care, focus on incorporating
palliative care principles into the daily practices of hospital care (Nelson et al., 2010). The
primary goal is to educate clinical staff involved in the patient’s routine care on how to address
basic palliative care needs. Conversely, inpatient palliative care consultation services, inpatient
palliative care units, and hospice programs may be classified as specialty palliative care provided
by palliative care experts who are trained to manage patients with complex symptoms, family
dynamics, and care decisions (Meier, 2011; von Gunten, 2002).
The diffusion of hospital-based integrative models is difficult to examine due to data
limitations. The focus of this study is therefore on specialty palliative care, which is described in
the following paragraphs.
Inpatient palliative care consultation services.
Inpatient palliative care consultation services, the prevailing model of palliative care
delivery in the hospital setting, provide palliative care consultations to patients and families
within the hospital. Such services typically involve an advanced practice registered nurse
(APRN) or physician as the primary provider who is trained in palliative care and has access to a
palliative care-trained interdisciplinary team comprising nurse practitioners, pharmacists,
psychologists, chaplains, social workers, therapists, and volunteers (Nelson et al., 2010; Wiencek
& Coyne, 2014). The goal is to provide support to the referring physician to address the needs of
patients and their families through recommendations relating to pain and symptom management,
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goals of care, and coordination of care, while the referring physician typically holds the primary
responsibility for the patient (Meier & McCormick, 2015). The AHA Annual Survey of
Hospitals defines inpatient palliative care consultation services (also referred to as palliative care
programs) as “an organized program providing specialized medical care, drugs, or therapies for
the management of acute or chronic pain and/or the control of symptoms administered by
specially trained physicians and other clinicians; and supportive care services, such as counseling
on advanced [sic] directives, spiritual care, and social services, to patients with advanced disease
and their families.”
Inpatient palliative care units.
Inpatient palliative care units are designated units or clusters of beds where specialized
medical care with an emphasis on comfort, symptom control, and quality of life is provided.
Such units distinguish themselves by centralized palliative care expertise, a family-patientfocused setting, and expert care and support for patients at the end of life and their families
(Wiencek & Coyne, 2014). Inpatient palliative care units typically care for patients who have
complex symptoms, are imminently dying, and/or cannot be treated in other hospital settings in
an optimal manner. These units serve not only these patients but also their family members. The
referring physician may transfer the patient’s primary care responsibility to the unit’s palliative
care clinicians or keep it after the patient’s transfer to the unit (Meier & McCormick, 2015).
Inpatient palliative care units may provide both curative treatment and palliative care, although
the focus is primarily on comfort care. The AHA Annual Survey of Hospitals defines palliative
care inpatient units as “a physically discreet, inpatient nursing unit where the focus is palliative
care. The patient care focus is on symptom relief for complex patients who may be continuing to
undergo curative treatment. Care is provided by palliative medicine specialists.”
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Hospice programs.
Another form of specialty palliative care includes hospice units and programs, designed
to care for patients with terminal illnesses and a life expectancy of six months or less who chose
to forgo life-prolonging treatments. The AHA Survey of Hospitals does not distinguish between
designated hospice units and hospice consultation services. Instead, it describes hospice
programs as “a recognized clinical program with specific eligibility criteria that provides
palliative medical care focused on relief of pain and symptom control and other services that
address the emotional, social, financial, and spiritual needs of terminally ill patients and their
families.”
Diffusion of Palliative Care Delivery Models
Figure 3 demonstrates the diffusion of palliative care services based on inpatient
palliative care consultation services (PAL), inpatient palliative care units (IPAL), hospice
programs (HOSPC) and NONE (i.e., no PAL, IPAL, or HOSPC present) for urban, non-federal,
short-term, and acute care hospitals nationwide and across the study sample for the time period
2007-2011. Note that the study sample includes hospitals located in Arizona, California, Florida,
Maryland, New Jersey, and New York, which were in operation throughout the study period and
had complete information for the study’s key and control variables (n=348). The national sample
consisted of all hospitals present in the 2007-2011 AHA Annual Hospital Survey data (n=1,687).
According to Figure 3, the national sample suggests an increase of palliative care in hospitals
nationwide, with 54.2% of hospitals having at least one of the three palliative care services in
place in 2007 compared to 57.9% of hospitals in 2011. Additionally, while the prevalence of
PAL and IPAL rose between 2007 and 2011, the presence of HOSPC decreased over the study
period.
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Figure 3. Comparison of Hospital-based Palliative Care in National and Study Sample
Note. Categories do not add up to 100% as hospitals may have multiple palliative care services in place.
IPAL=Inpatient palliative care units. HOSPC=Hospice programs. NONE= no PAL, IPAL, or HOSPC present.
PAL=Inpatient palliative care consultation services.

This development suggests a gradual shift away from HOSPC toward IPAL and PAL.
This development may be in part explained by the similarities between these services and by the
fact that IPAL may provide services to a broader patient population, including hospice patients.
Although similar patterns are present among the hospitals in the study sample, several
differences are noteworthy. First, hospitals with PAL in the study sample are more prevalent
throughout the study period compared to the national sample. While 52.3% and 61.8% of
hospitals in the study sample had a PAL in place in 2007 and 2011 respectively, 44.7% and
51.9% of hospitals nationwide had this service in place, respectively. The prevalence of hospitals
with IPAL is also higher in the study sample throughout the study period compared to the
prevalence of this service in hospitals nationwide. Among hospitals in the study sample, 15.8%
and 19% had an IPAL in place in 2007 and 2011, respectively. Among hospitals nationwide,
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only 12.7% and 14.6% of hospitals had this service in place in 2007 and 2011, respectively. It
follows that the study sample has fewer hospitals without any palliative care services (i.e.,
NONE) compared to the national sample throughout the study period. In other words, the study
sample over-represents hospitals with palliative care services. The study’s sample selection
approach is described in more detail in Chapter 4.
Relevance of Key Variables
Palliative care services have expanded because of the perceived need for these types of
services and empirical evidence that they are linked to hospital performance. This study focuses
on determining the benefits to hospitals and patients, including lower hospital costs, shorter
hospital stays, lower in-hospital mortality, and higher rates of hospice transfers.
From a hospital perspective, providing a service-mix that optimizes both economic
viability and quality of care is an important management strategy. Specifically, hospital costs and
hospital length of stay are considered key economic indicators of hospital performance. Whereas
lower hospital costs may increase hospitals’ profit margins, shorter lengths of stay can facilitate
patient turnover and care efficiency. From a patient perspective, lower in-hospital mortality and
higher rates of hospice transfers may be viewed as positive outcomes, as most patients prefer to
die at home or at least outside of the hospital setting.
The following paragraphs discuss in more detail the relevance of hospital costs, hospital
length of stay, in-hospital mortality, and transfer to hospice in the context of hospital
performance.
Dependent variable hospital cost.
In 2010, 5% of Medicare beneficiaries generated 39% of Medicare spending. These
“costly” beneficiaries include patients with multiple chronic conditions, who utilize inpatient
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hospital services, and who are at the end of life. Palliative care programs, particularly those that
are based in hospitals, target this patient population and are thus uniquely qualified to reduce
health care spending due to over- or misuse of health care services and inefficient care
coordination. Prior research has shown that palliative care programs can prevent health care costs
associated with expensive and preventable hospital services, such as hospital readmissions,
prolonged ICU stays, emergency department visits, and futile use of hospital resources (Meier,
2011). In particular, May et al. (2014) systematically reviewed empirical evidence regarding the
financial impact of hospital-based palliative care and identified consistent savings in hospital
costs, ranging from 9% to 25%. Morrison et al. (2011) examined the effect of palliative care
consultations on hospital costs among Medicaid enrollees and found that patients who received a
palliative care consultation incurred, on average, $6,900 less in hospital costs, spent less time in
the ICU, were less likely to die in the ICU, and were more likely to receive hospice referrals than
patients who received usual care.
Dependent variable length of stay.
Hospital length of stay (LOS) typically describes the number of days a patient was
hospitalized in an inpatient facility. Inpatient days are calculated by subtracting the day of
admission from the day of discharge. In health services research, hospital LOS is a widely used
indicator of hospital performance. While many factors influence LOS in the hospital (Gruenberg
et al., 2006), hospital LOS also provides insight into a hospital’s use of resources, and thus may
function as a proxy for efficiency concerning costs, capacity, and quality of care (Kroch, Duan,
Silow-Carroll, & Meyer, 2007).
Hospital LOS is a main determinant of hospital costs; that is, cost efficiency is often
equated with shorter hospital LOS, holding patient diagnosis and primary treatments constant.
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Medicare’s inpatient prospective payment system (IPPS), implemented in 1984, and many
commercial insurers have mechanisms in place to incentivize shorter hospital LOS (Cassel, Kerr,
Pantilat, & Smith, 2010b). Specifically, under Medicare’s IPPS, hospitals receive a fixed
payment per patient admission (Feder, Hadley, & Zuckerman, 1987). For each patient admission
within a given diagnosis-related group (DRG), the hospital payment is based on a historicallydetermined average of hospital costs of all patients within that particular DRG (Averill et al.,
2009). While hospitals typically expect to remain in close proximity to the average costs across
all patients within a given DRG, mechanisms to improve cost efficiency (i.e., to reduce hospital
LOS) without compromising quality of care are generally in the best interest of a hospital’s
financial performance.
Minimizing hospital LOS is also viewed as a central approach to improve a hospital’s
capacity management and patient flow. Hospitals operating at or close to maximum capacity are
likely to consider hospital LOS as an essential tool to avoid patient diversion to other hospitals
(Bazzoli, Brewster, Liu, & Kuo, 2003; Cassel et al., 2010b). If a hospital deviates from its
optimal capacity due to changes in demand, it is likely to adjust its supply of services to maintain
economic viability (Bazzoli et al., 2006). A hospital may also consider changing its management
of patient flow by streamlining the care continuum from admission to discharge of a patient.
Prior research has also linked quality of care with hospital LOS. However, the
relationship between hospital LOS and quality of care is complex. It is influenced by a variety of
factors, including factors related to “organisational culture and hospital bed availability, through
availability of ‘step down’ or intermediate care services, to the customs and cultures of the local
populace” (Clarke, 2002, p. 209). In addition, the various dimensions of quality of care
complicate a simple relational depiction. A widely used measure to capture quality of care in the
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hospital setting is hospital readmission rates. Hospital readmissions may happen due to
insufficient planning of discharge, severe illness progression, or inadequate allocation of followup care (Jencks, Williams, & Coleman, 2009). Despite inconclusive findings on the relationship
between hospital LOS and hospital readmissions, strategies have been employed to reduce
hospital readmission rates and hospital LOS simultaneously. Accordingly, hospital-based
palliative care may be a means to avoid unplanned hospital readmissions and reduce hospital
LOS by offering a systematic approach to determine patient-centered goals of care based on
diagnosis, prognosis, available treatments, and patient preferences and to facilitate efficient
patient flow and timely transitions to the most appropriate care settings (Fine, 2004).
Dependent variable in-hospital mortality.
Hospital mortality rates have been a widely used indicator of quality of care and patient
safety among hospitals in the United States. For a given hospital, the hospital mortality rate is
typically defined as the proportion of patients who die during hospitalization (i.e., in-hospital
mortality) or shortly after hospital discharge (i.e., 30-day mortality) (Borzecki, Christiansen,
Chew, Loveland, & Rosen, 2010). These types of hospital mortality rates may be reported for the
entire patient population (i.e., all-cause hospital mortality) or for patients with specific medical
conditions (i.e., condition-specific hospital mortality). If variation in hospital mortality is due to
variation in hospitals’ structural or procedural environments, lower hospital mortality rates may
indicate higher quality of care (Goodacre, Campbell, & Carter, 2015). More precisely, it may
provide evidence of clinical advances in diagnosing and treating patients, changes in discharge
patterns, and which structural or procedural characteristics of care can circumvent or minimize
preventable patient deaths (Kroch et al., 2007; Tourangeau, Cranley, & Jeffs, 2006). However,
variation in hospital mortality is also driven by variation in patient population; that is, higher
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mortality rates may be associated with a higher proportion of more complex or sicker patients for
a given hospital (Goodacre et al., 2015). Risk-adjustment also needs to take into account how
diagnoses and comorbidities are coded and how hospital readmissions are handled (Goodacre et
al., 2015; Nicholl, 2007). Given appropriate and sufficient risk-adjustment, variation in hospital
mortality rates are assumed to be attributable to suboptimal care (Girling et al., 2012).
A variety of national quality improvement efforts have focused on hospital mortality
rates, including public reporting and pay-for-performance (P4P) efforts. For example, the
Centers for Medicare and Medicaid Services (CMS) and the Hospital Quality Alliance (HQA)
started publicly reporting 30-day risk-standardized mortality rates for three common medical
conditions, namely for acute myocardial infarction and congestive heart failure in 2007 and for
pneumonia in 2008 (Centers for Medicare and Medicaid Services, 2015c). Nonetheless, the
practicality of mortality rates to reflect quality of care has been a matter of debate. Cassel et al.
(2010a) challenge the use of hospital mortality as a quality of care measure, as it equates patient
deaths with medical failure. Patient-specific factors, such as goals of care, are important
confounders of mortality for patients with serious chronic illnesses or at the end of life (Cassel et
al., 2010a). Hence, if death is inevitable and focus on comfort care is part of the patient’s
treatment plan, patient death is an unpreventable and expected outcome for that patient. While
hospitals with a greater proportion of such patients may experience higher risk-adjusted mortality
rates, they may not necessarily provide inferior quality of care. The use of risk-adjusted mortality
rates as a quality measure is based on the assumption that this measure includes a sufficiently
large proportion of preventable deaths to explain variation in risk-adjusted hospital mortality
(Goodacre et al., 2015). Yet recent studies have found weak associations between risk-adjusted
hospital mortality rates and preventable mortality rates, deeming risk-adjusted hospital mortality
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rates poor indicators of quality of care (Girling et al., 2012; Hogan et al., 2015). Hogan et al.
(2015) suggest that instead of relying on risk-adjusted mortality rates to assess a hospital’s
quality of care, “reviews of individual deaths should focus on identifying ways of improving the
quality of care, whereas the use of standardized mortality ratios should be restricted to assessing
the quality of care for conditions with high case fatality for which good quality clinical data
exist.” (p. 1) That is, risk-adjusted mortality measures may not be suitable for hospitals with a
large proportion of patients with serious, chronic, and terminal illnesses – patients who would
greatly benefit from palliative care.
Despite arguable evidence, it is unlikely that mortality rates will vanish from outcomesrelated quality domains (Cassel et al., 2010a; Reed, 2010). Cassel et al. (2010a) discusses several
approaches to adjust for palliative care-specific circumstances, such as mandating hospitals to
publish all diagnoses assigned to a patient. That is, palliative care involvement is typically listed
low among secondary diagnoses and, depending on the amount of secondary diagnoses, may not
appear at all. Finally, the authors propose to limit mortality analyses to patients undergoing highrisk procedures and patients with acute illnesses. If information on goals of care is not available
or not considered, a focus on acute illnesses and high-risk procedures may be an appropriate way
to recognize differences in hospital’s patient population and corresponding quality of care. While
this approach may support the notion that patients with non-acute illnesses (e.g., cancer) are
expected to die and patients with acute illnesses (e.g., pneumonia) are expected to live
(Holloway & Quill, 2007), objective comparison of mortality rates across hospitals are only fair
if differences in goals of care are sufficiently recognized.
In summary, the controversial application of hospital mortality to measure quality of care
emphasizes two important issues to consider when using mortality rates in such context. First, it
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is crucial to control for all relevant patient-level factors influencing mortality, including goals of
care (if available). This does not necessarily mean excluding all patients who receive palliative
care. While end-of-life or hospice care focuses on patients with a terminal illness, palliative care
is appropriate for all patients with a serious illness, regardless of acuity level. Nevertheless,
certain patient populations are more likely to have palliative care needs (e.g., cancer patients,
older patients) than others, which emphasizes the need to control for such confounding factors.
Second, attending to structure and process of care measures when analyzing a hospital’s quality
of care is essential. Besides difficulties in discriminating between hospitals based on hospital
mortality rate alone, the level of mortality rates does not suggest any practical improvement
activities (Shih & Schoenbaum, 2007). Hence, hospitals with palliative care services in place
may indicate a commitment to high-quality care with the patient’s well-being at its core. In
addition, palliative care services with appropriate structural and procedural formats are designed
to facilitate patient-centered care planning by determining a patient’s preference concerning lifeprolonging treatment and palliative care, including developing appropriate discharge planning
plans, supporting efficiency of care, and avoiding unnecessary hospital readmissions.
Dependent variable transfer to hospice.
The facilitation of hospice transfers may have positive associations with both patient and
organizational outcomes. Specifically, for patients at the end of life, a transfer to hospice care
may be a more appropriate and desirable alternative to prolonged hospitalization or in-hospital
death. Place of death has been proposed as a quality indicator for end-of-life care based on the
concept and empirical evidence that most patients prefer to die at home or at least outside of the
hospital setting (Bell, Somogyi-Zalud, & Masaki, 2009; Higginson & Sen-Gupta, 2000). In 2013,
the majority of patients who received hospice care (66.6%) died in their place of residence (i.e..,
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private residence, nursing home, and residential facility). The remaining hospice patients died in
hospice inpatient facilities (26.4%), and acute care hospitals (7%) (National Hospice and
Palliative Care Organization, 2014). Thus, patient preferences to die at home may be realized
under hospice care for most patients at the end of life.
Moreover, discharge management, including the facilitation of hospice transfers, may
also influence hospital utilization at the end of life with noteworthy implications for quality of
care, resource utilization, and health care spending. In particular, there is evidence that hospice
enrollment at the end of life among nursing home residents is linked to better pain management,
fewer physical restriction, and improved family satisfaction compared to nursing home residents
without hospice enrollment (Mukamel et al., 2012). In addition, inpatient care, particularly in the
critical care setting, is costly, often perceived as futile, and does not align with all patient and
family preferences at the end of life (Barrett, Smith, Elixhauser, Honigman, & Pines, 2014;
Huynh et al., 2013; Stricker, Rothen, & Takala, 2003). Still, one in three patients aged 65 and
older dies in the hospital, despite a steady decline in hospital inpatient deaths between 1989 and
2007 (Health, 2011). Teno et al. (2013) examined changes in sites of death, places of care, and
health care transitions for Medicare decedents in 2000, 2005, and 2009. The researchers found
that, while more Medicare patients died at home in 2009 compared to 2005, roughly 10% more
patients were admitted to the hospital in the last 90 days prior to death (69.3%) and about 20%
more patients were admitted to the ICU in the last 30 days (29.2%) during this period.
In summary, strategies to facilitate care transitions to other health care settings, such as
home hospice services or hospice medical facilities, promise to improve both organizational and
patient outcomes. Hospital-based palliative care may provide a unique opportunity for hospitals
to determine optimal patient-centered tools to assist care transitions, which align with a patient’s
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goals of care, optimize resource use, and reduce unnecessary health care spending by minimizing
ineffective treatment strategies.
Hospital Adoption of Palliative Care
Existing studies exploring the adoption of hospital-based palliative care services usually
focused on describing organizational and environmental factors that may be related to the
adoption of such services. A summary of their findings is provided in Table 3.
Nine studies, published between 2001 and 2015, examined the relationship between
market or hospital characteristics and the adoption of hospital-based palliative care services. The
studies vary by focus, empirical approach, and sample selection, definition of palliative care
services, theory application, and data structure.
The majority of studies (n=6) focused on hospital-based inpatient palliative care
consultation services. One study examined organizational and market factors associated with
hospital-based hospice programs (Harrison et al. 2005). Pan et al. (2001) focused on the two
palliative care-related services that were introduced into the AHA Survey of Hospitals in 1998,
namely hospital-based end-of-life services and pain management. White, Cochran, and Patel
(2002) created an end-of-life care index, ranging from 0 to 3 representing the presence of no to
all of three palliative care services, including end-of-life, hospice, or pain management services.
The authors examined the association between hospital and market characteristics on the number
of palliative care services provided by the hospital, hospital system, network, or joint venture.
In addition, most studies used cross-sectional hospital samples consisting of U.S. nonfederal acute care hospitals. Billings and Pantilat (2001) limited their study sample to a 100
randomly selected academic U.S. hospitals in operation in 1999. Morrison, Maroney-Galin,
Kralovec, and Meier (2005) studied the growth of hospital-based inpatient palliative care
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Table 3
Summary of Palliative Care Adoption Studies
Table 3 (continued)
Study
Study Sample
Research Method
Dumanovsky et al. 2293 hospitals Descriptive
(2015)
for 2013
Statistics,
multivariate logistic
United States
regression
3

DV(s)
Binary variable:
Presence of PAL
(hospital-based,
provided by health
system/network/joi
nt venture)
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Morrison
et al. (2011)

2,489 hospitals Descriptive
for 2009
Statistics

United States

Goldsmith
et al. (2008)
United States

2,452 hospitals Descriptive
for 2006
Statistics
Multivariate
logistic regression

Binary variable:
Presence of PAL
(hospital-based,
provided by health
system/network/joi
nt venture)
Binary variable:
Presence of PAL
(hospital-based, or
provided by health
system, network, or
joint venture)

Key Findings
Hospitals with more beds are more likely to provide
PC; public, Catholic Church-operated, and not-forprofit hospitals are more likely to provide PC than
for-profit hospitals; SCP hospitals are less likely to
provide PC;
Hospitals with ACGME accreditation, ACS-approved
cancer program, hospice affiliation, and AAMC
membership are more likely to provide PC; hospitals
with higher mean % in county graduating from 4-year
college are more likely to provide PC; hospitals
located in the East South Central and West South
Central are less likely to provide PC than hospitals
located in the Mid-Atlantic; hospitals located in the
Pacific region are more likely to provide PC than
hospitals located in the Mid-Atlantic region.
No statistical analysis employed/reported.

For-profit and public hospitals are less likely to
provide PC than not-for-profit hospitals;
SCP hospitals, hospitals with hospice affiliation and
ACS-approved cancer program are more likely to
provide PC; hospitals located in counties with higher
% of bachelor’s degree are more likely to provide PC;
Hospitals located in the Midwest and West are more
likely to provide PC than hospitals located in the
Northeast.

Table 3 (continued)
Study
Harrison
et al. (2005)
United States

Morrison
et al. (2005)
United States

Study Sample
Research Method
4,032 hospitals Descriptive
for 2001
Statistics
Correlation
Analysis
Multivariate
logistic regression

4,156 hospitals
for 2000;
4,064 for 2001
4,163 for 2002
4,226 for 2003

Descriptive
Statistics (20002003)
Multivariate
logistic regression
(using 2003 data)
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Stover
(2005)
United States

4,616 hospitals Descriptive
for 2000
Statistics
Correlation
Analysis
Multivariate
Logistic regression

DV(s)
Binary variable:
Presence of
hospital-based
HOSPC

Key Findings
Hospitals with more services and operating
expense per patient discharge are more likely to
offer HOSPC; hospitals located in counties with
higher per capita income and percentage of
residents 65 and older are more likely to offer
HOSPC; hospitals located in counties with higher
unemployment rate and HMO penetration are
less likely to offer HOSPC.
Binary variable:
Hospitals with more beds, critical care beds are
Presence of
more likely to provide PC; public, for-profit, and
hospital-based PAL federal/non-VA hospitals are less likely to
provide PC than not-for-profit hospitals; VA
hospitals are more likely to provide PC than notfor-profit hospitals; hospitals with ACS-approved
cancer program, AAMC membership, and
hospice affiliation are more likely to provide PC;
hospitals located in the census regions Middle
Atlantic, South Atlantic, East North Central,
West North Central, West South Central, and
Pacific are less likely to provide PC than
hospitals located in census region New England.
Binary variable:
Hospitals with ACS-approved cancer program,
Presence of
health system/network membership, more beds,
hospital-based PAL higher percentage of Medicare patients, and
COTH membership are more likely to provide
PC; for-profit hospitals are less likely to provide
PC than not-for-profit hospitals; catholic
hospitals are more likely to provide PC than notfor-profit hospitals.

Table 3 (continued)
Study
White
et al. (2002)

Study Sample
Research Method
3,939 hospitals Descriptive
for 1998
Statistics

United States
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Billings & Pantilat 100 hospitals
(2001)
for 1999

Descriptive
Statistics

United States
Pan
et al. (2001)
United States

1,120 hospitals Descriptive
for 1998/1999 Statistics
T-Tests

DV(s)
EOL care index
ranging between 0
and 3 based on
presence of EOL
services, PM,
and/or hospice
services (hospitalbased, or provided
by health system,
network, or joint
venture); 0=no
service present,1=1
service present,
2=2 services
present; 3=3
services present
Binary variable:
Presence of
hospital-based
PAL, IPAL,
HOSPC, and PM
Binary variable:
Presence of
hospital-based
EOL services and
PM

Key Findings
Catholic hospitals provide more EOL services than
hospitals with other ownerships; hospitals with more
beds offer more EOL services; hospitals located in
the census regions South Atlantic, East South Central,
West South Central, and Pacific provide fewer EOL
services than hospitals located in New England.

No statistical analysis employed/reported.

The average hospital with PC had more beds, critical
care beds, admissions, Medicare discharges, but less
full-time residents.

Note. AAMC=American Association of Medical Colleges. ACGME=Accreditation Council of Graduate Medical Education. ACS=American College of
Surgeons. COTH=Council of Teaching Hospitals. DV=Dependent variable. EOL=End-of-life. HMO=Health maintenance organization. HOSPC=Hospice
program. IPAL=Inpatient palliative care unit. PAL=Inpatient palliative care consultation service. PC=Palliative care. PM=Pain management. SCP=Sole
community provider. VA=Veterans Affairs.

consultation services in federal and non-federal acute care U.S. hospitals between 2000 and
2003. Pan et al. (2001) included all U.S. hospitals in their study sample. Three studies focused on
the associations between hospital-based palliative care provision and hospital characteristics
(Billings & Pantilat, 2001; Morrison et al. 2005; Pan et al., 2001), while the remaining six
studies examined the impact of hospital and market characteristics on hospital-based palliative
care provision. “Markets” in these cases were typically defined as counties within a given state.
Most studies (n=6) employed multivariate logistic regressions models, while the
remaining three studies reported descriptive statistics only (Billings et al., 2001; Morrison et al.,
2005; Pan et al., 2001). However, only one study acknowledged and accounted for
heteroscedasticity bias at the county-level by clustering standard errors by county (Stover, 2005).
Additionally, one study Morrison et al. (2011) reported the variation in the number of boardcertified palliative care physicians by Medicare deaths in a given state to indicate a lack of access
to palliative care. Most studies (n=6) also included controls for nine census regions (i.e., MidAtlantic, New England, South Atlantic, East-North Central, East-South Central, West-North
Central, West-South Central, Mountain, and Pacific) in their descriptive statistics or multivariate
logistic regression models to control for regional variation in palliative care provision.
The primary datasets used in the studies were the Area Health Resources Files (AHRF) to
collect market characteristics and the AHA Annual Survey of Hospitals to identify hospitals with
or without palliative care services and gather additional hospital characteristics, such as bed size,
ownership type, and teaching status. Billings et al. (2001)’s study was the only study that
randomly selected and surveyed hospitals in the Council of Teaching Hospitals (COTH)
directory to collect such information. This is likely due to the fact that the AHA Annual Survey
of Hospitals first inquired about hospital-based palliative care services in 2000 (Stover, 2005).
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One of the nine studies applied organizational theories to derive specific research
questions and hypotheses (Stover, 2005). The remaining eight studies focused largely on
providing a general overview of the prevalence of hospital-based palliative care services and
describing the organizational and environmental differences between hospitals with and without
palliative care services rather than using a theoretical or conceptual framework to explain why
such differences exist. Five of the nine studies belong to a series of reports published in five-year
intervals to give an account on the state of hospital-based palliative care programs in non-federal
acute care hospitals in the United States (Dumanovsky et al., 2015; Morrison et al., 2011;
Goldsmith, Dietrich, Du, & Morrison, 2008; Morrison et al., 2005; Pan et al., 2001). Several of
the nine studies found significant relationships between hospital-based palliative care services
and hospital or environmental characteristics. Hospital characteristics, including teaching status,
hospital size, hospice affiliation, and not-for-profit ownership had a positive association with the
probability of hospital provision of palliative care services. Environmental characteristics,
including educational level in a county and census region, were typically good predictors of
hospital-based palliative care services.
Hospital Performance Effects of Palliative Care
Fifty-six studies evaluating the effect of hospital-based palliative care on the study’s four
dependent variables, published between 1988 and 2015, have been reviewed in this study. A
summary of the empirical findings is presented in Table 4.
Note that several published reviews have previously summarized the empirical evidence
on the association between palliative care services and this study’s dependent variables.
Specifically, ten reviews synthesized empirical findings regarding the relationship between
palliative care services and hospital and ICU costs (Higginson et al., 2002; Douglas et al., 2003;
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Table 4
Summary of Outcome Evaluation Studies
Table 4 (continued)
4

Study
Ahrens
et al. (2003)

PC Type
Type:
PAL
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Type:
IPAL

United States
Andereck
et al. (2014)

Type:
PAL

France

Setting: IPAL
Sample:
209 PC
55 UC
Setting: ICU

Research
Design/Method
Single-center,
Non-RCT,
prospective, cohort
study

Relevant
Outcomes
Hospital
charges;
ICU LOS;
Hospital
LOS;
In-hospital
mortality

Single-center,
Observational

Hospital costs

Single-center,
RCT

Hospital
costs;
Hospital
LOS;
ICU LOS;

Multi-center,
Cluster RCT,
prospective
blinded

ICU LOS;
ICU mortality

Sample:
240 PC
238 UC

United States

Azoulay et al.
(2002)

Setting: ICU
Sample:
43 PC
108 UC

United States

Albanese
et al. (2013)

Setting/Sample

Type:
Integration

Setting: ICU
Sample:
87 PC
88 UC

Key Findings
Lower (~35%) mean hospital variable direct
charge per patient (p = .01), lower (~37%)
hospital variable indirect charges per patient
(p = .007), lower (~37%) fixed charges per
patient (p = .006) for PC than UC;
Lower (~31%) hospital LOS (p = .03),
lower (~36%) ICU LOS (p = .09) for PC
than UC; in-hospital mortality not
statistically different.
Lower (~69%) mean daily direct costs for
IPAL who died in IPAL than UC (p not
reported).

Live discharges:
ICU LOS, hospital LOS, and mean hospital
costs not statistically different.
Decedents:
ICU LOS, hospital LOS, and mean hospital
costs not statistically different.
ICU LOS and ICU mortality not statistically
different.

Table 4 (continued)
Study
Back
et al. (2005)

PC Type
Type:
PAL

United States
Bakitas
et al. (2009)

Type:
PAL
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Type:
PAL

United States
Binney
et al. (2014)
United States

Setting: Mixed
Sample:
82 PC
183 UC
Setting: Mixed

Research
Design/Method
Single-center,
Observational

Relevant
Outcomes
Hospital
LOS;
In-hospital
mortality

Single-center,
RCT

Hospital
LOS;
ICU LOS;
Hospice
transfer;
In-hospital
mortality
Hospital
charges;
Hospital LOS

Mean hospital LOS, ICU LOS, referrals to
hospice, and survival not statistically
different between PC and UC patients.

Hospital
costs;
Hospital
LOS;
ICU LOS;

Mean LOS in HOSPC of 3.5 days translates
into 585 ICU days avoided and $1,384,110
saved (2011 currency);
Lower mean hospital LOS for HOSPC
(10.3 days) than ICU patients (13.6 days)
(p < .05), higher mean ICU LOS for
HOSPC (9.8 days) than ICU patients
(7.2 days) (p < .05).

Sample:
161 PC
161 UC

United States

Bendaly
et al. (2008)

Setting/Sample

Type:
HOSPC

Setting: Mixed
Sample:
61 PC
55 UC
Setting:
Hospice
Sample:
167 PC (died)
99 UC (died)

Single-center,
Observational

Multi-center,
Observational

Key Findings
Lower (~24%) mean hospital LOS for PC
than UC (p < .05);
Fewer PC patients (21%) died in acute care
setting than UC patients (64%) (p < .05).

Lower (~16%) median total charges for PC
than UC (p = .001);
Mean hospital LOS not significantly
different.

Table 4 (continued)
Study
Campbell
et al. (2003)

PC Type
Type:
PAL
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Type:
PAL

United States
Carlson
et al. (1988)
United States

Setting: ICU
Sample:
Multi-organ
system failure
(MOSF):
21 PC
22 UC

United States

Campbell
et al. (2004)

Setting/Sample

Type:
PAL

Global cerebral
ischemia
(GCI):
20 PC
18 UC
Setting: ICU
Sample:
26 PC
26 UC
Setting: ICU
Sample:
93 patients

Research
Design/Method
Single-center
Observational,
historical controls

Relevant
Outcomes
Hospital
costs;
Hospital
LOS;
ICU LOS

Single-center,
Observational,
historical controls

Hospital
LOS;
ICU LOS;
In-hospital
mortality
Hospital
charges;
Hospital
LOS;
ICU LOS;
In-hospital
mortality;

Single-center,
Observational,
pre-post

Key Findings
MOSF patients:
Higher (~113%) mean daily cost savings
after DNR order for PC patients than UC if
CMO elected (p < .05);
Lower (~27%) mean hospital LOS for PC
patients than UC, mean ICU LOS not
statistically different.
GCI patients:
Difference in mean daily cost savings after
DNR order not statistically different;
Lower (~45%) mean hospital LOS (p <
.001) and lower (~48%) ICU LOS (p < .01)
for PC patients than UC.
Lower (~39%) mean hospital LOS
(p < .007), lower (~49%) mean ICU LOS
(p < .004) for PC than UC;
Mean in-hospital mortality not statistically
different.
Lower (~31-64%) mean hospital charges for
PC than UC (p < .05); lower (~33-70%)
mean hospital LOS for PC than UC (p <
.05);
ICU LOS and in-hospital mortality not
statistically different.

Table 4 (continued)
Study
Cassel
et al. (2010c)

PC Type
Type:
PAL

United States

Cheung
et al. (2010)

Type:
PAL

United States
Ciemins
et al. (2007)

Type:
PAL
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United States
Cowan
(2004)

Type:
PAL

United States

Curtis
et al. (2008)
United States

Type:
Integration

Relevant
Outcomes
Setting: Mixed
Hospital
charges;
Sample:
Hospice
91 PC patients
transfers;
20 PC patients
In-hospital
mortality
Setting: ICU
Single-center, RCT Hospital
LOS;
Sample:
ICU LOS;
10 PC patients
In-hospital
10 UC patients
mortality
Setting: Mixed Single-center,
Hospital
observational,
costs;
Sample:
interrupted timeHospital LOS
27 PC patients
series, matched
128 UC patients cohort design
Setting: Mixed Single-center,
Hospital
observational,
charges;
Sample:164 PC cohort study
patients 152 UC
patients
Setting/Sample

Setting: ICU
Sample:
337 PC patient
(post-PAL)
253 UC patients
(pre-PAL)

Research
Design/Method
Single-center
Observational,
before-and-after
study

Single-center,
observational, prepost study

Hospital
LOS;
ICU LOS;

Key Findings
Lower (~25%) mean hospital charges for
PC than UC (p not reported);
More transfers to hospice for PC than UC (p
not reported);
No increase in-hospital mortality (p not
reported).
Median hospital LOS, median ICU LOS,
hospital and ICU mortality not statistically
different.

Lower (~13%) mean daily costs for PC than
UC (p < .01); lower (~16%) mean costs per
admission for PC than UC (p < .00001);
Mean/Median hospital LOS not
significantly different.
Lower (~6%) mean daily charges for PC
than UC (p = .006);
PC reduces hospital LOS for patients with
hospital LOS ≥ 7 (0.55–3.55 days).

Lower (~19%) mean ICU LOS for PC
(post-PAL) than UC (pre-PAL) (p = .01),
lower (~20%) mean hospital ICU for PC
(post-PAL) than UC (pre-PAL) (p = .02).

Table 4 (continued)
Study
Curtis
et al. (2011)

PC Type
Type:
Integration

United States
Daly
et al. (2010)

Type:
Integration

United States
Davis
et al. (2005)

IPAL

Setting/Sample
Setting: ICU

Research
Design/Method
Multi-center, RCT

Sample:
669 PC patients
570 UC patients
Setting: ICU
Multi-center,
observational,
Sample:
pre-post study
354 PC patients
135 UC patients
N/A
Multi-center,
observational

Relevant
Outcomes
ICU LOS

Hospital
LOS;
ICU LOS;
In-hospital
mortality
Hospital
charges
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United States
Detering
et al. (2010)

Type:
PAL

Australia
Digwood
et al. (2011)
United States

Type:
IPAL

Setting: Mixed

Single-center, RCT In-hospital
mortality

Sample:
154 PC patients
155 UC patients
Setting: ICU
Single-center,
observational,
Sample:
pre-post
2,319 (preIPAL)
2,716 (postIPAL)

ICU LOS;
ICU
mortality;

Key Findings
ICU LOS not statistically different.

Mean hospital LOS, ICU LOS, hospital
mortality, and ICU mortality not statistically
different.

Higher (~9%) mean total charges in IPAL
than national mean charges (no p reported),
Lower (~33%) mean pharmacy and
laboratory charges in IPAL than national
mean charges (no p reported).
Lower ICU mortality for PC (0%) than UC
(15%) (p = .03); hospital mortality not
statistically different.

Lower mean ICU LOS after IPAL opening
(4 days) than before (4.6 days) (p = .014);
Lower (~24%) ICU mortality after IPAL
opening than prior to opening (p = .003).

Table 4 (continued)
Study
Dowdy
et al. (1998)

PC Type
Type:
PAL

Setting/Sample
Setting: Mixed

Type: IPAL Setting: IPAL
in cancer center

United States

Sample:
320 IPAL
patients
Type: IPAL Setting: IPAL
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Elsayem
et al. (2004)

Sample:
N/A

United States
Field et al.
(1989)
United States

Relevant
Outcomes
Hospital
charges;
ICU LOS
In-hospital
mortality

Single-center,
observational

Hospital
charges;
In-hospital
mortality;

Single-center,
observational,
longitudinal (19992004), IPAL
established in 1999
Single-center,
observational,
pre-post

In-hospital
mortality;
ICU mortality

In-hospital mortality remained constant over
time (p > .2);
ICU mortality decreased from 38% (1999)
to 28% (2004).

In-hospital
mortality;
Hospital
LOS;
ICU LOS;

In-hospital mortality and hospital LOS not
statistically different (no p reported);
Lower ICU LOS after intervention (6 days)
than before (12 days) (p < .01).

Sample:
31 PC patients
68 UC patients

United States

Elsayem
et al. (2006)

Research
Design/Method
Single-center, nonRCT

Type: PAL

Setting: ICU
Sample:
20 patients (pre
consult)
20 patients
(post-consult)

Key Findings
In-hospital mortality and hospital charges
not statistically different.
Live discharges:
Lower ICU LOS for PC than UC (p not
reported).
Decedents:
Lower (minus 13 days) ICU LOS for PC
than UC (no p reported).
In-hospital mortality between before and
after IPAL opening not different (no p
reported);
Lower (~38%) mean daily charges in IPAL
than in entire hospital (no p reported)

Table 4 (continued)
Study
Foreman
et al. (2015)

PC Type
Type:
PAL

Canada
Gade
et al. (2008)

Type:
PAL
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Type:
Integration

Canada

Hanson
et al. (2008)

Type: PAL

United States

Holloran et al. Type:
(1995)
Integration
United States

Setting: Mixed
Sample:
65 PC patients
35 UC patients
Setting: Mixed

Research
Design/Method
Single-center,
observational

Relevant
Outcomes
Hospital
costs;

Multi-center, RCT

Total health
care costs;
Hospital
LOS;
In-hospital
mortality;
Hospice
transfers
Hospital
LOS;
ICU LOS;

Sample:
275 PC patients
237 UC patients

United States

Hall et al.
(2004)

Setting/Sample

Setting: ICU
Sample:
138 patients
(pre PC)
168 patients
(post PC)
Setting: Mixed
Sample:
104 PC patients
1,813 UC
patients
Setting: ICU
Sample:
N/A

Single-center,
observational,
pre-post

Key Findings
Lower (~80%) medical-imaging costs
(p =.01), lower (~36%) laboratory costs
(p = .024), lower (~48%) total healthcare
costs (p = .001), and higher (~28%)
physician costs (p = .05) for PC than UC.
Lower (~31%) mean total healthcare costs
for PC than UC (p = .001);
Mean hospital LOS not statistically
significant;
Higher (~114%) in-hospital mortality for
PC than UC (p = .002);
Patients admitted to hospice not statistically
significant.
Reduced hospital LOS (16.4 to 10.5 days)
(p = .005)
ICU LOS not statistically different.

Single-center,
observational

Hospital
costs;
ICU mortality

Lower (~11%) daily variable costs for PC
than UC (p = .03); more (~20%) cost
savings if PC for more than 50% of hospital
LOS

Single-center,
observational,
pre-post

ICU LOS

Decreased LOS for SICU patients (p < .05).

Table 4 (continued)
Study
Hsu-Kim
et al. (2014)

PC Type
Type:
PAL

United States

Jung
et al. (2012)
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Type:
PAL

United States

Lautrette
et al. (2007)
France

Setting: ICU
Sample:
41 PC patients
80 UC patients

Type: IPAL Setting: IPAL

South Korea

Lamba
et al. (2012)

Setting/Sample

Type:
Integration

Research
Design/Method
Single-center,
observational

Single-center,
observational

Sample:
126 IPAL
patients
461 UC patients
Setting: ICU
Single-center,
observational, preSample:
post
Live discharges
58 Pre PC
73 Post PC
Decedents
21 Pre PC 31
(post PC)
Setting: ICU
Multi-center, RCT
Sample:
63 PC patients
63 UC patients

Relevant
Outcomes
Hospital
costs;
Hospital
LOS;
ICU LOS;
In-hospital
mortality
Hospital costs

Key Findings
Mean daily costs not statistically different;
Higher (~73%) hospital LOS, higher
(~100%) ICU LOS, and higher (~414%) inhospital mortality (p < .01) for PC than UC.

Lower (~27%) total medical costs for IPAL
than UC (p < .001); increasingly lower
(~33%) medical costs 1-2 months prior to
death for PC than UC (p = .001).

Hospital
LOS;
ICU LOS

Decedents:
Mean ICU LOS and mean hospital LOS
Not statistically different

Hospital
LOS;
ICU LOS

Mean hospital and ICU LOS not statistically
different.

Table 4 (continued)
Study

PC Type

Lilly
et al.
(2000,’03)

Type:
Integration
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Type:
HOSPC

Taiwan

Lustbader
et al. (2011)
United States

Setting: ICU
Sample:
396 Post PC
134 Pre PC
(2,361 PC
patients in 4year follow-up)

United States

Lo
et al. (2002)

Setting/Sample

Type: PAL

Setting: N/A
Sample:
912 hospice
patients
25,544 UC
patients
Setting: ICU
Sample:
Decedents
693 PC patients
515 UC patients

Research
Design/Method
Single-center,
observational,
pre-post

Relevant
Outcomes
ICU LOS;
ICU mortality

Observational
(based on
insurance claims
data)

Healthcare
costs

Single-center,
observational,
historical controls

Hospital
LOS;
ICU LOS;
ICU mortality

Key Findings
Lower median ICU LOS for PC (3 days)
than UC (4 days) (p =.01); ICU LOS
remains 3 days for PC patients in follow-up
period.
Decedents:
Lower median ICU LOS for PC patients
with highest risk of mortality (3 days) than
UC patients with highest risk of mortality (5
days) (p = .02);
Lower ICU mortality for PC (22.7%) than
UC (31.3%) (p = .01), lower ICU mortality
for PC in follow-up period (18%).
Lower total healthcare costs for PC than UC
patients (p = .01).

Shorter median hospital LOS for PC
(11 days) than UC (12 days) (p < .0106);
ICU LOS not statistically different;
Lower (~34%) ICU mortality for PC than
UC (p < .0005).

Table 4 (continued)
Study
Morrison
et al. (2008)

PC Type
Type: PAL

Setting/Sample
Setting: Mixed

Research
Design/Method
Multi-center,
observational

Relevant
Outcomes
Hospital costs

Multi-center,
observational

Hospital
costs;
ICU costs,
ICU LOS;
Hospice
transfer
ICU mortality

Sample:
Live discharges
2,630 PC patients
18,427 UC
patients

United States

Decedents:
2,278 PC patients
2,124 UC
patients
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Morrison
et al. (2011)
United States

Type: PAL

Setting: Mixed
Sample:
Live discharges:
290 PC patients
1,427 UC
patients
Decedents:
185 PC patients
149 UC patients

Key Findings
Live discharges:
Lower (~14%) total costs (p = .02), lower
(~19%) daily total costs (p < .001), lower
(~15%) direct costs per admission (p = .004),
lower (~21%) daily direct costs (p < .001),
lower (~35%) laboratory costs, lower (~73%)
ICU costs (p < .001) for PC than UC
Decedents:
Lower (~18%) total costs (p = .001), lower
(~22%) daily total costs (p < .001), lower
(~22%) direct costs per admission (p = .003),
lower (~45%) daily direct costs (p < .001),
lower (~34%) laboratory costs, lower (~27%)
pharmacy costs, lower (~45%) ICU costs
(p < .001) for PC than UC.
Live discharges:
Lower (~11%) mean total costs per admission
(p < .05), lower (~18%) mean daily costs
(p < .001), and lower ICU costs (p < .001) for
PC than UC;
More PC patients (30%) than UC patients (1%)
were discharged to hospice (p < .001);
Mean ICU LOS not statistically different.
Decedents:
Lower mean (~11%) total costs per admission (p
< .05), lower (~9%) mean daily costs (p < .01),
lower (~21%) mean pharmacy costs
(p < .05);
Mean ICU LOS shorter (~26%) for PC than UC
(p < .05);
Fewer PC patients (34%) than UC patients
(58%) died in the ICU (p < .05).

Table 4 (continued)
Study
Mosenthal et
al. (2008)

PC Type
Type:
Integration

United States

Norton
et al. (2007)

Type: PAL
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Type: PAL

United States

Sample:
Live discharges
244 Pre PC
321 Post PC
Decedents
42 Pre PC
46 Post PC
Setting: ICU

Setting: Mixed
Sample:
77 PC patients
(post PC)
77 UC patients
(pre PC)

United States

Penrod et al.
(2006)

Setting: ICU

Research
Design/Method
Single-center,
observational,
pre-post

Relevant
Outcomes
Hospital
LOS;
ICU LOS;
In-hospital
mortality

Single-center,
quasi-experimental

Hospital
LOS;
ICU LOS
In-hospital
mortality;

Single-center,
observational, prepost

Hospital
charges;
Hospital
LOS;

Multi-center,
observational

Hospital
costs;
Hospital
LOS;
ICU LOS

Sample:
126 PC patients
65 UC patients

United States
O’Mahony
et al. (2005)

Setting/Sample

Type:
Integration

Setting: Mixed
Sample:
82 PC patients
232 UC patients

Key Findings
Decedents:
Shorter mean ICU LOS for PC (6.1 days)
than UC (7.6 days) (no p reported), shorter
mean hospital LOS for PC (6.5 days) than
UC (14.4 days) (no p reported);
Lower in-hospital mortality for PC (14%)
than UC (15%) (no p reported).

Mean hospital LOS not statistically
different, lower (~45%) ICU LOS for PC
patients than UC patients (p = .0001);
Mean ICU mortality not statistically
different, PC patients who died in the ICU
had significantly shorter ICU LOS.
Lower median number of ventilator charges
for patients post PC (n=4) than patients
prior to PC (n=0) (p < .0001), lower (~63%)
median total ventilator charges
(p < .0001);
Lower median LOS for patients transferred
to hospice after PC (9 days) than prior to PC
(12 days) (p < .05).
Lower (~31%) daily direct costs for PC than
UC (p = .0001);
Mean hospital LOS not significantly
different between PC and UC (p = .44);
Mean ICU LOS shorter (~57%) for PC
patients than UC patients (p = .007).

Table 4 (continued)
Study
Penrod
et al. (2010)

PC Type

Setting/Sample

Type:
Integration

Setting: Mixed

Type:
Integration

Type: PAL

Type: PAL

Sample:
35 PC patients
35 UC patients
Setting: ICU
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United States
Schneiderman
et al. (2003)
United States

Setting: ICU
Sample:
678 expired
(pre PC)
823 expired
(post PC)
Setting: ICU

France

Schneiderman
et al. (2000)

Relevant
Outcomes
Hospital
costs;
Hospital
LOS;
ICU LOS;

Single-center,
observational,
pre-post

In-hospital
LOS;
ICU LOS

Single-center,
RCT,
Prospective

ICU LOS;
In-hospital
mortality

Multi-center, RCT,
Prospective

Hospital
LOS;
ICU LOS;
In-hospital
mortality

Sample:
606 PC patients
2,715 UC
patients

United States

Quenot
et al. (2011)

Research
Design/Method
Multi-center,
observational

Sample:
276 PC patients
270 UC patients

Key Findings
Lower daily direct hospital costs, nursing,
radiology, pharmacy, and laboratory costs
for PC than UC;
Mean hospital LOS higher (~79%) for PC
than UC; mean ICU LOS higher (~94%) for
PC than UC; PC less likely (~44%) to be
admitted to ICU than UC (no p reported).
Among patients who withheld or withdrew
life-prolonging therapy, fewer median ICU
days after intervention (7 days) than before
(13 days) (p < .05) until death in ICU, fewer
median hospital days after intervention (10
days) than before intervention (14 days)
until death in hospital (p < .05).
In-hospital mortality not statistically
different.
Decedents:
Lower (~68%) mean ICU LOS for ethics
patients than UC (p = .03).
In-hospital mortality not statistically
different.
Decedents:
Lower (~25%) mean hospital LOS for ethics
patients than UC (p = .01) and lower
(~18%) mean ICU LOS for PC than UC
(p = .03).

Table 4 (continued)
Study
Shelton
et al. (2010)
United States

Simoens
et al. (2010a)
Belgium
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Smith
et al. (2003)
United States

Stover (2005)
United States

PC Type
Type: PAL

Setting/Sample
Setting: ICU

Research
Design/Method
Single-center,
observational,
pre-post

Sample:
187 PC patients
(post PC)
190 UC patients
(pre PC)
Type: PAL Setting: Mixed Multi-center,
observational
Sample:
88 PC patients
53 UC patients
Type: IPAL Setting: IPAL
Single-center,
observational
Sample:
38 PC patients
(died in IPAL)
38 UC patients
(died in UC)
Type: PAL Setting: Mixed Multi-center,
observational
Sample:
555,521
patients

Relevant
Outcomes
Hospital
costs;
Hospital LOS

Key Findings
Mean costs and hospital LOS not
statistically different.

Hospital costs

Higher (~24%) mean daily costs for PC than
UC (p = .002); Lower (~17%) mean daily
costs for PC patients in ICU than UC
patients (p = .025).

Hospital
costs;
ICU LOS

Lower mean direct costs (p = .004) and
lower mean total costs (p = .0009) for PC
than UC;
ICU LOS not statistically different between
PC and UC.

Hospital
charges;
In-hospital
mortality

Hospitals with PAL do not have statistically
lower hospital charges or in-hospital
mortality.

Table 4 (continued)
Study
The
SUPPORT
Principal
investigators
(1995)
United States
Treece et al.
(2004)

PC Type

Setting/Sample

Type: PAL

Setting: Mixed

Type:
Integration

United States
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Weckmann
et al. (2013)
United States

White
et al. (2006)
United States

Type:
HOSPC

Sample:
2,652 PC
patients
2,152 UC
patients
Setting: ICU
Sample:
41 UC patients
(pre PC)
76 PC patients
(post PC)
Setting: Mixed

Research
Design/Method
Multi-center,
cluster RCT

Relevant
Outcomes
Hospital
charges;
In-hospital
mortality;
ICU mortality

Single-center,
observational,
Pre-post

Hospital
LOS;
ICU LOS

Single-center,
observational

Hospital
costs;
Hospital
LOS;

Single-center,
observational

Hospital costs

Sample:
7 hospice
patients
202 UC patients

Type: IPAL Setting: IPAL
Sample:
1,774 PC
patients (died in
IPAL)
520 UC patients
(died in UC)

Key Findings
For alive discharges, no difference in
resource use (in US$1993) (no p reported);
Lower median hospital charges for PC
($27,000) than UC ($33,000) (no p
reported);
Mean hospital and ICU mortality not
different (no p reported).
Median hospital LOS and median ICU LOS
not statistically different.

Decedents:
Lower hospital costs for HOSPC patients
than UC (p < .001);
Lower hospital LOS for HOSPC patients
than UC (p = .02);
Lower (~28%) costs for patients who
received PC consult than patients who did
not (p < .04).
Lower (~72%) mean direct costs for PC
patients than UC patients in the ICU (p not
reported), lower (~30%) mean direct costs
for PC patients than UC patients in other
settings (no p reported).

Table 4 (continued)
Study
Whitford
et al. (2014)
United States

PC Type

Setting/Sample

Type: PAL

Setting: Mixed
Sample:
Live discharges
1,177 PC
patients
3,531 UC
patients
Decedents
300 PC patients
900 UC patients

Research
Design/Method
Multi-center,
observational

Relevant
Outcomes
Hospital
costs;
Hospital
LOS;
Hospice
transfers

Key Findings
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More hospice transfers for PC (31%) than
UC (1%); hospital LOS not statistically
different.
Live discharges:
Lower (~5%) mean total hospital costs for
PC than UC (p < .05);
Higher procedure costs, evaluation and
management, image costs, and pharmacy
costs for PC than UC (no % or p reported).
Decedents:
Lower (~31%) mean total hospital costs
(p < .05); lower procedure, evaluation and
management, image, pharmacy costs for PC
than UC (no % or p reported).

Note. CMO=Comfort measures only. DNR=Do not resuscitate. GCI=Global cerebral ischemia. HOSPC=Hospice program. ICU=Intensive care unit.
IPAL=Inpatient palliative care unit. LOS=Length of stay. MOSF=Multi-organ system failure. N/A=Not available. PAL=Inpatient palliative care consultation
service. PC=Palliative care. RCT=Random controlled trial. SICU=Surgical intensive care unit. UC=Usual care.

Higginson et al., 2003; Zimmermann et al., 2008; Smith & Cassel, 2009; Higginson & Evans,
2010; Simoens et al., 2010b; El-Jawahri et al., 2011; Smith, Brick, O'Hara, & Normand, 2014;
May et al., 2014). Three reviews focused on synthesizing empirical evidence regarding the
association between palliative care services and hospital and/or ICU LOS (Cassel et al., 2010b;
Aslakson et al., 2014; Khandelwal et al., 2015).
Overall, most studies (n=32) evaluated inpatient palliative care consultation services, of
which approximately half (n=15) took place in ICUs. The remaining studies assessed the effects
of integrative models (i.e., primary palliative care) (n=13), inpatient palliative care units (n=8),
and hospice programs (n=3). The majority of integrative models embedded palliative care in the
ICU setting (n=11), while only two embedded palliative care in mixed hospital units (Penrod et
al., 2006; Penrod et al., 2010). Finally, the vast majority (n=46) were retrospective or prospective
observational cohort studies, ten studies applied a randomized controlled trial (RCT) design (e.g.,
Andereck et al., 2014; Bakitas et al., 2009).
Of 32 studies that evaluated hospital costs, charges or healthcare costs, most studies
(n=26) identified significantly fewer hospital costs, charges or healthcare costs for patients who
received palliative care compared to patients who did not. Six studies did not find any significant
differences between patients who received palliative care and patients who did not receive
palliative care (Andereck et al., 2014; Dowdy et al., 1998; Hsu-Kim et al., 2015; Shelton et al.,
2010; Stover, 2005; The SUPPORT Principal Investigators, 1995). Four studies reported mixed
findings regarding hospital costs (Foreman et al., 2015; Simoens et al., 2010a; Whitford et al.,
2014; Davis et al., 2005). More than a third of the studies (n=11) used hospital charges to
evaluate the economic impact of palliative care, although hospital charges are viewed as
inadequate proxies for hospital expenditures. In particular, hospital charges are merely the
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amount the hospital bills to the insurer or patient, not the actual costs the hospital incurred for a
certain procedure or service. Hospital charges also vary widely by hospital and are therefore not
suitable for comparing results across hospitals. The majority of studies (n=21) evaluated hospital
costs, a more accurate representation of hospital expenditures. Of those 21 studies, the majority
used the hospital’s cost-accounting system to retrieve cost measures. Two studies applied costto-charge ratios (CCR) to convert hospital charges into costs (Andereck et al., 2014; Whitford et
al., 2014). Two studies used alternative measures of costs (Gade et al., 2008; Lo, 2002). In
particular, Gade et al. (2008) examined all healthcare costs incurred within the six months after
hospitalization, while Lo (2002) used insurance payments from the Taiwanese National Health
Insurance claims database as a proxy for healthcare expenditures within one year prior to the
patient’s death. Overall, the results show that palliative care reduces hospitalization costs, which
is consistent with conclusions of similar recent reviews (May et al., 2014; Simoens et al., 2010b;
Smith et al., 2014). However, heterogeneous patient populations, particularly in non-RCT
studies, may result in selection bias and thus hinder the ability to compare the economic impact
of palliative care across studies.
More than half of the reviewed studies (n=30) examined hospital LOS. While 13 studies
were unable to find a difference in hospital LOS between palliative care and usual care patients
(e.g., Ciemins et al., 2007; Lamba et al., 2012; Penrod et al., 2006), 15 studies identified lower
hospital LOS for patients who received palliative care compared to patients who received usual
care (e.g., Carlson et al., 1988; Lustbader et al., 2011; Mosenthal et al., 2008). The remaining
two studies reported higher hospital LOS (Hsu-Kim et al., 2015; Penrod et al., 2010). Similarly,
31 studies measured ICU LOS, 14 of which found shorter ICU LOS (e.g., Penrod et al., 2006),
14 found no difference (e.g., Carlson et al., 1988), and two reported higher ICU LOS (Binney et
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al., 2014; Hsu-Kim et al., 2015) for patients who received palliative care than patients who
received usual care. Overall, empirical evidence on hospital and ICU LOS is inconclusive. The
variability in findings may be explained by multiple factors, including the use of research
designs. Cassel et al. (2010b) discussed many of these studies in regard to the relationship
between inpatient palliative care consultation services and hospital LOS in their literature
review. The researchers found that studies that revealed reduced hospital LOS were quasiexperimental designs or randomized controlled trials, which focused on ICU-based palliative
care consultations and primarily examined hospital LOS of deceased patients (Cassel et al.,
2010b). Particularly in observational studies, the ability to detect differences in hospital LOS
may also be influenced by the fact that palliative care consultations often occur relatively late in
the hospitalization period, which may result in Type II errors (Cassel et al., 2010b). Similarly,
concerns regarding simultaneity bias or reverse causation arise, as prolonged hospital/ICU LOS
may result in initiation of palliative care consultations. Cassel et al. (2010b) suggested
employing proactive palliative care consultations on a predetermined day of hospitalization or at
the time of hospital admission may mitigate these problems. Furthermore, the authors
recommended analyzing and reporting the effect of palliative care services on LOS for living and
deceased patients separately due to substantial interpretive and consequential differences of
reduced LOS for those two patient groups. Another systematic review that summarized studies
published between 1995 and March 2014 found more consistent evidence of reduced ICU LOS
(Khandelwal et al., 2015). Specifically, 11 of 16 studies reported reduced ICU LOS, while five
demonstrated no significant change. Two of the studies without significant changes in ICU LOS
examined the effect of a system-level palliative care interventions (e.g., addition of a family
support coordinator to the surgical ICU). Khandelwal and her colleagues (2015) concluded in
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their systematic review that effects may be easier to detect if palliative care interventions take
place at the patient level, because the effective palliative care consultations hinge on adapting
care plans to the needs of an individual patient. The mean reduction in ICU LOS across all
studies estimating ICU LOS was 26% with a standard deviation of 23% (Khandelwal et al.,
2015). Similar to Cassel et al. (2010b)’s supposition, the researchers attributed the observed
variability in ICU LOS partially to the distinction between alive and deceased patients in their
study sample.
Twenty-six studies evaluated in-hospital mortality, including hospital and ICU mortality.
Most of the studies (n=19) found no significant difference in hospital mortality between patients
who received palliative care and patients who received usual care. However, the studies
demonstrated consistently lower ICU mortality for patients who received palliative care
compared to patients who received usual care (e.g., Digwood et al., 2011; Lilly et al., 2000; Lilly
et al., 2003). These results suggest that palliative care facilitates the transition to lower levels of
care, which may also be reflected in lower hospital costs. Finally, a small number of studies
(n=4) evaluated the effects of hospital-based palliative care on hospice transfers (Cassel et al.,
2010c; Gade et al., 2008; Morrison et al., 2011; Whitford et al., 2014), three of which
demonstrated more transfers or referrals to hospice care for patients who received palliative care
compared to patients who received usual care (Cassel et al., 2010c; Morrison et al., 2011;
Whitford et al., 2014) and one found no significant difference in hospice transfers between
patients who received palliative care and patients who received usual care (Gade et al., 2008).
Study Contribution
This study aims to contribute to prior literature by using multiple measures of hospitalbased palliative care and robust analytical methodology. Specifically, this study takes a more
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comprehensive look at the nature of palliative care services and their effects on selected
outcomes than previous work by focusing on the provision of three types of hospital-based
specialty palliative care services, namely inpatient palliative care consultation services, inpatient
palliative care units, and hospice programs. All of these services are focused on providing endof-life care. The service descriptions, as identified in this chapter, emphasize symptom and pain
management and supportive care to address emotional, psychological, spiritual, financial, legal,
and social needs of seriously ill patients and their families.
While the definitions highlight the similarities of the nature of these services, there are
also two noteworthy differences. First, while hospice programs serve patients with certain
eligibility criteria only (i.e., patients with a terminal illness, life expectancy of six months or less,
and willingness to forgo curative treatment), inpatient palliative care consultation services and
inpatient palliative care units typically provide services to all patients with serious illnesses
regardless of stage of illness, prognosis, and continuation of curative treatments. Second, an
inpatient palliative care unit distinguishes itself from the other two services by being a
“physically discreet” ward. Conversely, hospice programs provide their services in the hospital,
at home, or in other freestanding care facilities. An inpatient palliative care consultation service
typically focuses on providing palliative care in the hospital, such as in general wards, ICUs, or
other specialized care units.
The similarities between these three services justify the assumption that the factors
causing a hospital to provide one type of palliative care service are the same as the factors
causing a hospital to offer the other two types of palliative care services; that is, this study
models the provision of each of these services jointly in research question one.
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On the other hand, each of these services may have a different impact on patient and
organizational outcomes. Therefore, this study examines the effect of each of these services on
selected outcomes separately in research questions two and three. For example, from a hospital's
perspective, it may be critical to know if having an inpatient palliative care unit has a greater
impact on economic viability and quality of care compared to the other two palliative care
services. Answers to questions, such as “Is an inpatient palliative care unit positively associated
with selected outcomes in the presence of a palliative care program and/or a hospice program?”
may be useful to hospital managers when deciding to expand, reduce, or modify end-of-life carerelated service mixes.
This study also distinguishes between and accounts for the source of palliative care
services; that is, whether palliative care services are hospital-based or not-hospital-based.
Hospital-based palliative care services are owned/provided by the hospital or its subsidiary.
Palliative care services that are provided by a health system, network, or joint venture in a
hospital’s local community are considered not-hospital-based in this study. The first research
question focuses on the provision of at least one of the three hospital-based palliative care
services as a dependent variable, and the corresponding analytical model controls for whether
not-hospital-based palliative care services are available to hospitals. The availability of nothospital-based palliative care services is viewed as an important predictor of hospital-based
palliative care services. Similarly, for research questions two and three, in addition to three
binary variables indicating the presence of hospital-based palliative care services, a control
variable for whether a not-hospital-based palliative care service is available is included in the
analysis to account for its potential effect on organizational and patient outcomes.
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Overall, this study aims to shed light on the differentiating effects of the types (i.e.,
inpatient palliative care consultation services, inpatient palliative care unit, and hospice program)
and sources (hospital-based or not-hospital-based) of palliative care services on selected
outcomes. A question of interest is “Do hospital-based palliative care services have significant
effects on outcomes when not-hospital-based palliative care services are present?” If findings
suggest otherwise, a hospital may not need to invest in hospital-based palliative care services
and, instead, take advantage of resources available through their networks, health systems, or
joint ventures in their local community.
In sum, although previous research has studied the nature and effect of hospital-based
palliative care services, a broader and more inclusive analysis of hospital-based palliative care
services is a natural extension of previous studies and is likely to carry more relevance in
decision-making processes at the hospital administrative level. Furthermore, no research study
has explored whether hospitals with more experience in providing palliative care services have
improved organizational and patient outcomes, as this study attempts to answer under research
question three.
This study also uses longitudinal data from several states, located in three of four census
regions to assure geographic diversity, to predict the association of hospital and market
characteristics with the provision of hospital-based palliative care. This study employs a
longitudinal analysis using data on patients, hospitals, and counties from years 2007 through
2011. While cross-sectional designs are limited to estimating correlations between variables,
longitudinal designs are able to account for hospital and market characteristics over time.
Moreover, this study includes a more inclusive set of control and independent variables derived
from organizational theory.
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Additionally, hierarchical generalized linear models (HGLM) and hierarchical linear
models (HLM) are employed to address this study’s research questions and test the
corresponding hypotheses. Although most research on health service organizations deals with
some form of nested data (e.g., patients nested within hospitals nested within counties nested
within states), the majority of studies on hospital adoption of health services and their effects on
organizational and patient outcomes have not properly accounted for the complexity of
hierarchical data. This study uses HGLM and HLM to estimate effects of variables measured at
different levels (i.e., patient, hospital, and county) on a hospital-level outcome (i.e., research
question one) and four patient-level outcomes (i.e., research questions two and three). In the
context of hierarchical data, this statistical approach has several advantages compared to
conventional estimation methods. Some conventional models ignore the hierarchical structure by
analyzing higher- and lower-level predictors in the same way. For example, county- and
hospital-level variables are included into the conventional, non-hierarchical, single-level model
to predict an outcome at the hospital level. Alternatively, patient-, hospital-, and county-level
variables are included in a single-level model to predict an outcome at the patient level. In these
approaches, standard errors are generally too small since they do not take into account the
clustering of the lower-level units within the higher-level units (Raudenbush & Bryk, 2002b).
Hence, these models are likely to induce Type I errors. In this study, the hierarchical nature of
the data is emphasized and modeled accordingly. Conversely, some studies aggregate lower level
information to a higher-level and include the aggregated information with other higher level
variables as predictor variables into the single-level model. For instance, patient-level
information, such as age, gender, or primary diagnosis, is averaged at the hospital level and
included as an explanatory variable. These models may suffer from inefficient regression
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estimates if the number of nested units within higher-level units varies significantly (Raudenbush
& Bryk, 2002b).
Summary
This chapter began with a review of the concept of palliative care, its evolution, and
delivery models. It continued with a description of the relevance of key variables in the context
of hospital performance and outlined existing evidence on the effects of hospital and market
characteristics on palliative care provision and the impact of hospital-based palliative care on
hospital costs, hospital length of stay, in-hospital mortality, and transfer to hospice.
The following chapter provides an overview of the theoretical framework used in this
study and develops propositions and corresponding hypotheses to address the study’s research
questions.
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Chapter 3: Theoretical Framework

The underlying conceptual framework for this study is based on organizational theories
and frameworks that have been used by other health services researchers to explain the nature of
hospital service adoption and how it potentially influences hospital performance. Five
propositions and hypotheses are derived from Resource Dependence Theory (RDT) and
Institutional Theory (IT) corresponding to research question one: which organizational and
environmental forces are associated with the provision of hospital-based palliative care services?
Donabedian’s (1980) Structure-Process-Outcome framework for quality assessment is applied to
derive one proposition and four hypotheses corresponding to research questions two and three,
respectively: do hospitals that provide palliative care services have improved organizational and
patient outcomes compared to those not providing such services?; and: Is a hospital’s experience
in providing palliative care services associated with improved organizational and patient
outcomes?
This chapter is divided into two main sections. The first section provides an overview of
Resource Dependence Theory (Pfeffer & Salancik, 1978), Institutional Theory (DiMaggio &
Powell, 1983; Meyer & Rowan, 1977), and how Oliver’s (1991) model of organizational
responsiveness combines both theories. Five propositions and hypotheses from these conceptual
perspectives are then developed to explain palliative care adoption in hospitals. The second
section discusses Donabedian’s (1980) Structure-Process-Outcome framework and establishes
two propositions and eight corresponding hypotheses relating palliative care services with the
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study’s patient and organizational outcomes: hospital costs, length of stay, in-hospital mortality,
and care transition to hospice. The last section concludes this chapter with a brief summary.
Hospital Adoption of Palliative Care
To address research question one, five propositions and corresponding hypotheses are
derived based on the theoretical perspectives of Resource Dependence Theory (Pfeffer &
Salancik, 1978) and Institutional Theory (DiMaggio & Powell, 1983; Meyer & Rowan, 1977).
Resource Dependence Theory is an open-system approach to organizational behavior.
According to this theory, a hospital’s survival is contingent on two major determinants: the
availability of internal resources and the ability to acquire and maintain critical resources from
the environment (Scott & Davis, 2007). Critical resources include economic resources,
reputation, and knowledge. This theory posits that organizations are not self-sufficient and must
therefore engage in exchanges with other organizations, stakeholders, and the environment to
acquire the resources necessary for their survival (Pfeffer & Salancik, 1978). If a hospital is not
entirely in control of all conditions or resources necessary to achieve a desired goal or outcome,
a certain degree of dependence between actors arises (Casciaro & Piskorski, 2005; Pfeffer &
Salancik, 1978). The act of exchanging resources creates power and dependence relations, which
make hospitals vulnerable to the demands of resource providers. Dependence is a measure of
how potent external constituents in a hospital’s environment are and to what degree they need to
be taken into consideration in the decision-making process (Pfeffer & Salancik, 1978). Then, in
order to secure a stable flow of critical resources, reduce dependence, and maximize autonomy,
hospitals may choose between a variety of strategies and tactics to coordinate these relations
(Scott & Davis, 2007).
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Institutional Theory, like Resource Dependence Theory, is an open-natural approach to
organizational behavior. This theory argues that organizations are shaped and constituted by their
institutional environments and corresponding pressures (Scott & Davis, 2007). At the center of
this theory lies the concept of institutionalization. Institutionalization has been defined as a
means or process to infuse intrinsic value to organizational structures or activities to promote
organizational self-maintenance (Scott, 1987). These organizational structures or activities are
viewed as adaptive systems formed in response to internal participants and external demands
(Selznick, 1996). Once these structures or activities become valued, they are replicated by other
organizations over time and are assigned similar meaning within a given society – they become
institutionalized (Scott, 1987). These institutional demands or pressures can be viewed as highly
rationalized myths that are binding for some organizations.
Oliver’s (1991) model of organizational responsiveness combines the theoretical views of
Institutional Theory and Resource Dependence Theory (Oliver, 1991). Both theories have been
used successfully in prior research studies to explain why, how, and when hospitals respond to
external demands, pressures, and expectations (Campbell & Alexander, 2005; Proenca, Rosko, &
Zinn, 2000; Zinn, Weech, & Brannon, 1998). The basic argument to justify this combined
approach is that both these open-system approaches to organizational behavior focus on the
organization’s exchange with the environment (Scott & Davis, 2007). The theories assume that
organizational strategic choice and response are restricted and shaped by multiple external
demands, pressures, and expectations to which organizations must respond to secure survival,
stability, and predictability (Oliver, 1991). Organizational responses to institutional pressures
imposed by the environment may vary between complying with and resisting such demands.
While RDT suggests that powerful constituents are those who control scarce resources,
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institutional theorists assume that power resides in those who shape and enforce institutional
rules, norms, and beliefs, such as government agencies, interest groups, and public opinion
(Oliver, 1991; Proenca et al., 2000). Organizational responsiveness to demands of external
constituents then varies according to the different assumptions about the degree of choice,
awareness of pressures, and self-interest. Resource Dependence Theory assumes an active role of
management (i.e., that organizational change is intentional) and that organizations seek to
maintain autonomy and obtain resources for survival. Institutional Theory adopts a more passive
role of management. It posits that organizations seek legitimacy for survival by conforming to
collective norms and beliefs. Yet institutional theorists started to acknowledge explicitly the role
of agency, organizational interest, and strategic choice in explaining the variation in
organizational responses to institutional environments (Goodrick & Salancik, 1996; Oliver,
1991; Pache & Santos, 2010; Scott, 1987). Research has suggested that organizational interest
and discretion is greater when institutional rules are uncertain, unclear, conflicting, or
inconsistent with technical requirements (Goodrick & Salancik, 1996; Pache & Santos, 2010).
Conflicting institutional demands typically arise in environments where multiple, uncoordinated
actors with different views on what is effective and legitimate coexist (i.e., fragmentation) and
where these actors have the ability to enforce their demands (i.e., centralization) (Pache &
Santos, 2010). The health care environment is indeed inherently complex, uncertain and highly
dynamic, manifested by fragmented health care delivery, ambiguous policies and values,
incompatible financial incentives, and multifaceted regulatory systems, (Proenca et al., 2000).
This diverse environment is likely to pose different, potentially competing demands on hospitals,
so that their responsiveness is likely to vary according to type, relative intensity of external
pressures, and organizational goals and interests.
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Hospitals are increasingly providing palliative care services to their patient population.
The hospital’s environment may pose demands, expectations, and norms onto a hospital, to
which it may respond through providing palliative care services. Both the internal (i.e.,
organizational factors) and external environment (i.e., market factors) determine how the hospital
functions. According to RDT and IT, organizational and environmental factors may explain why
hospitals decide to provide palliative care services. The combined approach by Oliver (1991) is
appropriate to explain why hospitals decide for or against providing palliative care services. In
this model, five drivers of strategic responses to institutional pressures to conform to norms,
demands, or expectations are presented: cause, constituents, control, context, and content. These
five categories will function as an overarching conceptual framework for the first five
propositions and the corresponding hypotheses to address research question one.
The first antecedent of strategic responsiveness relates to the cause of institutional
pressures, which refers to “the rationale, set of expectations, or intended objectives that underlie
external pressures for conformity” (Oliver, 1991, p. 161). This factor refers to the reason that a
focal hospital is pressured to conform to norms, demands, or expectations. A related factor is
control, which relates to the method or means by which a hospital is pressured to conform to
external pressures. Due to its similarity, control will not be discussed separately (Fareed, 2013).
The decision to conform or not depends on how much a hospital agrees with and values the
objectives and intentions of institutional constituents who try to pressure hospitals to be more
economically and socially accountable. Integrating palliative care into the hospital’s service mix
is said to improve quality of care and increase a hospital’s economic viability through costsavings when provided to patients who are most likely to benefit from palliative care services
(Center to Advance Palliative Care, 2014). In particular, the National Quality Forum (NQF)
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developed quantifiable quality indicators for palliative care in the hospital setting; the Joint
Commission provides an advanced certification for palliative care; and the National Consensus
Project for Quality Palliative Care (NCP) promotes evidence-based practices to optimize
palliative care programs. An industry-wide emphasis on the importance of palliative care in
providing high-quality care may be viewed as an institutional pressure, which, in turn, may
influence a hospital with similar values and objectives to provide palliative care services in hope
of reaching or maintaining legitimacy and economic health (Oliver, 1991; Proenca et al., 2000).
This is particularly true for large hospitals, as their size increases their visibility and public
exposure. From an economic perspective, a positive relationship between hospital size and
palliative care provision may also imply the existence of economies of scope. Therefore, it is
proposed,
Proposition 1: Hospital size is positively associated with the provision of palliative care
services.


Hypothesis 1: Hospitals with more staffed and set-up beds are more likely to provide
palliative care services compared to hospitals with fewer staffed and set-up beds,
ceteris paribus.

Another antecedent of strategic responsiveness relates to the environmental context, in
which institutional pressures are exercised. According to RDT, the level of market competition is
an essential external factor that influences organizational change (Zinn et al., 1998). Greater
competition increases the demand on a shared pool of resources (Fareed & Mick, 2011; Zinn et
al., 1998). Hospitals must compete for the same resources, which makes inputs scarcer and
pressures hospitals to differentiate themselves from competitors (Kazley & Ozcan, 2007).
Providing hospital-based palliative care services may be seen as a method to attract patients and
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manage organizational interdependence (Scott & Davis, 2007). In areas with a higher density of
competitors, more hospitals compete for the same patient population (e.g., patient referrals).
Providing hospital-based palliative care services may be a visible indicator of the hospital’s
effort to accommodate the internal and external stakeholders. In competitive markets, hospitals
may argue that the provision of palliative care services makes them more attractive to potential
patients, who have a wider variety of health care settings to choose from compared to less
competitive markets (Kazley & Ozcan, 2007). Offering hospital-based palliative care services
may establish a competitive advantage in securing the flow of resources needed for
organizational success (Zinn et al., 1998). Thus,
Proposition 2: Market competition is positively associated with the provision of palliative
care services.


Hypothesis 2: Hospitals in more competitive markets (i.e., counties) are more likely
to provide palliative care services compared to hospitals in less competitive markets
(i.e., counties), ceteris paribus.

Interconnectedness is another context-related predictor of organizational conformity
(Oliver, 1991). Organizations in highly interconnected environments are predicted to be more
likely to comply with the values, norms, or expectations of the environment, facilitated by
voluntary or regulatory diffusion of information and best-practice guidelines (DiMaggio &
Powell, 1983; Meyer & Rowan, 1977; Pfeffer & Salancik, 1978). Hospitals affiliated with a
health system typically have access to greater internal resources (e.g., capital to invest in
palliative care services) to respond to environmental pressures (Banaszak-Holl, Zinn, & Mor,
1996). On the other hand, the availability of alternative sources for key resources may also
moderate the need to comply with such pressures (Zinn, Weimer, Spector, & Mukamel, 2010).
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That is, having access to palliative care services through a health system, network, or joint
venture in the local community provides an alternative source of such services. Hospitals
affiliated with a health system, network, or joint venture offering palliative care services at
another location may be less likely to provide their own palliative care services. Therefore, it is
proposed,
Proposition 3: The availability of alternative sources for palliative care services is
negatively associated with the provision of palliative care services.


Hypothesis 3: Hospitals that have access to palliative care services through a health
system, network, and/or joint venture in their local community are less likely to
provide palliative care services in-house, ceteris paribus.

Constituents are stakeholders who express expectations, norms, or demands, to which
hospitals may feel pressured to conform (Oliver, 1991). Providing cost-effective care is one of
the primary demands of public payers, such as Medicare. Palliative care practices in the hospital
setting have been shown to contain hospital costs, reduce length of stay in the hospital and ICU,
decrease the use of unnecessary treatments, and decrease 30-day hospital readmissions (Nelson,
Chand, Sortais, Oloimooja, & Rembert, 2011). Providing hospital-based palliative care services
may be viewed as a means to meet demands related to the provision of cost-effective care. In
addition, Medicare patients are typically good candidates for palliative care services, as they are
older and tend to spend an extended period of time in the hospital at the end of life. Hospitals
with a greater Medicare share of inpatient days are more likely to depend on Medicare
reimbursements for economic survival than hospitals with a lower proportion of Medicare
patients. Thus, it is proposed,
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Proposition 4: Medicare dependence is positively associated with the provision of
palliative care services.


Hypothesis 4: Hospitals with a greater Medicare share of inpatient days are more
likely to provide palliative care services compared to hospitals with a smaller
Medicare share of inpatient days, ceteris paribus.

The final antecedent of strategic responsiveness, content, relates to which particular
expectations, norms, or demands the hospital needs to conform. In other words, content refers to
the nature of environmental pressures (Oliver, 1991). If such pressures are consistent with the
hospital’s internal goals, values, and mission, a hospital is more likely to conform. Hospital
teaching status may reflect a hospital’s internal goals, values, and mission. Teaching hospitals
are dedicated to providing clinical care, conducting research, and teaching the future workforce.
Teaching hospitals may view the provision of palliative care services as an important part of
teaching and providing comprehensive care. Specifically, the education and training of medical
students may be viewed as essential to provide quality palliative care to an aging population that
increasingly deals with serious chronic illnesses, such as cancer. Therefore, it is proposed,
Proposition 5: Teaching status is positively associated with the provision of palliative
care services.


Hypothesis 5: Hospitals that are COTH (Council of Teaching Hospitals) members are
more likely to provide palliative care services compared to hospitals that are nonCOTH members, ceteris paribus.

Hospital Performance Effects of Palliative Care
To address research questions two and three, two propositions and eight corresponding
hypotheses are derived based on Donabedian’s (1980) Structure-Process-Outcome (SPO)
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framework for quality assessment. Donabedian identifies three categories of quality measures,
namely structure, process, and outcomes of care. Structural characteristics affect the process of
care, which, in turn, affect outcomes of care. Structure is described as “the attributes of the
setting in which care occurs” (Donabedian, 1988, p. 1745). The main proposition of the
structural component is that high-quality care can only occur in the “appropriate” setting.
Structural attributes of a hospital setting may be described in terms of environmental,
organizational, and patient characteristics. Process refers to the actual provision of care. Finally,
outcome denotes “the effects of care on the health status of patients and populations”
(Donabedian, 1988, p. 1745). This model provides a conceptual framework to test whether
hospital-based palliative care services have an association with organizational and patient
outcomes.
This study views palliative care services as a structural component of care, as palliative
care services provide hospitals with a “systematic approach” to coordinate and manage care for
complex patients and assist with appropriate transitioning between health care settings (Center to
Advance Palliative Care, 2014). Studies have found that palliative care services lead to cost
containment due to decreased hospital and ICU length of stay (Campbell & Guzman, 2003;
2004), and more appropriate utilization of health care services, such as laboratory tests, and
radiological tests (Lautrette et al., 2007; O'Mahony et al., 2010).
In this study, it is proposed that hospitals that provide palliative care services produce
improved organizational and patient outcomes compared to hospitals that do not provide
palliative care services. Furthermore, hospitals that are more experienced in providing palliative
care services have better outcomes than hospitals that are less experienced in providing palliative
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care services. The two propositions and their corresponding hypotheses related to organizational
patient outcomes are formally stated as follows:
Proposition 6: The provision of palliative care services is associated with improved
patient and organizational outcomes.


Hypothesis 6a: Patients treated in hospitals that provide palliative care services incur
lower hospital costs than patients treated in hospitals that do not provide such
services, ceteris paribus.



Hypothesis 6b: Patients treated in hospitals that provide palliative care services have
shorter hospital LOS than patients treated in hospitals that do not provide such
services, ceteris paribus.



Hypothesis 6c: Patients treated in hospitals that provide palliative care services are
less likely to die during hospitalization than patients treated in hospitals that do not
provide such services, ceteris paribus.



Hypothesis 6d: Patients treated in hospitals that provide palliative care services are
more likely to transfer to hospice than patients treated in hospitals that do not provide
such services, ceteris paribus.

Proposition 7: Greater experience in providing palliative care is associated with improved
patient and organizational outcomes.


Hypothesis 7a: Patients treated in hospitals that are more experienced in providing
palliative care services incur lower hospital costs than patients treated in hospitals that
are less experienced, ceteris paribus.
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Hypothesis 7b: Patients treated in hospitals that are more experienced in providing
palliative care services have shorter hospital LOS than patients treated in hospitals
that are less experienced, ceteris paribus.



Hypothesis 7c: Patients treated in hospitals that are more experienced in providing
palliative care services are less likely to die during hospitalization than patients
treated in hospitals that are less experienced, ceteris paribus.



Hypothesis 7d: Patients treated in hospitals that are more experienced in providing
palliative care services are more likely to be transferred to hospice than patients
treated in hospitals that are less experienced, ceteris paribus.

Summary
This chapter established a theoretical framework by drawing on Institutional Theory,
Resource Dependence Theory, and Donabedian’s Structure-Process-Outcome framework to
explain the impact of hospital and market factors on palliative care provision and the effects of
palliative care services on patient and organizational outcomes. Based on the theoretical
framework, seven propositions and 13 corresponding hypotheses were derived. The next chapter
describes this study’s research methodology, including research design, data sources, study
sample, variable measurement, empirical methodology, and sensitivity analyses.
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Chapter 4: Methodology

This chapter explains the research methods used to explore the nature of hospital-based
palliative care provision and the relationship between hospital-based palliative care provision
and hospital costs, hospital length of stay, in-hospital mortality, and transfer to hospice.
The first section identifies the research design; the next four sections describe the data
sources, study sample, variable measurement, and the empirical methodology employed to
investigate the study’s research questions. The last section outlines the set of sensitivity analyses
used to evaluate the robustness of the empirical results. The chapter concludes with a summary.
Research Design
This study, observational and retrospective in nature, aims to examine the relationship
between hospital and market characteristics and hospital-based palliative care provision (research
question one) and the association between hospital-based palliative care provision and patient
and organizational outcomes (research questions two and three).
To test the seven propositions and 13 hypotheses presented in the previous section, this
study analyzes a longitudinal data set, which encompasses a five-year (2007-2011) time frame
and six U.S. states (Arizona, California, Florida, Maryland, New Jersey, and New York). A twolevel hierarchical generalized linear model (HGLM) is used to analyze the five hypotheses
proposed under research question one. Four three-level HGLM or hierarchical linear models
(HLM) are estimated to test the hypotheses proposed under research questions two and three.
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General, short-term, acute care, non-federal, and urban hospitals in the U.S. are units of
analysis nested within counties for research question one. Hospital i is the lower level unit nested
within the higher level unit county j (i.e., level-2 unit). Independent and control variables were
obtained or constructed at the hospital or county level. For research questions two and three, the
lowest level units of analysis are hospital visits of patients aged 18 and older with one of eight
primary diagnoses deemed most likely to benefit from palliative care. Further detail is provided
in a later section of this chapter. Patient i is a level-1 unit nested within hospital j (i.e., level-2
unit) nested within county k (i.e., level-3 unit). Independent and control variables were obtained
or constructed at the patient, hospital, or county level.
Two additional empirical specifications are noteworthy. First, all analytical models in this
study are estimated using a balanced sample of hospitals; that is, hospitals that consistently
provided hospital information across the five-year study period. A balanced panel was used to
facilitate the construction of palliative care adoption patterns for hospitals across the study
period. Finally, years (i.e., time points) are not modelled as an additional hierarchical level in any
of the analytical models outlined in the previous paragraph. Specifically, for research question
one, level-1 units consist of hospitals with five observations for the years 2007 through 2011. For
research questions two and three, level-2 units constitute hospitals with five observations for the
years 2007 through 2011.
Data Sources
Administrative data are obtained and merged from a variety of sources to acquire wideranging information about market and hospital characteristics, hospitals’ patterns of palliative
care provision, and measures of hospital performance. The two primary data sources for this
study are the AHA Annual Survey of Hospitals and State Inpatient Databases (SID) for Arizona,
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California, Florida, Maryland, New Jersey, and New York from 2007 to 2011. The AHA Annual
Survey of Hospitals is conducted on a yearly basis by the American Hospital Association and
collects information from over 6,400 hospitals nationwide with an annual response rate of more
than 75%. Participating hospitals respond to approximately 1,000 questions spanning a variety of
categories, including organizational structure, demographics, staffing, service utilization,
facilities and services, and managed care affiliations (American Hospital Association, 2014).
The SID are assembled by the Healthcare Cost and Utilization Project (HCUP), which is
sponsored by the Agency for Healthcare Research and Quality (AHRQ). A wide range of clinical
and non-clinical data elements are available for each inpatient discharge record, including patient
demographics, primary and secondary diagnoses, hospital length of stay, payer source, hospital
charges, and disposition at discharge (Agency for Healthcare Research and Quality, 2015).
The study also includes data from four supplemental administrative databases: the Area
Health Resources Files (AHRF), the HealthLeader-Interstudy databases, the Medicare Hospital
Cost Reports, and data provided by the American Nurses Credentialing Center (ANCC). These
data are used to construct control variables at the hospital and county level. The AHRF,
maintained by the National Center for Health Workforce Analysis (NCHWA), Bureau of Health
Workforce within the Health Resources and Services Administration (HRSA), encompasses over
6,000 current and historical data elements for counties nationwide, including population
demographics, hospital utilization, health care professions, and health facilities. The
HealthLeaders-InterStudy databases are used to obtain annual HMO and PPO enrollment data.
The Healthcare Cost Report Information System (HCRIS), collected and maintained by the
Centers for Medicare and Medicaid Services (CMS), provides a variety of financial performance
data for Medicare-certified hospitals by fiscal year, including data elements from hospitals’
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income statements and balance sheets (Centers for Medicaid and Medicare Services, 2015b).
Finally, information on hospitals recognized as a Magnet organization by the ANCC Magnet
Recognition Program® in the years 2007 through 2011 are hand-collected from the ANCC’s
website. Magnet organizations are acknowledged for their excellence in a variety of nursing
processes and high-quality patient care (American Nurses Credentialing Center, 2014).
Data from the AHA Annual Survey of Hospitals and SID are merged by the hospital’s
AHA identification number. The merged dataset is then linked with the Medicare Hospital Cost
Reports by the hospital’s Medicare provider number. Hospitals with a cost reporting period of
less than 360 and more than 370 days are excluded. Hand-collected data on ANCC Magnet
designation are manually added to the merged dataset by hospital name. Finally, market-level
information from AHRF and HealthLeaders-InterStudy are merged by the hospital’s county
federal information processing standard (FIPS) code.
Study Sample
Data from hospitals in the following six states are used to examine the three research
questions: Arizona, California, Florida, Maryland, New Jersey, and New York. There are several
reasons for choosing hospitals from the aforementioned states. First, these states provide
consistent and comprehensive information on hospital characteristics and hospitalized patients
over the study period required to investigate the study’s research questions. Hospitals within
these states also experienced a growing trend in hospital-based palliative care provision over the
study’s time period. Additionally, the included states are located in three of the four U.S. census
regions and constitute approximately 19% of general medical and surgical hospitals nationwide.
These states also have a sufficiently large number of hospitals within counties and patients
within hospitals, which is necessary to estimate this study’s hierarchical models with random
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effects at the county and hospital level. Finally, three of the states, California, Arizona, and
Florida, are traditional retirement states. As the elderly are one of the primary target populations
for palliative care, findings from this study may provide valuable insight for policy makers in
states with a high proportion of elderly residents.
Several additional sample exclusion criteria are employed to establish homogeneity of the
study sample. First, specialty hospitals, such as prison hospitals, psychiatric hospitals,
rehabilitation facilities, and hospitals that restrict admissions primarily to children, are excluded
from the study sample. Specialty hospitals serve specific patient populations, to whom they
provide a more limited array of services than general acute care hospitals. Patterns of palliative
care adoption among specialty hospitals are therefore likely to be different from patterns at
general acute care hospitals. Additionally, hospitals under federal control, such as Veterans
Affairs (VA) hospitals, are also excluded from the study sample, because they are federally
mandated to make a palliative care consult team available (Veterans Health Administration,
2008). The study focuses on non-federal, general acute care hospitals in metropolitan counties.
Among the study states, the percentage of inpatient discharge records in metropolitan areas
ranges from 91.83% in California to 100% in New Jersey. Finally, hospitals that did not respond
to the AHA Annual Survey of Hospitals consistently throughout the study’s time period and
hospitals that had missing values for key or control variables were excluded from the study
sample.
Several additional patient-level exclusion criteria are employed in this study to establish a
homogenous patient sample. First, SID inpatient discharge records are restricted to patients aged
18 and older. While pediatric and adult palliative care are similar in nature, palliative care needs

82

of children with complex and serious illnesses often differ from palliative care needs of adult
patients.
Second, SID inpatient discharge records are also limited to patients who are assigned one
of the following eight primary diagnoses deemed most likely to benefit from and receive
palliative care services: acute cerebrovascular disease, acute myocardial infarction, cancer,
congestive heart failure, chronic obstructive pulmonary disease, dementia, HIV infection, and
dementia. The selection of primary diagnoses is based on the most frequent causes of death
nationwide (Murphy et al., 2013) and prior literature (Santa-Emma, Roach, Gill, Spayde, &
Taylor, 2002; Stover, 2005; Weissman & Meier, 2011). Disease categories generated by the
Clinical Classification Software (CCS) for the International Classification of Diseases, 9th
Revision, Clinical Modification (ICD-9-CM) are used to identify this study’s patient population.
The CCS was developed by the Healthcare Cost and Utilization Project (HCUP) and is a
standardized coding system, which places ICD-9-CM codes into manageable and clinically
meaningful categories (Healthcare Cost and Utilization Project, 2015).
By limiting the study’s patient sample to patients with the above-mentioned primary
diagnoses, the analysis more clearly focuses on those individuals most likely to benefit from
palliative care services. It may be noted that an inclusion criterion based on primary diagnosis
may include inpatient discharge records from patients who did not receive palliative care
services or, conversely, exclude inpatient discharge records from patients who received palliative
care services. Hence, these sample selection criteria only approximate the hospital’s patient
population most likely to benefit and receive palliative care services. Table 5 displays the CCS
categories and corresponding ICD-9-CM diagnosis chapters that are associated with the study’s
eight primary diagnoses.
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Table 5
Primary Diagnosis, CCS Category, and ICD-9-CM Diagnosis Chapter

5

Primary Diagnosis
Acute cerebrovascular disease
Acute myocardial infarction
Cancer
Congestive heart failure
COPD
Dementia
HIV
Pneumonia

CCS
Category
109
100
11-45
108
127
653
5
122

ICD-9-CM Diagnosis Chapter
7 - Diseases of circulatory system
7 - Diseases of circulatory system
2 – Neoplasms
7 - Diseases of circulatory system
8 - Diseases of respiratory system
5 - Mental illness
1 - Infectious and parasitic diseases
8 - Diseases of respiratory system

Note. CCS=Clinical classification software. COPD=Chronic obstructive pulmonary disease. HIV=Human
immunodeficiency virus. ICD-9-CM=International Classification of Diseases, 9th Revision, Clinical Modification.

Approximating the study’s palliative care patient population is necessary, as ICD-9-CM
codes uniquely identifying palliative care patients are largely absent or lack consistent
application. Finally, inpatient discharge records with missing values for any dependent or control
variable and inpatient discharge records with reported hospital lengths of stay greater than 30
days are excluded from the study sample. Table 6 provides an overview of the number of
patients, hospitals, and counties dropped based on this study’s sample exclusion criteria, missing
or invalid values.
According to Table 6, 93.66% of patients, 66.11% of hospitals, and 51.95% of counties
were dropped based on the study’s sample exclusion criteria, missing or invalid values for at
least one of the study’s patient and hospital characteristics. Note that there was no missing
information on any of the study’s county characteristics.
The majority of patients aged 18 and older (84.49%) did not have one of the study’s eight
selected primary diagnoses. About one in every four urban, non-federal, general, acute care
hospitals (22.84%) did not have information on the availability of at least one of the three
palliative care services (PAL, IPAL, or HOSPC) for one or more study years. For a given
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Table 6
Stepwise Removal Process of Study Observations Across All Study Years

6
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Overall sample
Sample criteria
Patient: Patients aged < 18 years
Patient: Primary DX not ACD, AMI, cancer, CHF, COPD, dementia,
HIV, or pneumonia
Patient: Length of stay > 30 days
Hospital: Federal, non-urban, long-term, and specialty hospitals
Missing/inconsistent values
Key Variables
PAL, IPAL, and/or HOSPC (missing)
PAL, IPAL, and/or HOSPC (unrealistic implementation patterns)
Number of set-up and staffed beds (Hypothesis 1)
1 minus Herfindahl-Hirschman Index (Hypothesis 2)
Presence of PC services in health system/network/JV (Hypothesis 3)
Share of Medicare patients (%) (Hypothesis 4)
Teaching hospital (Hypothesis 5)
Control Variables
Hospital
Patient
County
Final sample
Annual average
% overall sample analyzed

Patient
59,315,052

Hospital
5,134

County
1,155

9,783,840

12

0

41,848,720
124,338
533,942

176
4
1,230

0
0
410

1,127,506
1,266,206
0
0
0
0
0

848
859
0
0
0
0
0

60
80
0
0
0
0
0

627,701
239,460
0
3,763,339
752,668
6.34%

265
0
0
1,740
348
33.89%

50
0
0
555
111
48.05%

Note. ACD=Acute cerebrovascular disease. AMI=Acute myocardial infarction. CHF=Congestive heart failure. COPD=Chronic obstructive pulmonary
disease. DX=Diagnosis. HIV=Human immunodeficiency virus. HOSPC=Hospice program. IPAL=Inpatient palliative care unit. JV=Joint venture.
PAL=Inpatient palliative care consultation service. PC=Palliative care.

palliative care service, information was missing both at random in a given study year for some
hospitals and throughout the study period for other hospitals.
Moreover, 859 hospitals were excluded from the study sample because of unrealistic
implementation patterns for PAL, IPAL, or HOSPC; that is, these hospitals repeatedly switched
between having and not having a palliative care service during the five year study period. Note
that consistent implementation patterns of palliative care services were an essential prerequisite
for constructing the three key independent variables to address research question three, namely
experience in providing PAL, IPAL, or HOSPC, as described later in this chapter. Regarding
research question one, it is also important to avoid modeling false changes in palliative care
provision over the study period, as within-hospital coding errors in the dependent variable are
magnified in the context of modeling random effects.
In addition, imputations were performed for 27 hospitals. Specifically, 18 hospitals were
categorized as hospitals with no palliative care service throughout the study period if they had no
palliative care service in any study period except in one year between 2008 and 2010. Similarly,
nine hospitals were categorized as hospitals with continuous provision of a palliative care service
throughout the study period if they had a palliative care service in all study years except in one
year between 2008 and 2010.
Variable Measurement
The following sections are grouped into descriptions of key variables, including
dependent variables, key independent variables, and control variables for the three research
questions. Dependent variables and control variables for research questions two and three are
discussed within one section, as they are the same for both research questions.
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Research question one: dependent and key independent variables.
Research question one examines which hospital and market characteristics are associated
with the hospital provision of palliative care services. Five propositions and corresponding
hypotheses have been proposed. Table 7 provides an overview of the dependent variable and five
key independent variables constructed to model hospital-based palliative care provision.
Research question one: control variables.
Hospital provision of palliative care may be influenced by other factors present in the
hospital’s institutional environment. These factors are included as control variables in the
analytical model and can be grouped into hospital and market characteristics.
Several hospital characteristics are included in the models to control for confounding
factors associated with the provision of hospital-based palliative care. Specifically, lagged
operating margin as a proxy for financial performance (measured as the ratio of net patient
income and net profit revenue in the prior year), ANCC Magnet recognition as a proxy for higher
quality of care, and ownership type as a proxy for a hospital’s mission, are potential confounders
that may affect the hospital’s decision to adopt palliative care services. Binary variables, based
on the information reported in the AHA Annual Survey of Hospitals, are used to denote the
hospital’s type of ownership: for-profit, public, and not-for-profit (reference group). In regard to
ANCC Magnet recognition, a binary variable is constructed, using hand-collected information
from the ANCC website, to identify hospitals that were recognized as Magnet organizations.
Additionally, patient severity or complexity may influence a hospital’s decision to
provide palliative care services. That is, hospitals with a higher case-mix index (CMI) may be
more likely to offer palliative care services in order to meet patients’ palliative care needs. This
index is constructed and provided by the Centers for Medicare and Medicaid Services (CMS)
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Table 7
A Description of Key Variables, Research Question One

7

Construct
Variable
Dependent Variable
Hospital-based Presence of PAL,
PC provision
IPAL, and/or
HOSPC

Independent Variables
H1: Size
Hospital bed size

H2: Market
competition

1 – HerfindahlHirschman Index
(HHI)

H3: Availability
of alternative
palliative care
resources

Presence of PAL,
IPAL, and/or
HOSPC in a
hospital’s health
system, network,
and/or joint
venture.

H4: Medicare
dependence

Share of
Medicare patients

H5: Teaching
status

COTH
membership

Measurement

Unit

Database

Binary variable;
=1 if hospital has PAL, IPAL,
and/or HOSPC; =0 otherwise

Hospital

2007-2011
AHA
Annual
Hospital
Surveys

Continuous variable;
measured as the number of
staffed and set-up beds (in
10s).

Hospital

Continuous variable;
constructed by subtracting the
sum of the squares of market
shares of admissions for all
hospitals in the county from
1; values range from 0 to 1.
Values closer to 1 indicate
higher levels of competition.
Binary variable;
=1 if hospital has PAL, IPAL,
and/or HOSPC in health
system, network and/or joint
venture; =0 otherwise.
Hospitals in the same county
belonging to the same health
system are combined.
Continuous variable;
calculated by dividing
Medicare inpatient days by
total inpatient days.

County

2007-2011
AHA
Annual
Hospital
Surveys
2007-2011
AHA
Annual
Hospital
Surveys

Binary variable; =1 if hospital
is COTH-member; =0
otherwise.

Hospital

Hospital

2007-2011
AHA
Annual
Hospital
Surveys

Hospital

2007-2011
AHA
Annual
Hospital
Surveys
2007-2011
AHA
Annual
Hospital
Surveys

Note. AHA=American Hospital Association. COTH=Council of Teaching Hospitals. HHI=Herfindahl-Hirschman
Index. HOSPC=Hospice program. IPAL=Inpatient palliative care program. PAL=Inpatient palliative care
consultation service.
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and represents a hospital’s average diagnosis-related group (DRG) relative weight. It is
calculated by summing the DRG weights for all Medicare discharges and dividing the sum by
the total number of discharges. Similarly, several additional characteristics of the hospital’s
patient population may influence the hospital’s need or desire to provide palliative care services,
including the percentage of patients with primary diagnoses most likely to benefit from palliative
care, the percentage of patients aged 65 and older, the percentage of Hispanic patients, the
percentage of black patients, and the hospital’s average length of stay. Moreover, a hospital’s
nursing capacity may influence the likelihood of providing palliative care services. Nursing
capacity is measured as a continuous variable by dividing the hospital’s number of full-time
registered nurses by total nurses.
Multiple demand-related county characteristics are included as control variables.
Specifically, environmental uncertainty may affect the hospital’s managerial decision to conform
to institutional demands (Oliver, 1990). Environmental uncertainty depends on the availability of
critical resources in the environment (i.e., munificence) (Pfeffer & Salancik, 1978) and may
influence the hospital’s decision or ability to provide palliative care services. The following
variables are used in this study to account for munificence: the fraction of uninsured individuals
aged between 18 and 64, market size (i.e., the number of total residents in the county), inflationunadjusted per capita income, the unemployment rate for individuals aged 16 and older, HMO
penetration (i.e., the percentage of fully insured lives covered by HMO), and PPO penetration
(i.e., the percentage of fully insured lives covered by PPO) in the hospital’s county. Finally, the
area wage index is included to account for geographic cost differences or price factors. This
index is computed and provided by CMS and comprises the ratio of the average hourly wage of a
geographic area to the average hourly wage nationwide. Hospital geographic areas are defined in
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accordance with the Core-Based Statistical Areas (CBSAs), established by the Office of
Management and Budget. The national average hourly wage is calculated by dividing total wage
costs by total hours for hospitals nationwide, whereas the average hourly wage for each
geographic area is calculated by dividing total wage costs by total hours for hospitals in the
geographic area. Therefore, hospitals located in the same geographic area are assigned the same
values for the area wage index.
To account for time-specific effects, dummy variables are included for each year with
year 2007 as the reference. Lastly, this study accounts for geographic variation by including five
state indicators, as prior research consistently demonstrated significant geographic variation in
hospital-based palliative care provision (e.g., Dumanovsky et al., 2015). California is treated as
the reference.
Research questions two and three: dependent and key independent variables.
Research question two investigates whether patients treated in hospitals with palliative
care services incur lower hospital costs, have shorter hospital stays, are less likely to die during
hospitalization, and are more likely to be transferred to hospice, corresponding to hypotheses 6a
through 6d. Research question three explores whether patients treated in hospitals that are more
experienced in providing palliative care services incur lower hospital costs, have shorter hospital
stays, are less likely to die during hospitalization, are more likely to be transferred to hospice,
corresponding to Hypotheses 7a through 7d. Table 8 presents the dependent and independent
variables used to test these eight hypotheses.
Four important features are noteworthy concerning the measurement of the key
dependent and independent variables presented in Table 8. First, in regard to length of stay, the
last day of hospitalization for patients transferred to hospice is determined by the day of hospice
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Table 8
A Description of Key Variables, Research Questions Two and Three

8

Construct
Variable
Measurement
Dependent Variables – Research Questions Two and Three
Organizational
Hospital costs
Continuous variable;
outcome
measured in constant
2007 U.S. dollars; log of
total patient charges
multiplied by hospital’s
CCR and (PPI2007/PPI2007+)
Patient
Hospital length of
Count variable;
outcome
stay (LOS)
LOS is defined by the
difference between day of
admission and day of
discharge or death
Patient
In-hospital mortality Binary variable;
Outcome
1=died during hospital
stay; 0=otherwise.
Patient
Outcome

Transfer to hospice

Binary variable;
1=discharged to home
hospice or hospice
facility; 0=otherwise.
Independent Variables – Research Question Two
H6a-d:
Presence of hospital- Three binary variables;
Palliative care
based:
1) 1=hospital has PAL;
provision
1) PAL
0=otherwise.
2) IPAL
2) 1=hospital has IPAL;
3) HOSPC
0=otherwise.
3) 1=hospital has
HOSPC; 0=otherwise.
Independent Variables – Research Question Three
H7a-d:
Years of experience Three continuous
Palliative care
providing hospitalvariables;
experience
based:
1) # of years PAL
1) PAL
present (since 2006).
2) IPAL
2) # of years IPAL
3) HOSPC
present (since 2006).
3) # of years HOSPC
present (since 2006).

Unit

Database

Patient

2007-2011
SID for
AZ, CA,
FL, MD,
NJ, & NY

Patient

2007-2011
SID for
AZ, CA,
FL, MD,
NJ, & NY

Patient

2007-2011
SID for
AZ, CA,
FL, MD,
NJ, & NY

Patient

2007-2011
SID for
AZ, FL, NJ,
& NY

Hospital

2007-2011
AHA
Annual
Hospital
Surveys

Hospital

2007-2011
AHA
Annual
Hospital
Surveys

Note. AHA=American Hospital Association. AZ=Arizona. CA=California. CCR=Cost-to-charge ratio. FL=Florida.
HOSPC=Hospice program. IPAL=Inpatient palliative care program. LOS=Length of stay. MD=Maryland, NJ=New
Jersey. NY=New York. PAL=Inpatient palliative care consultation service. PPI=Producer-price index. SID=State
inpatient database.
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transfer regardless of whether the patient is transferred to a hospital-based or an outside hospice
facility.
Second, in regard to hospital costs, a hospital’s cost-to-charge ratio (CCR) is the ratio of
a hospital’s total operating and capital-related expenses and total hospital charges using
information from the Medicare Hospital Cost Reports. The ratio ranges from zero to one, where
a value closer to zero constitutes a greater difference between hospital costs and hospital charges.
The Agency for Healthcare Research and Quality provides CCR files for 2007 through 2011
used to convert the patient’s hospital charges into their corresponding cost estimates. This study
applies a hospital-specific all-payer inpatient CCR (APICC) if available. If APICC is not
available, a weighted group-average all-payer inpatient CCR (GAPICC) is used, which is a
weighted average of CCR for a hospital in a given group. A group is defined by state, urban/rural
location, for-profit/not-for-profit ownership, and number of beds. The hospital’s proportion of
beds in a given group are used as the weight for each hospital.
Third, in regard to hospice transfers, transfers to home hospice include patients who were
discharged to receive hospice care at their place of residence, which may include a patient’s
private residence, nursing home, or assisted-living facility. Transfers to a hospice facility include
discharges to hospital-based hospices and outside hospice facilities.
Finally, in regard to palliative care experience, note that hospitals with PAL, IPAL, or
HOSPC present in 2007 are treated as hospitals with one year of experience in 2007. Hospitals
that discontinued a palliative care service were assigned a “0” in years of and after
discontinuation. Additionally, hospitals without a palliative care service throughout the study
period were assigned a “0” for experience in all years. This specification assumes time has a
linear effect.
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Two additional sample restrictions warrant further explanation. First, to examine research
questions two and three in regard to transfer to hospice, the analytical model excludes patients
treated in California and Maryland, because neither state provides information on transfer to
hospice. Second, separate analytical models for decedents and patients discharged alive are
estimated to assess research questions two and three concerning length of stay. In the context of
outcome evaluation, length of stay has a considerably different meaning for these two patient
populations. In particular, the end of the hospital stay is the time of discharge for survivors,
whereas the end of the hospital stay is determined by the patient’s death for decedents.
Research questions two and three: control variables.
All analytical models include the same set of control variables, which may be grouped
into patient, hospital, and market characteristics. Also, all hospital and market characteristics
included in the analytical model to investigate research question one, as described in the previous
sections, are incorporated as control variables in the analytical models to explore research
questions two and three. Note that one hospital control variable, a hospital’s average length of
stay, is not included in the 3-level HGLM with length of stay as the dependent variable to assure
model convergence.
Several patient characteristics, including demographic and clinical factors that may affect
hospital costs, length of stay, in-hospital mortality, and hospice transfers are included in the
analytical models. Patient demographics include the patient’s age, gender, race or ethnicity, and
payer type, income, residential location, and source of admission. This study focuses on patients
aged 18 or older on the day of hospital admission. The patient’s age is categorized into five
groups: 18-49 (the reference group), 50-64, 65-74, 75-84, and 85 or older. The patient’s gender is
measured as a binary variable with male patients being the reference group. Individuals are
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classified into one of the four race/ethnicity categories: non-Hispanic white (the reference
group), non-Hispanic African-American, Hispanic, and other. The patient’s payer type is divided
into five categories: Medicare (the reference group), Medicaid, private insurance, self-pay, or
charity/other. The patient’s income is approximated by a four-level categorical variable that
identifies in which state level income quartile the median household income in the patient’s zip
code falls. Specifically, values between 1 and 4 are assigned to identify the poorest to wealthiest
populations, respectively. The poorest population functions as the reference group. In addition,
the patient’s residential location is divided into one of the following categories: central/fringe
area with at least 1 million residents (the reference group), large metropolitan area with between
50,000 and 999,999 residents, and micropolitan/rural areas with fewer than 50,000 residents. The
patient’s source of hospital admission is divided into five categories: emergency room (the
reference group), routine, another hospital, another healthcare facility, and court/law
enforcement. Note that routine admissions include physician or HMO referrals and outpatient or
clinic transfers.
The following clinical indicators are also included in the analytical models. The patient’s
Charlson-Comorbidity Index (CCI) and number of surgical procedures are measured as
continuous variables and used to capture the patient’s medical severity. Furthermore, the
patient’s primary diagnosis is accounted for by seven binary variables indicating whether the
patient was assigned one of seven primary diagnoses using the Clinical Classifications Software
(CCS) based on ICD-9-CM codes: acute cerebrovascular disease (ACD) (ccs code = 109), acute
myocardial infarction (AMI) (CCS category = 100), congestive heart failure (CHF) (CCS
category = 108), chronic obstructive pulmonary disease (COPD) (CCS category = 127),
dementia (CCS category = 653), pneumonia (CCS category = 122), and HIV infection (CCS
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category = 5). Cancer patients, identified by the CCS categories 11 through 45, are treated as the
reference. Finally, a binary variable indicating whether a patient had a palliative care encounter
is included by identifying the ICD-9 CM code V66.7 among the patient’s secondary diagnoses.
Although patients can have palliative care encounters regardless of whether they are treated in
hospitals with specialty palliative care services (i.e., PAL, IPAL, and HOSPC), hospitals with
such services record about 30% more palliative care encounters than hospitals without such
services. Note that including and excluding this variable suggested that the key parameter
estimates in the models with hospital costs, length of stay, and transfer to hospice as dependent
variables were robust to including and excluding this variable. However, the results of the model
with in-hospital mortality as the dependent variable differ substantially and, thus, are discussed
separately in Chapter 5.
Empirical Methodology
Preliminary analysis.
Several preliminary analyses are performed. First, the data are analyzed carefully to
identify outliers and missing values, as described in a previous section of this chapter. Study
variables are assessed individually, over time and in different binary combinations to examine
the quality of the data. Scatterplots, histograms, and box plots are used to identify extreme values
to be excluded from the study sample. Distributive properties are examined to determine
appropriate data transformations. Descriptive statistics are also used to decide on the unit of
measurement. Data management is performed using Stata/MP for Windows (64-bit), Version
14.0. Hierarchical linear modeling is conducted using MELOGIT command in Stata and the
MIXED and GLIMMIX procedure in SAS for Windows (64-bit), Version 9.4.

95

Model assumptions.
In hierarchical modeling, several formal assumptions are required to be met to generate
unbiased, consistent, and accurate estimates (Raudenbush & Bryk, 2002a). The first set of
assumptions pertains to the unbiasedness of the coefficients estimating the effects of the
covariates. Specifically, level-1 covariates are independent of the level-1 error term. Similarly,
level-2 and level-3 covariates are independent of the level-2 and level-3 error terms, respectively.
In addition, the covariates at each level are not correlated with the random effects at the other
levels. The second set of assumptions relates to the random effects in the model and thus affects
the consistency and accuracy of standard error estimation. In particular, in the case of continuous
outcome models (i.e., hospital costs), each level-1 error term is normally distributed,
independent, and has a mean of zero and variance of 𝜎 2 for every level-1 unit. Furthermore, the
random errors at higher levels are independent from each other. Note that in the case of binary
outcome models (i.e., palliative care provision, in-hospital mortality, and transfer to hospice), the
level-1 error variance has a mean of zero and a fixed variance at 𝜋 2 ⁄3. Finally, in the case of
count outcome models (i.e., length of stay), the level-1 error variance is assumed to be equal to
the mean.
Research question one: empirical model.
A two-level HGLM is employed to address research question one and the corresponding
hypotheses 1 through 5. The empirical model is based on the notion that hospitals are nested
within counties, meaning a hospital’s log-odds of having at least one of three palliative care
services (i.e., PAL, IPAL, and/or HOSPC) in place may differ across counties. Hospital
characteristics are modeled at the lowest level with subscript j and county characteristics at the
higher level with subscript k. Each hierarchical level is provided with a level-specific model, in

96

which hospital characteristics predict palliative care provision and county characteristics predict
the average county’s palliative care provision. The level-specific models are then joined into a
combined model for hypothesis testing. The combined model may be expressed by the following
equation,
Empirical Model Research Question One, Palliative Care Provision
(𝑃𝐶_𝑃𝑅𝑂𝑉)𝑗𝑘 = 𝛾00 + 𝛾10 (𝑆𝐼𝑍𝐸)𝑗𝑘 + 𝛾20 (𝐴𝐿𝑇)𝑗𝑘 + 𝛾30 (𝑀𝐸𝐷𝐶_𝐼𝑁𝑃𝑆𝐻𝐴𝑅𝐸)𝑗𝑘 + 𝛾40 (𝑇𝐸𝐴𝐶𝐻)𝑗𝑘
+ 𝛾50 (𝐶𝑁𝑇𝑅𝐿𝑆1)𝑗𝑘 + 𝛾01 (𝐶𝑂𝑀𝑃)𝑘 + 𝛾02 (𝐶𝑁𝑇𝑅𝐿𝑆2)𝑘 + 𝛾03 (𝑌𝐸𝐴𝑅)𝑘 + 𝑒𝑗𝑘 + 𝑢0𝑘 .

where j = 1, 2, …, 𝑛𝑘 hospitals and k = 1, 2, …, N counties, (PC_PROV)𝑗𝑘 is hospital j’s
log-odds of providing at least one of three palliative care services (i.e., PAL, IPAL, and/or
HOSPC), and 𝛾00 is the average log-odds of having at least one of three palliative care services
across all hospitals when all covariates equal zero. Furthermore, (𝑆𝐼𝑍𝐸)𝑗𝑘 is hospital j’s bed
size, (𝐴𝐿𝑇)𝑗𝑘 is a binary variable (1 = hospital j’s has access to palliative care services through a
health system, network, or a joint venture, 0 = otherwise), (𝑀𝐸𝐷𝐶_𝐼𝑁𝑃𝑆𝐻𝐴𝑅𝐸)𝑗𝑘 is hospital j’s
share of Medicare patients, (𝑇𝐸𝐴𝐶𝐻)𝑗𝑘 is a binary variable (1 = hospital j is a member of
COTH, 0 = otherwise), (𝐶𝑁𝑇𝑅𝐿𝑆1)𝑗𝑘 is a vector of hospital-specific control variables,
(𝐶𝑂𝑀𝑃)𝑘 is county k’s level of hospital competition, (𝐶𝑁𝑇𝑅𝐿𝑆2)𝑘 is a vector of county-specific
control variables, (𝑌𝐸𝐴𝑅)𝑘 is a vector of year dummies for years 2008 through 2011, 𝑒𝑗𝑘 is the
error variance across patients with mean 0 and fixed variance, and 𝑢0𝑘 is the error variance
across counties.
The five (alternative) hypotheses under research question one and their corresponding
null hypotheses are stated below. Statistical significance is examined using individual t-tests.
Null and Alternative Hypotheses, Hypothesis 1
𝐻0 : 𝛾10 = 0 ; 𝐻1 : 𝛾10 > 0.
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Null and Alternative Hypotheses, Hypothesis 2
𝐻0 : 𝛾01 = 0 ; 𝐻2 : 𝛾01 > 0.

Null and Alternative Hypotheses, Hypothesis 3
𝐻0 : 𝛾20 = 0 ; 𝐻3 : 𝛾20 < 0.

Null and Alternative Hypotheses, Hypothesis 4
𝐻0 : 𝛾30 = 0 ; 𝐻4 : 𝛾30 > 0.

Null and Alternative Hypotheses, Hypothesis 5
𝐻0 : 𝛾40 = 0 ; 𝐻5 : 𝛾40 > 0.

Research questions two and three: empirical models.
Four three-level HGLM and HLM are employed to address research questions two and
three and the corresponding hypotheses. The empirical models are based on the notion that
patients are nested within hospitals, and hospitals are nested within counties. Specifically, patient
characteristics are modeled at the first level with subscript i, hospital characteristics are modeled
at the second level with subscript j, and county characteristics are modeled at the third level with
subscript k. Each hierarchical level can be modeled separately. These models are then joined into
combined models used for hypothesis testing for each of the four dependent variables,
respectively. Specifically, the combined models for hospital costs, (COSTS)𝑖𝑗𝑘 , length of stay,
(LOS)𝑖𝑗𝑘 , in-hospital mortality, (INH_MORT)𝑖𝑗𝑘 , and transfer to hospice, (TR_HOSPC)𝑖𝑗𝑘 ,
respectively are stated as follows,
Empirical Model Research Questions Two and Three, Hospital Costs
(COSTS)𝑖𝑗𝑘 = 𝛾000 + 𝛾100 (𝐶𝑁𝑇𝑅𝐿𝑆1)𝑖𝑗𝑘 + 𝛾010 (𝑃𝐴𝐿)𝑗𝑘 + 𝛾020 (𝐼𝑃𝐴𝐿)𝑗𝑘
+ 𝛾030 (𝐻𝑂𝑆𝑃𝐶)𝑗𝑘 + 𝛾040 (𝑃𝐴𝐿_𝐸𝑋𝑃)𝑗𝑘 + 𝛾050 (𝐼𝑃𝐴𝐿_𝐸𝑋𝑃)𝑗𝑘
+ 𝛾060 (𝐻𝑂𝑆𝑃𝐶_𝐸𝑋𝑃)𝑗𝑘 + 𝛾070 (𝐶𝑁𝑇𝑅𝐿𝑆2)𝑗𝑘 + 𝛾001 (𝐶𝑁𝑇𝑅𝐿𝑆3)𝑘
+ 𝛾002 (𝑌𝐸𝐴𝑅)𝑘 + 𝑒𝑖𝑗𝑘 + 𝑟0𝑗𝑘 + 𝑢00𝑘 .
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where i = 1, 2… 𝑛𝑗𝑘 patients, j = 1, 2… 𝑛𝑘 hospitals, k = 1, 2… N counties, (COSTS)𝑖𝑗𝑘
is patient i’s hospital costs, and 𝛾000 is the average hospital costs across all hospitals. In addition,
(𝐶𝑁𝑇𝑅𝐿𝑆1)𝑖𝑗𝑘 is a vector of patient characteristics, (𝑃𝐴𝐿)𝑗𝑘 is a binary variable (1 = hospital j
has an inpatient palliative care consultation service, 0 = otherwise), (𝐼𝑃𝐴𝐿)𝑗𝑘 is a binary variable
(1 = hospital j has an inpatient palliative care unit, 0 = otherwise), (𝐻𝑂𝑆𝑃𝐶)𝑗𝑘 is a binary
variable (1 = hospital j has a hospice program, 0 = otherwise), (𝑃𝐴𝐿_𝐸𝑋𝑃)𝑗𝑘 is hospital j’s years
of experience in offering an inpatient palliative care consultation service, (𝐼𝑃𝐴𝐿_𝐸𝑋𝑃)𝑗𝑘 is
hospital j’s years of experience in offering an inpatient palliative care unit, (𝐻𝑂𝑆𝑃𝐶_𝐸𝑋𝑃)𝑗𝑘 is
hospital j’s years of experience in providing a hospice program, (𝐶𝑁𝑇𝑅𝐿𝑆2)𝑗𝑘 is a vector of
hospital characteristics, (𝐶𝑁𝑇𝑅𝐿𝑆3)𝑘 is a vector of county characteristics, (𝑌𝐸𝐴𝑅)𝑘 is a vector
of year dummies for years 2008 through 2011, 𝑒𝑖𝑗𝑘 is the error variance between patients, 𝑟0𝑗𝑘 is
the error variance across hospitals, and 𝑢00𝑘 is the error variance across counties.
Empirical Model Research Questions Two and Three, Length of Stay
(LOS)𝑖𝑗𝑘 = 𝛾000 + 𝛾100 (𝐶𝑁𝑇𝑅𝐿𝑆1)𝑖𝑗𝑘 + 𝛾010 (𝑃𝐴𝐿)𝑗𝑘 + 𝛾020 (𝐼𝑃𝐴𝐿)𝑗𝑘 + 𝛾030 (𝐻𝑂𝑆𝑃𝐶)𝑗𝑘
+ 𝛾040 (𝑃𝐴𝐿_𝐸𝑋𝑃)𝑗𝑘 + 𝛾050 (𝐼𝑃𝐴𝐿_𝐸𝑋𝑃)𝑗𝑘 + 𝛾060 (𝐻𝑂𝑆𝑃𝐶_𝐸𝑋𝑃)𝑗𝑘
+ 𝛾070 (𝐶𝑁𝑇𝑅𝐿𝑆2)𝑗𝑘 + 𝛾001 (𝐶𝑁𝑇𝑅𝐿𝑆3)𝑘 + 𝛾002 (𝑌𝐸𝐴𝑅)𝑘 + 𝑒𝑖𝑗𝑘 + 𝑟0𝑗𝑘 + 𝑢00𝑘 .

where i = 1, 2… 𝑛𝑗𝑘 patients, j = 1, 2… 𝑛𝑘 hospitals, k = 1, 2… N counties, (LOS)𝑖𝑗𝑘 is
patient i’s hospital length of stay, 𝛾000 is the average hospital length of stay across all hospitals,
and 𝑒𝑖𝑗𝑘 is the error variance across patients with a mean equal to the variance. The remaining
variables have the same definitions as noted above.
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Empirical Model Research Questions Two and Three, In-hospital Mortality
(INH_MORT)𝑖𝑗𝑘
= 𝛾000 + 𝛾100 (𝐶𝑁𝑇𝑅𝐿𝑆1)𝑖𝑗𝑘 + 𝛾010 (𝑃𝐴𝐿)𝑗𝑘 + 𝛾020 (𝐼𝑃𝐴𝐿)𝑗𝑘
+ 𝛾030 (𝐻𝑂𝑆𝑃𝐶)𝑗𝑘 + 𝛾040 (𝑃𝐴𝐿_𝐸𝑋𝑃)𝑗𝑘 + 𝛾050 (𝐼𝑃𝐴𝐿_𝐸𝑋𝑃)𝑗𝑘
+ 𝛾060 (𝐻𝑂𝑆𝑃𝐶_𝐸𝑋𝑃)𝑗𝑘 + 𝛾070 (𝐶𝑁𝑇𝑅𝐿𝑆2)𝑗𝑘 + 𝛾001 (𝐶𝑁𝑇𝑅𝐿𝑆3)𝑘
+ 𝛾002 (𝑌𝐸𝐴𝑅)𝑘 + 𝑒𝑖𝑗𝑘 + 𝑟0𝑗𝑘 + 𝑢00𝑘 .

where i = 1, 2… 𝑛𝑗𝑘 patients, j = 1, 2… 𝑛𝑘 hospitals, k = 1, 2… N counties,
(INH_MORT)𝑖𝑗𝑘 is patient i’s log-odds of in-hospital mortality, 𝛾000 is the average log-odds of
in-hospital mortality across all hospitals, and 𝑒𝑖𝑗𝑘 is the error variance across patients with mean
0 and fixed variance. The remaining variables have the same definitions as noted above.
Empirical Model Research Questions Two and Three, Transfer to Hospice
(TR_HOSPC)𝑖𝑗𝑘 = 𝛾000 + 𝛾100 (𝐶𝑁𝑇𝑅𝐿𝑆1)𝑖𝑗𝑘 + 𝛾010 (𝑃𝐴𝐿)𝑗𝑘 + 𝛾020 (𝐼𝑃𝐴𝐿)𝑗𝑘 + 𝛾030 (𝐻𝑂𝑆𝑃𝐶)𝑗𝑘
+ 𝛾040 (𝑃𝐴𝐿_𝐸𝑋𝑃)𝑗𝑘 + 𝛾050 (𝐼𝑃𝐴𝐿_𝐸𝑋𝑃)𝑗𝑘 + 𝛾060 (𝐻𝑂𝑆𝑃𝐶_𝐸𝑋𝑃)𝑗𝑘
+ 𝛾070 (𝐶𝑁𝑇𝑅𝐿𝑆2)𝑗𝑘 + 𝛾001 (𝐶𝑁𝑇𝑅𝐿𝑆3)𝑘 + 𝛾002 (𝑌𝐸𝐴𝑅)𝑘 + 𝑒𝑖𝑗𝑘 + 𝑟0𝑗𝑘 + 𝑢00𝑘 .

where i = 1, 2… 𝑛𝑗𝑘 patients, j = 1, 2… 𝑛𝑘 hospitals, k = 1, 2… N counties,
(TR_HOSPC)𝑖𝑗𝑘 is patient i’s log-odds of hospice transfer, 𝛾000 is the average log-odds of
hospice transfer across all hospitals, and 𝑒𝑖𝑗𝑘 is the error variance across patients with mean 0
and fixed variance. The remaining variables have the same definitions as noted above.
To test the four (alternative) hypotheses under research question two, joint hypothesis
tests are used. Note that statistical significance of the three key parameters (i.e., dummy variables
for PAL, IPAL, and HOSPC) cannot be tested using individual t-tests due to the nature of the
palliative care experience variable used to address research question three. Specifically, hospitals
with a palliative care service in a given year are coded having at least one year of experience
providing this service. Individual t-tests are invalid in this set-up, as they test the statistical
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significance of the key parameters when palliative care experience and other covariates is zero.
Therefore, three joint hypothesis tests are conducted to address research question two, which
evaluate a 1-year effect of PAL, IPAL, and HOSPC on hospital costs, length of stay, in-hospital
mortality, and transfer to hospice, respectively.
Null and Alternative Hypotheses 6a, Hospital Costs
𝐻0 : 𝛾010 + 𝛾040 = 0; 𝐻6𝑎 : 𝛾010 + 𝛾040 < 0.
𝐻0 : 𝛾020 + 𝛾050 = 0; 𝐻6𝑎 : 𝛾020 + 𝛾050 < 0.
𝐻0 : 𝛾030 + 𝛾060 = 0; 𝐻6𝑎 : 𝛾030 + 𝛾060 < 0.

Null and Alternative Hypotheses 6b, Length of Stay
𝐻0 : 𝛾010 + 𝛾040 = 0; 𝐻6𝑏 : 𝛾010 + 𝛾040 < 0.
𝐻0 : 𝛾020 + 𝛾050 = 0; 𝐻6𝑏 : 𝛾020 + 𝛾050 < 0.
𝐻0 : 𝛾030 + 𝛾060 = 0; 𝐻6𝑏 : 𝛾030 + 𝛾060 < 0.

Null and Alternative Hypotheses 6c, In-hospital Mortality
𝐻0 : 𝛾010 + 𝛾040 = 0; 𝐻6𝑐 : 𝛾010 + 𝛾040 < 0.
𝐻0 : 𝛾020 + 𝛾050 = 0; 𝐻6𝑐 : 𝛾020 + 𝛾050 < 0.
𝐻0 : 𝛾030 + 𝛾060 = 0; 𝐻6𝑐 : 𝛾030 + 𝛾060 < 0.

Null and Alternative Hypotheses 6d, Transfer of Hospice
𝐻0 : 𝛾010 + 𝛾040 = 0; 𝐻6𝑑 : 𝛾010 + 𝛾040 > 0.
𝐻0 : 𝛾020 + 𝛾050 = 0; 𝐻6𝑑 : 𝛾020 + 𝛾050 > 0.
𝐻0 : 𝛾030 + 𝛾060 = 0; 𝐻6𝑑 : 𝛾030 + 𝛾060 > 0.

To address research question three, the effects of palliative care experience are tested
using individual t-tests. The four (alternative) hypotheses and their corresponding null
hypotheses are stated as follows,
Null and Alternative Hypotheses 7a, Hospital Costs
𝐻0 : 𝛾040 = 0; 𝐻7𝑎 : 𝛾040 < 0.
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𝐻0 : 𝛾050 = 0; 𝐻7𝑎 : 𝛾050 < 0.
𝐻0 : 𝛾060 = 0; 𝐻7𝑎 : 𝛾060 < 0.

Null and Alternative Hypotheses 7b, Length of Stay
𝐻0 : 𝛾040 = 0; 𝐻7𝑏 : 𝛾040 < 0.
𝐻0 : 𝛾050 = 0; 𝐻7𝑏 : 𝛾050 < 0.
𝐻0 : 𝛾060 = 0; 𝐻7𝑏 : 𝛾060 < 0.

Null and Alternative Hypotheses 7c, In-hospital Mortality
𝐻0 : 𝛾040 = 0; 𝐻7𝑐 : 𝛾040 < 0.
𝐻0 : 𝛾050 = 0; 𝐻7𝑐 : 𝛾050 < 0.
𝐻0 : 𝛾060 = 0; 𝐻7𝑐 : 𝛾060 < 0.

Null and Alternative Hypotheses 7d, Transfer to Hospice
𝐻0 : 𝛾040 = 0; 𝐻7𝑑 : 𝛾040 > 0.
𝐻0 : 𝛾050 = 0; 𝐻7𝑑 : 𝛾050 > 0.
𝐻0 : 𝛾060 = 0; 𝐻7𝑑 : 𝛾060 > 0.

Sensitivity Analysis
Several sensitivity analyses are performed to evaluate the robustness of the empirical
results regarding the associations between the five key independent variables and the probability
of palliative care provision corresponding to research question one. Specifically, three alternative
specifications using respectively the provision of inpatient palliative care consultation services,
inpatient palliative care units, and hospice programs are used to determine whether the results are
robust across alternative measures of palliative care provision. It is possible that the effects of
key independent variables have different effects on the provision of the three different types of
palliative care services.
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Several sensitivity analyses are conducted to examine the effects of palliative care on
hospital performance. First, in regard to hospital costs, separate models for decedents and
survivors are estimated to evaluate whether palliative care services have consistent effects on
hospital costs across the two patient populations. Empirical evidence exists that patients who
received a palliative care consultation and subsequently died during hospitalization incurred
significantly lower hospital costs than survivors who received a palliative care consultation
during their hospital stay (Whitford et al., 2014). Second, length of stay for patients who were
transferred to hospice is examined to assess the effects of palliative care services on discharge
timing when subsequent hospice transfers were initiated. Third, the effects of palliative care
services on transfer to hospice are examined based on a patient sample, which includes patients
who were transferred to hospice and patients who were discharged to home health care or a
skilled nursing facility. This sensitivity analysis is performed to assess whether hospital-based
palliative care services increases a patient’s probability of hospice transfer when compared to
patients with the above-mentioned discharge statuses. Finally, the effects of palliative care
services on in-hospital mortality are evaluated for each primary diagnosis individually to
determine how sensitive the results are to the selection of different patient populations.
Summary
This chapter identified the research design, data sources, study sample, variable
measurement, the empirical methodology, and sensitivity analyses used in this study. This study
employs a pooled, cross-sectional research design. Data elements from six different data sources
are linked to create the study’s sample, including a variety of patient, hospital, and county
information.
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The study’s three research questions are investigated with a balanced panel of hospitals
from six states over a period of five years. A two-level HGLM is used to address research
question one. Three-level HGLM and HLMs are used to investigate research questions two and
three. The empirical findings of these analytical models and their corresponding sensitivity
analyses are presented in Chapter 5.
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Chapter 5: Results

This chapter presents the study findings based on the data and methodology discussed in
the previous chapter and is divided into four sections. The first section provides descriptive
statistics on patients, hospitals, and counties for Arizona, California, Florida, Maryland, New
Jersey, and New York during the study period 2007 to 2011. The second and third sections report
the empirical results of the study’s analytical models and sensitivity analyses for each research
question. The last section provides a brief summary.
Results of Descriptive Analysis
Number of patients, hospitals, and counties.
During the study period, a total of 59,315,052 patient visits across all hospitals in the
study states were recorded in the SID discharge files. About 6.34% of those were included in the
study, amounting to 3,763,339 patient records. As discussed earlier, patient records were
included in the study sample only if they belonged to patients who were 18 years or older, had
one of eight primary diagnoses, and were treated in urban, non-federal, general, and acute care
hospitals. More than half of patients in the study sample were treated in California (30.49%) and
Florida (23.14%). Patients in New York and New Jersey accounted for approximately 15% of the
study sample, respectively. Arizona and Maryland had the smallest patient shares with 7.05%
and 9.24%, respectively. The study’s patients received medical care in 348 hospitals located in
111 counties across the six study states. The average state in the study sample is comprised of 19
urban counties, with Arizona having the least (n=5) and California the most (n=28). The number
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of hospitals per county varied from one to 37, with a sample average of three. Specifically, 42
counties had one hospital, 41 counties had between two and three hospitals, 17 counties had four
to six hospitals, and 10 counties had seven to 14 hospitals. One county consisted of 37 hospitals.
The average hospital had 2,163 patients meeting the sample criteria annually, with one reporting
only 37 and another reporting 16,773 patients.
Characteristics of patients.
Table 9 provides a comparison of patients across patient disposition. The majority of
patients were 65 years and older (61.06%), and white (67.02%). The sample was almost evenly
split between female and male patients. While the distribution of patient gender and
race/ethnicity was similar across patient disposition, the average patient who expired during the
hospital stay was five years older than the average patient discharged alive, with 73 and 68 years
respectively. The median household income quartile by patient zip code as a proxy for patient
income was relatively evenly distributed among the four quartiles. Relatively more patients
belonged to the lowest quartile (26.72%) than the wealthiest quartile (22.02%). Most patients
resided in central/fringe areas with at least one million residents (73.72%). The remaining
patients lived in metropolitan areas with 50,000 to 999,999 residents (23.42%) or micro/rural
areas with fewer than 50,000 residents (2.92%). Note that while the study examined urban
hospitals only, patients who were treated in these hospitals may live in non-urban areas.
Most patients were covered by Medicare (60.92%), followed by private insurance
(22.52%), Medicaid (9.82%), self-pay (3.72%), and other means (3.02%). The distributions of
patient income, urban/rural residence, and type of health insurance were comparable across
patient disposition. The majority of patients were admitted through the emergency room
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Table 9
Descriptive Statistics for Patient Characteristics by Patient Disposition, 2007-2011
Table 9 (continued)
Patient Disposition
Discharged
Alive
Died in Hospital
Patient Characteristics
#
(%)
#
(%)
Control Variables
Gender
Male
1,788,429 (49.82)
85,265 (50.42)
Female
1,805,702 (50.22)
83,943 (49.62)
Age
18-49 (reference)
482,482 (13.42)
12,735
(7.52)
50-64
941,314 (26.22)
32,328 (19.12)
65-74
774,266 (21.52)
33,409 (19.72)
75-84
843,400 (23.52)
48,534 (28.72)
85+
552,669 (15.42)
42,202 (24.92)
Race/Ethnicity
White (reference)
2,403,946 (66.92)
116,865 (69.12)
Black
511,582 (14.22)
19,370 (11.42)
Hispanic
430,656 (12.02)
18,747 (11.12)
Other
247,947
(6.92)
14,226
(8.42)
Median HH Income (level: ZIP)
Lowest quartile (reference)
963,620 (26.82)
42,879 (25.32)
b
2nd lowest quartile
906,482 (25.22)
42,831 (25.32)
b
2nd highest quartile
934,837 (26.02)
43,929 (26.02)
Highest quartile
789,192 (22.02)
39,569 (23.42)
Urban/Rural Residencec
Central/Fringe (reference)
2,651,346 (73.82)
123,559 (73.02)
Metro
839,217 (23.32)
40,732 (24.12)
Micro/Ruralb
103,568
(2.92)
4,917
(2.92)
9

Total
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#

(%)

1,873,694
1,889,645

(49.82)
(50.22)

495,217
973,642
807,675
891,934
594,871

(13.22)
(25.92)
(21.52)
(23.72)
(15.82)

2,520,811
530,952
449,403
262,173

(67.02)
(14.12)
(11.92)
(7.02)

1,006,499
949,313
978,766
828,761

(26.72)
(25.22)
(26.02)
(22.02)

2,774,905
879,949
108,485

(73.72)
(23.42)
(2.92)

Table 9 (continued)
Patient Characteristics
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Health Insurance
Medicare (reference)
Medicaid
Private
Self-pay
Other
Source of Admission
Emergency room (reference)
Another hospital
Another HCF
Court/Law enforcementb
Routine
Primary Diagnosis
Cancer (reference)
ACD
AMI
CHF
COPD
Dementia
HIV
Pneumonia
Charlson-Comorbidity Indexa
Number of surgical proceduresa
Palliative care encounter
No (reference)
Yes
Dependent Variables
Length of staya

Patient Disposition
Discharged Alive
Died in Hospital
#
(%)
#
(%)

Total
#

(%)

2,181,588
357,106
814,570
131,655
109,212

(60.72)
(9.92)
(22.72)
(3.72)
(3.02)

112,118
13,443
32,255
5,989
5,403

(66.32)
(7.92)
(19.12)
(3.52)
(3.22)

2,293,706
370,549
846,825
137,644
114,615

(60.92)
(9.82)
(22.52)
(3.72)
(3.02)

1,838,797
140,063
85,786
2,076
1,527,409

(51.22)
(3.92)
(2.42)
(0.12)
(42.52)

98,704
13,643
7,370
84
49,407

(58.32)
(8.12)
(4.42)
(0.02)
(29.22)

1,937,501
153,706
93,156
2,160
1,576,816

(51.52)
(4.12)
(2.52)
(0.12)
(41.92)

1,035,008
384,756
416,531
679,175
404,673
65,411
42,644
565,933
2.50
2.03

(28.82)
(10.72)
(11.62)
(18.92)
(11.32)
(1.82)
(1.22)
(15.72)
(2.50)
(2.71)

51,520
38,976
25,171
21,354
6,558
976
2,678
21,975
3.16
3.46

(30.42)
(23.02)
(14.92)
(12.62)
(3.92)
(0.62)
(1.62)
(13.02)
(2.68)
(3.77)

1,086,528
423,732
441,702
700,529
411,231
66,387
45,322
587,908
2.53
2.09

(28.92)
(11.32)
(11.72)
(18.62)
(10.92)
(1.82)
(1.22)
(15.62)
(2.22)
(2.78)

3,538,455
55,676

(98.52)
(1.52)

125,997
43,211

(74.52)
(25.52)

3,664,452
98,887

(97.42)
(2.62)

5.39

(4.60)

6.88

(6.57)

5.46

(4.72)

Table 9 (continued)
Patient Characteristics
Hospital costs (in 2007 US$)
Died in hospital
No
Yes
Transferred to hospice
No
Yes
Total

a

Patient Disposition
Discharged Alive
Died in Hospital
#
(%)
#
(%)
12,380 (12,948)
19,547 (23,426)
-

-

2,768,815 (96.52)
101,065 (3.52)
3,594,131 (100)

-

Total
#
(%)
12,703 (13,675)

-

3,594,131 (95.52)
169,208 (4.52)

169,208 (100)

2,178,845 (96.12)
89,321 (3.92)
3,763,339 (100)

109

Note. ACD=Acute cerebrovascular disease. AMI=Acute myocardial infarction. CHF=Congestive heart failure. COPD=Chronic obstructive pulmonary disease.
HCF=Healthcare facility. HH=Household. HIV=Human immunodeficiency virus. ZIP=Zone improvement plan. Two-sample z-tests are used to compare the
proportions across patient disposition.
a
Means and standard deviations are reported for Charlson-Comorbidity Index, number of surgical procedures, length of stay, and hospital costs; t-tests are used
to test differences in means across patient disposition. All differences across patient disposition are significant at the p<.05 level. bThe proportions by patient
disposition are not statistically significant (p>.1). cCentral/Fringe: ≥1 million residents; Metro: 50,000-999,999 residents; Micro/Rural: <50,000 residents.

(51.52%) and more than a third of patients were admitted routinely (41.92%). A significantly
higher percentage of expired patients were admitted from another hospital or healthcare facility
(12.54%) compared with patients discharged alive (6.34%). Patients discharged alive were also
more likely to be admitted routinely (42.52%) than expired patients (29.22%).
A total of 169,208 patients died during hospitalization (4.52%) and 89,321 of patients
who lived to be discharged were transferred to hospice (3.92%). About a third of patients had a
cancer-related primary diagnosis (28.92%). The second most common primary diagnosis was
congestive heart failure (18.62%), followed by pneumonia (15.62%), acute myocardial infarction
(11.72%), acute cerebrovascular disease (11.32%), COPD (10.92%), dementia (1.82%), and HIV
(1.22%). Acute cerebrovascular disease was more prevalent among decedents (23.02%)
compared with survivors (10.72%). In contrast, COPD was significantly less prevalent among
expired patients (3.92%) than patients discharged alive (11.32%). Altogether, decedents were
sicker than patients who were discharged alive. On average, decedents had a higher CharlsonComorbidity Index (3.16 versus 2.5) and more surgical procedures (3.46 versus 2.03). Decedents
also stayed in the hospital longer and incurred higher hospital costs than survivors. The average
decedent had a hospital LOS of 6.88 days and incurred $19,547 in hospital costs, whereas the
average survivor was discharged after 5.39 days and incurred $12,380 in hospital costs. The
differences were statistically significant. In addition, one in four decedents had a palliative care
encounter (25.52%). Among survivors, very few had a palliative care encounter (1.52%).
In summary, the majority of patients were white, at least 65 years old, covered by
Medicare, and lived in urban areas. Most patients were admitted to the hospital through the
emergency room and had a primary diagnosis related to cancer, congestive heart failure, or
pneumonia. There were also noteworthy differences between patients who died during
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hospitalization and patients who lived to be discharged. On average, expired patients were sicker
than survivors with longer hospital LOS, more surgical procedures, and a higher CharlsonComorbidity Index. Decedents also incurred higher hospital costs, were more likely to have a
palliative care encounter and to be admitted to the hospital for acute cerebrovascular disease.
Characteristics of hospitals.
In Table 10, the hospitals in the study sample are compared with all general, acute care,
short-term, non-federal, and urban hospitals present in the 2007-2011 AHA Annual Survey of
Hospitals data. Each hospital-year combination was treated as an observation to calculate the
averages and percentages presented in Table 10.
Table 10
Comparison of Hospitals in the AHA Database and the Study Sample, 2007-2011

10

Hospital Characteristics
Bed size M (SD)
Ownership n (%)
For-profit
Public
Not-for-profit
Teaching status n (%)
COTH member
Non-teaching
PC provision n (%)
PAL, IPAL, and/or HOSPC
PAL
IPAL
HOSPC
Years of experience with PC
(since 2006) M (SD)
PAL
IPAL
HOSPC

National Sample
(n=1,687)
267 (229)

Study Sample
(n=348)
331 (234)

248 (14.70)
256 (15.17)
1,183 (70.13)

45 (12.93)
52 (14.95)
251 (72.12)

***

228 (13.51)
1,460 (86.54)

62 (17.82)
286 (82.18)

***
***

216
200
61
86

***
***
***
*

943
820
227
449

(55.89)
(48.60)
(13.44)
(26.60)

1.38 (1.72)
0.34 (0.99)
0.73 (1.41)

(61.95)
(57.36)
(17.53)
(24.83)

1.64 (1.77)
0.45 (1.13)
0.66 (1.35)

Difference
***

**

***
***
**

Note. AHA=American Hospital Association. COTH=Council of Teaching Hospitals. HOSPC=Hospice program. IPAL=
Inpatient palliative care unit. M=Mean. PAL=Inpatient palliative care consultation service. PC=Palliative care. SD=Standard
deviation. t-tests were conducted to compare means of national and study samples for bed size and years of PC in place. Twosample z-tests of proportions were performed to compare proportions of national and study samples for all other variables.

* p < .1 ** p < .05 *** p < .01.
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Note that results were computed and reported for hospitals with complete information
only and for hospitals that were in operation throughout the study period. It is expected that
hospitals with palliative care services are more prevalent in the study sample than in the national
sample. Several of the states in the study sample have passed or introduced legislation or
initiatives promoting increased access to palliative care, including California, Florida, Maryland,
and New Jersey (Adondakis & Daniell, 2015; Center to Advance Palliative Care, 2016). In
comparison to the national sample, these states may be more proactive in supporting palliative
care than other states. Thus, hospitals with palliative care services are more likely to be located
in these states. It is also expected that the average number of hospital beds is higher in the study
sample than in the national sample, as every study state (except Arizona) has a higher population
density than the national average and thus needs to be equipped to serve more patients. No
notable differences in teaching status or hospital ownership are expected.
The average hospital in the study sample is larger than the average hospital in the
national sample. The study sample has proportionately more not-for-profit and teaching
hospitals, but fewer for-profit hospitals than the national sample. The two samples also differ
significantly in regard to their palliative care adoption characteristics. As anticipated, the study
sample has proportionately more hospitals with at least one of three palliative care services.
Hence, the results from this study sample may only be generalizable across the study states or to
states with similarly high hospital-based palliative care prevalence.
The distribution of the individual palliative care services also differs significantly.
Specifically, the study sample has a significantly higher proportion of hospitals with inpatient
palliative care consultation services and inpatient palliative care units, but significantly fewer
hospitals that provide hospice programs. Similarly, the average hospital in the study sample has
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inpatient palliative care consultation services and inpatient palliative care units in place longer
and hospice programs in place shorter compared with the average hospital in the national sample.
Characteristics of counties.
Table 11 compares urban counties in the study sample with urban counties in the national
sample. Note that results are computed and reported for counties with non-missing information
only. It is expected that market competition is higher in the study sample than in the national
sample, as the study states have, on average, more hospitals located in urban counties than all
U.S. states. Furthermore, it is expected that the average population size is larger among urban
counties in the study sample than the national sample due to higher population density in the
majority of study states compared to the national average. No noteworthy differences in the
remaining county characteristics are expected.
Table 11
Comparison of Urban Counties in the AHA Database and the Study Sample, 2007-2011
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County Characteristics
Market competition
Area wage index
HMO penetration rate
PPO penetration rate
Per capita income
Population size
Unemployment rate
Uninsured rate

National Sample (n=899)
Mean
SD
0.33 (0.30)
0.96 (0.15)
6.5 (7.39)
13.4 (6.22)
36,826 (9,143)
283,918 (548,743)
7.45 (2.88)
19.34 (6.27)

Study Sample (n=111)
Difference
Mean
SD
***
0.49 (0.29)
***
1.12 (0.19)
***
12.89 (10.08)
13.32 (8.03)
***
43,765 (13,453)
***
762,012 (1,117,598)
***
8.38 (3.87)
***
20.42 (6.32)

Note. AHA=American Hospital Association. HMO=Health maintenance organization. PPO=Preferred provider
organization. SD=Standard deviation. t-tests were conducted to compare means.
* p < .1 ** p < .05 *** p < .01.

While the differences in means for most county characteristics were statistically
significant at the 1% level, the average PPO penetration rates were not statistically different
between the two groups. Compared to counties in the national sample, counties in the study
113

sample were on average more competitive, had a higher area wage index, higher HMO
penetration rate, higher per capita income, larger population, and higher unemployment rate.
Descriptive statistics of key variables.
Table 12 presents the annual means and standard deviations of the dependent variable
and the five key independent variables used to examine research question one. There was an
increase in palliative care provision (i.e., hospitals with PAL, IPAL, and/or HOSPC) over the
study period, with levels of palliative care provision ranging between 59% in 2007 and 66% in
2011 (p = .051). In addition, hospitals experienced a slight increase in hospital beds. Specifically,
the average hospital had 326 and 334 beds in 2007 and 2011, respectively. However, the increase
was not statistically significant. Hospitals also experienced a small increase in Medicare
inpatient days between 2007 and 2011, ranging from 46.4% in 2007 to 48.5% in 2011 (p < .036).
This increase may be an indication of an aging patient population. Moreover, while 51% of
hospitals had access to palliative care services through a health system, network, or joint venture
in 2007, 56% of hospitals had such access in 2011. The difference was not statistically
significant. There were no notable and statistically significant fluctuations in the number of
teaching hospitals or market competition over the study period. Note that there was little withinvariation for teaching status and hospital beds. Therefore, the coefficients estimated for these
variables are likely to derive from between-hospital variation.
Table 13 presents annual means and standard deviations of the four dependent variables
and key independent variables used to examine research questions two and three. According to
Table 13, the number of patients transferred to hospice and the log of inflation-adjusted hospital
costs remained stable over the study period. On average, 4% of patients in the study sample were
transferred to hospice annually.
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Table 12
Descriptives Statistics of Key Variables by Year, Research Question One

12

Variable
Dependent Variable
Provision of PAL, IPAL, and/or HOSPC

115

Independent Variables
H1: Number of staffed and set-up beds
H2: 1 minus HHI
H3: Presence of PC in health
system/network/JV
H4: Share of Medicare inpatient days (%)
H5: Membership with COTH

2007
Mean

(SD)

2008
Mean

(SD)

2009
Mean

2010

2011

(SD)

Mean

(SD)

Mean

(SD)

0.59 (0.49)

0.60 (0.49)

0.62 (0.49)

0.63

(0.48)

0.66 (0.48)

326 (227)
0.47 (0.31)

329 (234)
0.48 (0.29)

331 (235)
0.48 (0.29)

335
0.49

(238)
(0.29)

334 (236)
0.50 (0.28)

0.51 (0.50)
46.4 (13.8)
0.18 (0.38)

0.52 (0.50)
46.9 (13.3)
0.18 (0.38)

0.53 (0.50)
47.4 (13.3)
0.18 (0.38)

0.54
47.3
0.18

(0.50)
(13.6)
(0.38)

0.56 (0.50)
48.5 (13.2)
0.18 (0.38)

Note. COTH=Council of Teaching Hospitals. HHI=Herfindahl-Hirschman Index. HOSPC=Hospice program. IPAL=Inpatient palliative care unit. JV=Joint
venture. PAL=Inpatient palliative care consultation service. PC=Palliative care. SD=Standard deviation.

Table 13
Descriptive Statistics of Key Variables by Year, Research Questions Two/Three
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Variable
Dependent Variables
(n=3,763,339)
In-hospital mortality
Length of stay
Transfer to hospice*
Hospital costs
(2007 US$)
Log of hospital costs
(2007 US$)

2007

2008

2009

2010

2011

Mean

(SD)

Mean

(SD)

Mean

(SD)

Mean

(SD)

Mean

(SD)

0.05
5.60
0.04

(0.22)
(4.80)
(0.19)

0.05
5.54
0.04

(0.21)
(4.77)
(0.20)

0.05
5.44
0.04

(0.21)
(4.71)
(0.20)

0.04
5.39
0.04

(0.20)
(4.67)
(0.20)

0.04
5.32
0.04

(0.20)
(4.63)
(0.20)

(13,412) 12,679

(13,767)

12,911

(14,045)

12,779

(13,695) 12,676

(13,446) 12,475
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9.09

(0.84)

9.09

(0.82)

9.07

(0.83)

9.09

(0.83)

9.11

(0.82)

0.52
0.16
0.27

(0.50)
(0.37)
(0.45)

0.54
0.17
0.26

(0.50)
(0.37)
(0.44)

0.59
0.18
0.25

(0.49)
(0.39)
(0.43)

0.60
0.18
0.23

(0.49)
(0.39)
(0.42)

0.62
0.19
0.23

(0.49)
(0.39)
(0.42)

0.52

(0.50)

1.05

(0.98)

1.63

(1.44)

2.19

(1.90)

2.80

(2.35)

0.16

(0.37)

0.31

(0.70)

0.45

(1.02)

0.61

(1.36)

0.74

(1.65)

0.27

(0.45)

0.52

(0.87)

0.68

(1.23)

0.84

(1.59)

1.01

(1.94)

Independent Variables
(n=348)
H7: Presence of PAL
Presence of IPAL
Presence of HOSPC
H8: Years of experience
with PAL (since ‘06)
Years of experience
with IPAL (since ‘06)
Years of experience
with HOSPC (since ’06)

Note. IPAL=Inpatient palliative care unit. HOSPC=Hospice program. PAL=Inpatient palliative care consultation service. SD=Standard deviation.
* Means and deviations calculated based on patients treated in hospitals in Arizona, Florida, New Jersey, and New York (n=2,268,166).

The average patient’s hospital costs fluctuated between $12,475 and $12,911 over the
study period. The average length of stay decreased slightly over the study period, from 5.6 days
in 2007 to 5.32 days in 2011 (p < .001). Similarly, the number of patients who died in the
hospital declined from 5% in the first three study years to 4% in 2010 and 2011.
Table 13 also shows a steady growth in the number of hospitals with PAL. Specifically,
while 52% of hospitals offered PAL in 2007, 62% of hospitals had such a service in place by
2011. Hospitals also experienced an increase in IPAL, from 16% of hospitals in 2007 to 19% of
hospitals in 2011. Conversely, HOSPC were less prevalent in 2011 compared to 2007, with 23%
and 27% of hospitals, respectively reporting having such programs. Not surprisingly, the
average years of having PAL, IPAL, or HOSPC in place since 2006 increased over the study
period.
Descriptive statistics of control variables.
Table 14 reports means and standard deviations of all hospital and market control
variables used for all three research questions averaged across the study period. Specifically,
hospital control variables and state indicators were averaged across all hospitals and study years,
while market control were averaged across all counties and study years. Natural logtransformations were used for three variables, namely average length of stay, population size,
and unemployment rate.
The majority of hospitals were not-for-profit (72%). The patient population of an average
hospital consisted of 13.88% black patients, 18.97% Hispanic patients, and 36.05% patients aged
65 years and older. On average, patients stayed in the hospital for 4.6 days (or 1.5 mean log).
Note that calculations of means and standard deviations for patient characteristics in Table 14 are
based on all hospital patients, whereas those in Table 9 are based on the study’s patient sample.
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Table 14
Descriptive Statistics of Control Variables, All Research Questions

14

Control Variables
Hospital Control Variables (n = 348)
Operating margin (lagged)
Ownership
For-profit
Public
Not-for-profit (reference)
Magnet hospital
Average length of stay (log)*
Hospital patients with 1 of 8 primary DX (%)
Hospital patients aged ≥ 65 (%)
Hospital patients black (%)
Hospital patients Hispanic (%)
Ratio of RN to total nurses
Hospital all-patient DRG case mix
County Control Variables (n = 111)
Area Wage Index
HMO Penetration (%)
PPO Penetration (%)
Per capita income (in 1,000)
Population size (in 10,000) (log)
Unemployment rate (for ages ≥ 16 in county) (log)
Rate of uninsured (for ages < 65 in county) (%)
Year 2007 (reference)
Year 2008
Year 2009
Year 2010
Year 2011
State
Arizona
California
Florida
Maryland
New Jersey
New York

Mean

(SD)

-0.15

(0.12)

0.13 (0.34)
0.15 (0.36)
0.72 (0.48)
0.03 (0.17)
1.50 (0.19)
13.61 (3.89)
36.05 (13.17)
13.88 (15.92)
18.97 (20.28)
0.80 (0.11)
1.51 (0.24)
1.12 (0.19)
12.89 (10.07)
13.32 (8.03)
43.76 (13.45)
3.81 (0.98)
2.03 (0.44)
20.42 (6.32)
0.20 (0.40)
0.20 (0.40)
0.20 (0.40)
0.20 (0.40)
0.20 (0.40)
0.07
0.39
0.20
0.08
0.12
0.14

(0.25)
(0.49)
(0.40)
(0.28)
(0.33)
(0.35)

Note. DRG=Diagnosis-related group. DX=Diagnosis. HMO=Health maintenance organization. PPO=Preferred
provider organization. RN=Registered nurse. SD=Standard deviation.
* Not included in model with length of stay as a dependent variable.
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The average hospital served a patient population consisting of 13.61% patients with PCbenefiting primary diagnoses, ranging from 3.04% to 35.28%. The spread indicates that some
hospitals in the study sample serve relatively few patients with diagnoses likely to utilize and
benefit from palliative care, whereas others serve relatively high numbers of such patients. In
addition, hospital beds, teaching status, and ownership type did not have substantial withinhospital variation over the study period.
On average, the study’s counties had PPO and HMO penetration rates of 13.32% and
12.89%, respectively. In addition, the average county had an unemployment rate of 8.38% (or
2.03 mean log), 20.42% uninsured rate, and about 43,760 US dollars per capita income across all
study years. The majority of hospitals were located in California and Florida, amounting to 59%
of hospitals in the study sample. In addition, area wage index, per capita income, and population
size have little within-hospital variation. Overall, county characteristics hardly change over the
study period. Finally, due to the study’s balanced sample, the number of hospitals in the sample
was unchanged over time.
Empirical Analysis: Research Question One
This section is divided into two parts. The empirical results of the main analytical model
are first reported and discussed, followed by a presentation and summary of sensitivity analyses
conducted to evaluate the robustness of the results generated by the main analytical model. Prior
to estimating the full model, an unconditional model (i.e., a model without any covariates) is
estimated to calculate the intra-class correlation coefficient (ICC), which is employed to identify
how the total variance in the probability of palliative care provision is divided into betweenhospital variation and between-county variation.
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Results of main analysis.
Table 15 reports the results generated from the two-level HGLM with hospital-based
palliative care provision as the dependent variable. Note that the ICC indicated that a statistically
significant proportion of the variation in the probability of palliative care provision was at the
county level (22.66%).
Table 15
Results of 2-Level Model for Palliative Care Provision
Table 15 (continued)
Variable
Key Independent Variables
Number of set-up and staffed beds (in 10s)
1 - Herfindahl-Hirschman Index
Presence of PC services in health system/network/JV
Share of Medicare patients (%)
Teaching hospital
Hospital Control Variables
Operating margin (lagged)
Public
For-profit
Magnet Hospital
Ratio RN to total nurses
Hospital all-patient DRG case-mix
Patients with 1 of 8 primary DX (%)
Hospital patients Hispanic (%)
Hospital patients Black (%)
Hospital patients aged ≥ 65 (%)
Average length of stay (log)
County Control Characteristics
Area Wage Index
PPO penetration rate (%)
HMO penetration rate (%)
Per Capita Income (in 1,000 US$)
Population size (in 10,000 residents) (log)
Unemployment rate (log)
Rate of uninsured aged 18 through 64 (%)
Year
2008
15
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Odds Ratio

SE

1.0375***
3.0801
0.5564***
0.9958
1.2330

0.0068
2.9928
0.0971
0.0089
0.3635

0.4322
0.2779***
0.1059***
1.3544
4.4536**
7.3099***
1.0043
0.9825***
0.9908
0.9784
1.2021

0.2912
0.0799
0.0282
0.6922
3.3621
3.3836
0.0355
0.0056
0.0079
0.0134
0.6719

1.8982
0.9950
1.0043
1.0317
0.7672
0.7146
1.0733*

3.2079
0.0258
0.0298
0.0202
0.2462
0.6146
0.0450

1.2240

0.4322

Table 15 (continued)
Variable
2009
2010
2011

Odds Ratio
1.5246
1.5514
1.7526

SE
1.0548
1.1593
1.2440

1.9942
0.2396
3.2205
1.3769
1.7324
0.0056*

2.6016
0.2397
3.7562
1.2880
1.7296
0.0176

State
Arizona
Florida
Maryland
New Jersey
New York
Intercept

Note. DRG=Diagnosis-related group. DX=Diagnosis. HMO=Health maintenance organization. JV=Joint venture.
PC=Palliative care. PPO=Preferred provider organization. RN=Registered nurse. SE=Standard error.
* p < .1 ** p < .05 *** p < .01.

In support of Hypothesis 1, the results indicated that the ratio of the probability of
providing palliative care services compared to the probability of not providing such services was
3.75% higher for a 10-bed increase in hospital size (p < .01), controlling for other variables in the
model. In reference to Hypothesis 2, the results suggested that market competition was not
significantly associated with the likelihood of palliative care provision (p = .25), ceteris paribus.
In favor of Hypothesis 3, the findings showed that the ratio of the probability of providing
palliative care services compared to the probability of not providing such services was 44.36%
lower if a hospital had access to palliative care services through a health system, network, or
joint venture (p < .01), keeping other variables constant in the model. Against the predictions
posited in Hypothesis 4 and 5, the results indicated that hospitals’ dependence on Medicare and
teaching status were not significantly associated with the probability of palliative care provision
(p > .1), ceteris paribus.
Five hospital control variables and one county control variable yielded statistically
significant results. Specifically, the ratio of the probability of providing palliative care services
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compared to the probability of not providing such services was 72.21% and 89.41% lower for
public and for-profit hospitals, respectively, compared with not-for-profit hospitals (p < .01). In
addition, the odds of providing hospital-based palliative care was positively associated with the
ratio of registered nurses and total nurses (odds ratio: 4.45; p = .048) and hospital all-patient
DRG case-mix (odds ratio: 7.31; p < .01). That is, an increase in the ratio of registered nurses to
total nurses by one standard deviation (SD = 0.11) increases the odds of hospital-based palliative
care provision by 18%, whereas an increase in case-mix by one standard deviation (SD = 0.24)
increases the odds by 62.37%. Conversely, the odds of providing palliative care was significantly
negatively associated with the percentage of Hispanic patients (odds ratio: 0.98; p < .01). Finally,
a county’s rate of the uninsured (odds ratio: 1.07; p = .091) was positively associated with the
odds of providing palliative care.
Results of sensitivity analysis.
Table 16 presents the results of the sensitivity analyses using alternative measures for
hospital-based palliative care provision. Three alternative models were employed to examine the
effects of the study’s five key independent variables on the provision of inpatient palliative care
consultation services, inpatient palliative care units, and hospice programs, respectively.
According to Table 16, hospital size had a consistently positive association with each of
the three palliative care services. The odds ratios were larger than 1, indicating a 2.9% to 4.3%
higher probability of providing PAL, IPAL, or HOSPC compared to the probability of not
providing PAL, IPAL, or HOSPC for every 10-bed increase in hospital size. These empirical
findings are consistent with the results produced in the main analytical model and with the
relational expectation suggested in Hypothesis 1. In addition, market competition was not
significant in any of the three alternative scenarios.
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Table 16
Sensitivity Analyses with Alternative Measures for Palliative Care Provision

16

Variable
H1: Number of set-up and staffed
beds (in 10s)
H2: 1 - HHI
H3: Presence of PC services
in health system/network/JV
H4: Share of Medicare patients
H5: Teaching hospital

PAL
Odds
SE
Ratio

IPAL
Odds
SE
Ratio

HOSPC
Odds
SE
Ratio

1.043***

0.007 1.029***

0.006 1.037***

0.007

2.545

2.572 0.204

0.220 1.028

1.327

0.856

0.144 0.673**

0.123 0.081***

0.018

0.999
1.998**

0.009 1.022*
0.594 0.541**

0.012 0.974***
0.168 0.979

0.010
0.297

Note. HHI=Herfindahl-Hirschman Index. HOSPC=Hospice program. IPAL=Inpatient palliative care unit. JV=Joint
venture. PAL=Inpatient palliative care consultation service. PC=Palliative care. SE=Standard error.
* p < .1 ** p < .05 *** p < .01.

The presence of palliative care services in a hospital’s health system, network, or joint
venture was not significant in predicting the odds of providing PAL, but in predicting the odds of
providing HOSPC (odds ratio: 0.081; p < .01) and IPAL (odds ratio: 0.673; p < .05). These
findings partially supported the relationship depicted in Hypothesis 3 with two of three palliative
care services being positively associated with the presence of palliative care services in a
hospital’s local community. Although a hospital’s share of Medicare patients was not associated
with the probability of providing PAL, this variable significantly predicted the odds of providing
IPAL and HOSPC. While a hospital’s share of Medicare patients was positively (odds ratio:
1.02; p < .05) associated with the odds of providing IPAL, it was negatively associated with the
odds of providing HOSPC (odds ratio: 0.97, p < .01). These findings partially agreed with the
predictions posited in Hypotheses 4. Finally, while a hospital’s teaching status was negatively
associated with the odds of providing IPAL (odds ratio: 0.541, p < .05) and was not significantly
associated with the odds of providing HOSPC, it was positively associated with providing PAL
(odds ratio: 1.998, p < .01) as proposed in Hypothesis 5.
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Empirical analysis: research questions two and three
This section is structured in a way similar to the previous section. After the empirical
results of the main analytical model are presented, the findings of several sensitivity analyses are
reported and summarized for each dependent variable separately. Unconditional models are
estimated to calculate the ICC to identify how the total variance in hospital costs, in-hospital
mortality, transfer to hospice, and length of stay, respectively, is distributed among the patient,
hospital, and county level.
Hospital costs.
Results of main analysis.
Table 17 presents the results generated from the three-level HGLM with hospital costs as
the dependent variable. Note that the ICC suggested that a statistically significant proportion of
the variation in hospital costs were at the patient (87.68%), hospital (7.39%), and county level
(4.93%).
Table 17
Results of 3-Level Model for Hospital Costs, 2007-2011
Table 17 (continued)
Variable
Research Questions Two and Three
PAL
IPAL
HOSPC
Years of PAL experience (since 2006)
Years of IPAL experience (since 2006)
Years of HOSPC experience (since 2006)
Patient Control Variables
Patient Age
50-64
65-74
75-84
85+
17
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Coefficient

SE

-0.0087***
-0.0163***
0.0004
0.0115***
0.0018***
-0.0034***

0.0020
0.0020
0.0021
0.0005
0.0006
0.0006

0.0300***
0.0222***
0.0275***
0.0155***

0.0011
0.0013
0.0014
0.0015

Table 17 (continued)
Variable

Coefficient

Patient Gender
Female
Patient Ethnicity/Race
Black
Hispanic
Other
Median HH Income (level: ZIP)
2nd lowest quartile
2nd highest quartile
Highest quartile
Patient Location
Metro
Micro/Rural
Health Insurance
Medicaid
Private
Self-pay
Other
Admission Source
Another hospital
Another HCF
Court/Law enforcement
Routine
Primary Diagnosis
HIV
AMI
ACD
CHF
COPD
Pneumonia
Dementia
Charlson-Comorbidity Index
Number of surgical procedures
Palliative care encounter
Hospital Control Variables
Number of set-up and staffed beds (in 10s)
Operating margin (lagged)
Presence of PC services in health system/network/JV
Share of Medicare patients (%)
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SE

-0.0135***

0.0006

-0.0057***
-0.0143***
-0.0093***

0.0011
0.0011
0.0013

0.0083***
0.0048***
-0.0035***

0.0010
0.0010
0.0011

0.0431***
0.0638***

0.0017
0.0022

-0.0102***
-0.0720***
-0.1094***
-0.0930***

0.0013
0.0010
0.0019
0.0020

-0.1033***
0.0041*
-0.0923***
-0.0764***

0.0017
0.0021
0.0132
0.0009

0.0802***
-0.1560***
0.2123***
0.0292***
-0.0633***
0.0482***
-0.1129***
0.0314***
0.1890***
-0.1481***

0.0031
0.0013
0.0013
0.0011
0.0013
0.0012
0.0025
0.0002
0.0001
0.0020

0.0014***
0.0652***
-0.0111***
-0.0012***

0.0001
0.0064
0.0016
0.0001

Table 17 (continued)
Variable
Teaching hospital
Public
For-profit
Magnet Hospital
Ratio RN to total nurses
Hospital all-patient DRG case-mix
Patients with 1 of 8 primary DX (%)
Hospital patients Hispanic (%)
Hospital patients Black (%)
Hospital patients aged ≥ 65 (%)
Average length of stay (log)
County Control Characteristics
1 - Herfindahl-Hirschman Index
Area Wage Index
PPO penetration rate (%)
HMO penetration rate (%)
Per Capita Income (in 1,000 US$)
Population size (in 10,000 residents) (log)
Unemployment rate (log)
Rate of uninsured aged 18 through 64 (%)
Year
2008
2009
2010
2011
State
Arizona
Florida
Maryland
New Jersey
New York
Intercept

Coefficient
0.0544***
0.0119**
0.0313***
-0.0200***
-0.0329***
-0.0324***
-0.0010*
-0.0007***
-0.0030***
-0.0030***
0.2263***

SE
0.0038
0.0060
0.0058
0.0017
0.0053
0.0064
0.0006
0.0001
0.0004
0.0003
0.0103

-0.0367***
0.5084***
0.0010***
-0.0024***
-0.0011***
0.0347***
0.0573***
-0.0015***

0.0061
0.0155
0.0001
0.0003
0.0002
0.0133
0.0057
0.0002

-0.0230***
-0.0794***
-0.0755***
-0.0353***

0.0022
0.0047
0.0052
0.0050

-0.0462
-0.1514***
-0.1454***
-0.1261***
-0.3635***
7.9857***

0.0718
0.0425
0.0555
0.0471
0.0466
0.0710

Note. ACD=Acute cerebrovascular disease. AMI=Acute myocardial infarction. CHF=Congestive heart failure.
COPD=Chronic obstructive pulmonary disease. DRG=Diagnosis-related group. DX=Diagnosis. HCF=Healthcare
facility. HH=Household. HIV=Human immunodeficiency virus. HMO=Health maintenance organization.
HOSPC=Hospice program. IPAL=Inpatient palliative care unit. PAL=Inpatient palliative care consultation service.
PC=Palliative care. PPO=Preferred provider organization. RN=Registered nurse. SE=Standard error. ZIP=Zone
improvement plan.
* p < .1 ** p < .05 *** p < .01.
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The point estimate for a 1-year-effect of IPAL was associated with 1.43% lower hospital
costs (i.e., 𝑒 −0.0163 + 0.0018 − 1 = −0.014, p < .01). Although the financial benefits of having an
IPAL diminished over time, the point estimates for annual effects after the first year were
consistently associated with lower hospital costs given that years of experience never exceeded
five years. Specifically, the point estimates for hospitals with two to five years of IPAL
experience ranged between 1.25% (i.e., 𝑒 −0.0163 +2∗ 0.0018 − 1 = −0.0125, p < .01) and 0.7%
(i.e., 𝑒 −0.0163 + 5∗0.0018 − 1 = −0.007, p < .01) lower hospital costs, respectively. While the
point estimate of a 1-year effect of HOSPC was statistically insignificant, each additional year of
HOSPC experience significantly reduced hospital costs by 0.34% (p < .01). Taking this pattern
of decline into account, after the first year in place, the presence of HOSPC was associated with
significantly lower hospital costs, ranging between 1.67% and 0.65% lower hospital costs.
Furthermore, the point estimate of a 1-year effect of PAL was not statistically significant (i.e.,
𝑒 −0.0087+0.0115 − 1 = 0.003, p = .143). However, each additional year of PAL experience was
associated with 1.16% higher hospital costs (p < .01), ceteris paribus. Thus, while IPAL and
HOSPC were generally associated with lower hospital costs, PAL programs were generally
associated with higher hospital costs.
The majority of patient characteristics significantly affected hospital costs, ceteris
paribus. First, patient age had a positive association with hospital costs. Compared to the patients
aged between 18 and 49, patients in age group 50-64, 65-75, 75-84, and 85 and older incurred
3.05%, 2.24%, 2.79%, and 1.57% higher hospital costs, respectively. In addition, female patients
incurred 1.34% lower hospital costs than male patients. Black, Hispanic, and other
races/ethnicities had 0.57%, 1.42%, and 0.92% lower hospital costs compared to white patients.
Compared to the patients in the lowest quartile of median household income, patients in the
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second lowest and second highest quartiles accumulated between 0.83% and 0.49% higher
hospital costs, respectively. Conversely, patients in the highest quartile incurred 0.34% lower
hospital costs than patients in the lowest quartile. Patients from metro and micro/rural areas
incurred significantly higher hospital costs (4.41% and 6.58%, respectively) compared to patients
from central/fringe areas.
Compared to patients covered by Medicare, patients covered by Medicaid, private
insurance, self-pay, and other means (e.g., charity), incurred 1.01%, 6.95%, 10.36%, and 8.88%
lower hospital costs, respectively. Furthermore, patients who were transferred from another
hospital, admitted by court or law enforcement, and patients who were admitted routinely
incurred 9.81%, 8.82%, and 7.36% lower hospital costs respectively, compared to patients who
were admitted through the emergency room. However, patients transferred from another health
care facility incurred slightly higher hospital costs (0.41%) than patients who were admitted
through the emergency room.
Moreover, compared to cancer patients, patients with HIV, ACD, CHF, and pneumonia
incurred 8.35%, 23.65%, 2.96%, and 4.94% higher hospital costs. Patients with any of the
remaining primary diagnoses had significantly lower costs compared to cancer patients. For
example, patients with AMI incurred 14.44% lower hospital costs compared to cancer patients.
Similarly, compared to cancer patients, dementia patients incurred 10.68% lower hospitals costs.
The number of surgical procedures and Charlson-Comorbidity Index were positively associated
with hospital costs. Specifically, one additional surgical procedure was associated with an
increase in hospital costs of 20.8%. An increase of Charlson-Comorbidity Index by one standard
deviation (SD = 2.22) resulted in 7.2% higher hospital costs. Finally, patients with a documented
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palliative care encounter had 13.77% lower hospital costs compared to patients without such a
documented encounter.
At the hospital level, several control variables were significantly associated with hospital
costs, although their effect sizes were small, ceteris paribus. Specifically, an increase in ten
hospital beds and one-percentage point increase in lagged operating margin were associated with
a 0.14% and 6.74% increase in hospital costs, respectively. Hospitals with access to palliative
care services through a health system, network, or joint venture incurred 1.11% lower hospital
costs compared to hospitals without such access. A one-percentage point increase in a hospital’s
share of Medicare patients was associated with a 0.12% decrease in hospital costs. Teaching
hospitals incurred 5.59% higher hospital costs compared to non-teaching hospitals. For-profit
and public hospitals had 3.18% and 1.2% higher hospital costs compared to not-for-profit
hospitals, respectively. Magnet hospitals incurred 1.98% lower hospital costs compared to
hospitals without Magnet designation. A hospital’s all-patient DRG case-mix and ratio of
registered nurses to total nurses were negatively associated with hospital costs, with coefficients
of -0.03 respectively. A one percent increase in a hospital’s share of patients with one of the
study’s eight primary diagnoses, percentage of Hispanic patients, percentage of Black patients,
and percentage of patients aged 65 were also associated with somewhat lower hospital costs.
Finally, a 10% increase in average length of stay was associated with a 2.18% increase in
hospital costs.
All eight market control variables were significantly associated with hospital costs,
keeping other variables constant in the model. Specifically, market competition, HMO
penetration rate, per capita income, and the rate of uninsured were associated with somewhat
lower hospital costs. On the other hand, the population size, unemployment rate, PPO
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penetration rate, and area wage index were positively associated with hospital costs. For
example, a 10% increase in county’s area wage index was associated with 7.49% higher hospital
costs.
Results of sensitivity analysis.
Table 18 reports the results of the sensitivity analyses for hospital costs. Separate models
were employed for patients who died during hospitalization and patients who were discharged
alive.
Table 18
Sensitivity Analyses for 3-Level Model for Hospital Costs by Patient Disposition

18

Decedents
Coefficient
SE

Variable
Research Questions Two and Three
PAL
IPAL
HOSPC
Years of PAL experience (since 2006)
Years of IPAL experience (since 2006)
Years of HOSPC experience (since 2006)

-0.0053
0.0003
-0.0308**
0.0175***
0.0034
-0.0106***

0.012
0.012
0.013
0.003
0.004
0.003

Survivors
Coefficient
SE
-0.0095***
-0.0185***
0.0020
0.0117***
0.0022***
-0.0033***

0.0020
0.0020
0.0021
0.0005
0.0006
0.0006

Note. HOSPC=Hospice program. IPAL=Inpatient palliative care unit. PAL=Inpatient palliative care consultation
service. SE=Standard error.
* p < .1 ** p < .05 *** p < .01.

Among decedents, the 1-year effects of PAL and IPAL on hospital costs were statistically
insignificant, while a 1-year effect of HOSPC reduced hospital costs by 4.06% (i.e.,
𝑒 −0.0308−0.0106 − 1 = −0.0406, p < .01). Among survivors, the 1-year effect of IPAL resulted in
1.62% (i.e., 𝑒 −0.0185+0.0022 − 1 = −0.0162, p < .01) reduced hospital costs, whereas the 1-year
effects of PAL and HOSPC had no significant impact on hospital costs among survivors.
The effects of a hospital’s experience in providing PAL, IPAL, or HOSPC were similar
across patient disposition. Among survivors, one additional year of PAL experience was
associated with 1.18% higher hospital costs, whereas one additional year of PAL experience was
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associated with 1.77% higher hospital costs for decedents. Furthermore, one additional year of
HOSPC was associated with 1.05% lower hospital costs among decedents, while one additional
year of HOSPC was associated with 0.33% lower hospital costs for survivors. In addition, one
additional year of IPAL was associated with 0.22% higher hospital costs among patients who
were discharged alive, but was not associated with hospital costs among decedents.
Length of stay.
Results of main analysis.
Table 19 reports the results generated from the three-level hierarchical models with LOS
as a dependent variable for patients discharged alive and patients who died during
hospitalization, respectively. The effects of the model parameters on length of stay are reported
in incidence rate ratios (IRR). Note that the ICC provided evidence that 99.72% of the variance
in length of stay was at the patient level, whereas less than half of a percent was at the hospital
(0.22%) and county level (0.06%).
Table 19
Results of 3-Level Model for Length of Stay, 2007-2011
Table 19 (continued)
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Survivors
IRR
SE

Variable
Research Questions Two and Three
PAL
IPAL
HOSPC
Years of PAL experience (since 2006)
Years of IPAL experience (since 2006)
Years of HOSPC experience (since 2006)
Patient Control Variables
Patient Age
50-64
65-74
75-84
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1.0078***
0.9875***
1.0036**
0.9926***
1.0056***
1.0014***

0.0015
0.0014
0.0015
0.0004
0.0004
0.0004

Decedents
IRR
SE
1.0164***
0.9769***
0.9970
0.9934***
1.0109***
1.0026*

0.0058
0.0056
0.0060
0.0016
0.0018
0.0016

1.0285*** 0.0008 1.0413*** 0.0041
1.0545*** 0.0010 1.0327*** 0.0046
1.1272*** 0.0011 1.0614*** 0.0047

Table 19 (continued)
Variable
85+
Patient Gender
Female
Patient Ethnicity/Race
Black
Hispanic
Other
Median HH Income (level: ZIP)
2nd lowest quartile
2nd highest quartile
Highest quartile
Patient Location
Metro
Micro/Rural
Health Insurance
Medicaid
Private
Self-pay
Other
Admission Source
Another hospital
Another HCF
Court/Law enforcement
Routine
Primary Diagnosis
HIV
AMI
ACD
CHF
COPD
Pneumonia
Dementia
Charlson-Comorbidity Index
Number of surgical procedures
Palliative care encounter
Hospital Control Variables
Number of set-up and staffed beds (in 10s)
Operating margin (lagged)
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Survivors
Decedents
IRR
SE
IRR
SE
1.1918*** 0.0013 1.0522*** 0.0050
1.0226*** 0.0005 0.9998

0.0019

1.0338*** 0.0008 1.0360*** 0.0034
1.0021*** 0.0008 1.0002
0.0034
1.0014
0.0010 0.9883*** 0.0036
0.9880*** 0.0007 1.0012
0.0029
0.9791*** 0.0007 0.9876*** 0.0030
0.9615*** 0.0008 0.9887*** 0.0033
1.0016
0.0012 1.0003
0.0051
0.9699*** 0.0016 0.9701*** 0.0066
1.0573***
0.8923***
0.9397***
0.9554***

0.0010
0.0007
0.0013
0.0014

1.0733***
0.9931**
0.9282***
0.9276***

0.0042
0.0030
0.0057
0.0060

1.0772***
1.0393***
1.1628***
0.8568***

0.0013
0.0015
0.0100
0.0005

1.0364***
0.9190***
0.8334***
0.8249***

0.0041
0.0028
0.0051
0.0053

1.2425***
0.6002***
1.2154***
1.0526***
1.0776***
1.2368***
1.4466***
1.0504***
1.1311***
1.2256***

0.0024
0.0006
0.0011
0.0008
0.0010
0.0010
0.0025
0.0001
0.0001
0.0020

1.0666***
0.4957***
0.7210***
0.9737***
1.1753***
1.0664***
1.2182***
1.0298***
1.1032***
1.0636

0.0073
0.0019
0.0025
0.0033
0.0056
0.0035
0.0155
0.0005
0.0002
0.0027

1.0011*** 0.0001 1.0007*** 0.0002
1.0440*** 0.0049 1.1268** 0.0203

Table 19 (continued)
Survivors
IRR
SE

Variable
Presence of PC services in health
system/network/JV
Share of Medicare patients (%)
Teaching hospital
Public
For-profit
Magnet Hospital
Ratio RN to total nurses
Hospital all-patient DRG case-mix
Patients with 1 of 8 primary DX (%)
Hospital patients Hispanic (%)
Hospital patients Black (%)
Hospital patients aged ≥ 65 (%)
County Control Characteristics
1 - Herfindahl-Hirschman Index
Area Wage Index
PPO penetration rate (%)
HMO penetration rate (%)
Per Capita Income (in 1,000 US$)
Population size (in 10,000 residents) (log)
Unemployment rate (log)
Rate of uninsured aged 18 through 64 (%)
Year
2008
2009
2010
2011
State
Arizona
Florida
Maryland
New Jersey
New York
Intercept

Decedents
IRR
SE

1.0001

0.0011 0.9913

0.0044

1.0009
1.0557***
0.9995***
1.0169***
1.0017***
0.9692***
0.9824***
0.9958
0.9997***
0.9992***
1.0016

0.0001
0.0029
0.0042
0.0042
0.0012
0.0037
0.0045
0.0004
0.0001
0.0002
0.0002

0.9997***
1.0350***
0.9374
0.9940***
0.9578*
1.0287***
0.9472*
0.9975***
0.9990
0.9997**
0.9988

0.0003
0.0111
0.0123
0.0129
0.0048
0.0157
0.0153
0.0015
0.0002
0.0005
0.0006

0.9840***
0.8050***
1.0002**
1.0004*
1.0002
1.0335***
1.0422***
0.9984***

0.0043
0.0089
0.0001
0.0002
0.0002
0.0062
0.0043
0.0002

1.0207***
1.1863***
0.9977
0.9998**
0.9989**
1.0229***
0.9204***
1.0021

0.0181
0.0431
0.0003
0.0007
0.0004
0.0097
0.0142
0.0007

0.9629***
0.8498***
0.8279***
0.8260***

0.0015
0.0029
0.0031
0.0030

0.9907
1.0013
0.9841***
0.9645

0.0059
0.0126
0.0136
0.0132

0.9901
1.0840***
1.0273
1.1755***
1.0751***
3.4726***

0.0283
0.0209
0.0263
0.0258
0.0223
0.1285

0.8915
1.0240**
0.9158***
1.1084***
1.1666***
4.6567***

0.0370
0.0310
0.0338
0.0338
0.0354
0.3530

Note. ACD=Acute cerebrovascular disease. AMI=Acute myocardial infarction. CHF=Congestive heart failure.
COPD=Chronic obstructive pulmonary disease. DRG=Diagnosis-related group. DX=Diagnosis. HCF=Healthcare
facility. HH=Household. HIV=Human immunodeficiency virus. HMO=Health maintenance organization.
HOSPC=Hospice program. IPAL=Inpatient palliative care unit. IRR=Incidence rate ratio. PAL=Inpatient palliative
care consultation service. PC=Palliative care. PPO=Preferred provider organization. RN=Registered nurse.
SE=Standard error. ZIP=Zone improvement plan.
* p < .1 ** p < .05 *** p < .01.
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The following results are interpreted controlling for other variables in the model. The
empirical results were mixed concerning research questions two and three. The point estimate of
a 1-year effect of HOSPC was associated with 0.5% (i.e., 𝑒 0.0036+0.0014 − 1 = 0.005, p < .01)
longer lengths of stay for survivors. Each additional year of HOSPC experience was also
associated with 0.14% longer lengths of stay (p < .01), leading HOSPC of all durations to be
positively associated with length of stay among survivors. Furthermore, the point estimate of a 1year effect of IPAL was associated with 0.7% (i.e., 𝑒 −0.0126+0.0056 − 1 = −0.007, p < .01)
shorter lengths of stay for survivors, whereas each additional year of IPAL experience was
associated with 0.56% longer lengths of stay (p < .01). That is, while the point estimate of a 2year effect was still associated with shorter lengths of stay without being statistically significant,
the point estimates of the following years were significantly associated between 0.41% and
1.54% longer lengths of stay. Moreover, the point estimate of a 1-year effect of PAL was not
statistically significant among survivors. However, each additional year of PAL experience was
associated with 0.74% shorter lengths of stay (p < .01). Specifically, the point estimates of a
second through fifth year were consistently associated between 0.7% and 2.88% shorter lengths
of stay.
Among decedents, the point estimate of a 1-year effect of PAL was associated with
0.97% (i.e., 𝑒 0.0163−0.0066 − 1 = 0.0097, p < .1) longer lengths of stay, whereas each additional
year of PAL experience yielded 0.66% shorter lengths of stay (p < .01). Specifically, the point
estimates of a fifth year yielded 1.66% shorter lengths of stay (p < .05). The point estimates of a
second through fourth year were not statistically significant. Furthermore, the point estimate of a
1-year effect of IPAL was associated with a 1.25% (i.e., 𝑒 −0.0234+0.0108 − 1 = −0.0125, p <
.05) decrease in length of stay for decedents. However, each additional year of IPAL experience
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was associated with 1.09% longer lengths of stay (p < .01). In particular, the point estimates of a
third through fifth year were associated with 0.92%, 2.01%, and 3.12% longer lengths of stay,
respectively. The point estimate of a second year was not significantly associated with length of
stay among decedents. Although the point estimate of a 1-year-effect of HOSPC was not
statistically significant (i.e., 𝑒 −0.003+0.0026 − 1 = −.0004, p = .95), each additional year of
HOSPC experience yielded 0.26% longer lengths of stay among decedents. However, the point
estimates of a second through fifth year were not significantly associated with length of stay.
Several patient control variables were associated with length of stay, ceteris paribus.
Specifically, patient age is a significant risk factor of length of stay among both survivors and
decedents. Compared with survivors aged 18-49, lengths of stay of survivors in age groups 5064, 65-74, 75-85, and 85+ were on average 2.85%, 5.45%, 12.72%, and 19.18% longer,
respectively. Similar age effects were detected among decedents such that the effects were
generally larger for older patients. Female survivors had 2.26% longer length of stay compared
with male survivors. Among decedents, patient gender was not significantly associated with
length of stay. Black and Hispanic survivors had 3.38% and 0.21% longer length of stay
compared with white survivors. Decedents of other ethnicities had shorter lengths of stay
compared with white decedents, whereas Black decedents had 3.6% longer lengths of stay.
Compared with patients in the lowest quartile of income, patients in the higher quartiles of
income had between 1.2% and 3.85% shorter lengths of stay. Similar income effects were
observed among decedents. Moreover, among survivors and decedents, patients residing in micro
or rural areas had 3% shorter lengths of stay compared with patients residing in urban areas.
Survivors covered by Medicaid had 5.73% longer lengths of stay compared to Medicare
patients, while survivors covered by self-pay, private insurance, and other means had between
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4.46% and 10.7% shorter lengths of stay compared with Medicare patients. Health insurance had
a similar effect on the study’s decedents’ lengths of stay. Both survivors and decedents with
routine admissions had 14.32% and 17.51% shorter lengths of stay compared with patients
admitted through the emergency room, respectively. In addition, patients in both groups
transferred from another hospital had 3.64% and 7.72% longer lengths of stay compared to
patients in the reference group, respectively. Survivors transferred from other health care
facilities and admitted through court/law enforcement had on average 3.93% and 16.28% longer
lengths of stay respectively compared to survivors admitted through the emergency room,
whereas decedents had 8.1% and 16.66% shorter lengths of stay, respectively.
Compared with cancer survivors, HIV, COPD, pneumonia, and dementia survivors had
longer lengths of stay. Conversely, survivors with AMI had on average 40% shorter lengths of
stay than cancer patients. Similar patterns were observed among decedents. Furthermore,
survivors with ACD and CHF had 21.54% and 5.26% longer lengths of stay respectively,
whereas decedents with these primary diagnoses had 27.9% and 2.63% shorter lengths of stay
compared with cancer patients. One additional surgical procedure was associated with 13.11%
longer length of stay among survivors and 10.32% longer lengths of stay among decedents. A
one standard deviation (SD=2.22) increase in a patient’s Charlson-Comorbidity Index was
associated with 11.53% longer lengths of stay among survivors and 6.7% longer lengths of stay
among decedents. Survivors with a documented palliative care encounter experienced a 22.56%
longer lengths of stay compared with survivors without a documented palliative care encounter.
Among decedents, lengths of stay were 6.36% longer when a palliative care encounter was
documented.
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Several hospital control variables were significantly associated with length of stay,
keeping other variables constant. Note that hospital effects differed between patient groups.
Specifically, survivors treated in teaching, for-profit, and Magnet hospitals had longer lengths of
stay, whereas survivors treated in public hospitals had shorter lengths of stay. More hospital beds
and a higher lagged operating margin were associated with longer lengths of stay. Conversely, a
higher ratio of registered nurses and total nurses, hospital all-patient DRG case-mix, percentage
of Hispanic and Black patients were associated with shorter lengths of stay. Among decedents,
more hospital beds, a higher lagged operating margin, and a higher ratio of registered nurses and
total nurses were associated with longer lengths of stay. Decedents treated in for-profit and
Magnet hospitals had significantly shorter lengths of stay. A higher hospital all-patient DRG
case-mix, a higher percentage of patients with the study’s eight primary diagnoses, and a higher
percentage of Black patients were associated with shorter lengths of stay among decedents.
The majority of market control variables were significantly associated with length of
stay, ceteris paribus. Among survivors, patients treated in hospitals located in counties with
higher market competition, area wage index, and rate of uninsured had shorter lengths of stay. In
addition, survivors treated in hospitals located in counties with higher PPO and HMO penetration
rates, population sizes, and unemployment rates had longer lengths of stay. Decedents treated in
hospitals located in counties with higher market competition, area wage index, and population
sizes had longer lengths of stay, whereas decedents treated in hospitals located in counties with
higher HMO penetration rates, per capita income, and unemployment rates had shorter lengths of
stay.

137

Results of sensitivity analysis.
Table 20 presents the results of the sensitivity analyses for length of stay for patients who
were transferred to hospice.
Table 20
Sensitivity Analyses for Length of Stay until Transfer to Hospice
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Variable
Research Questions Two and Three
PAL
IPAL
HOSPC
Years of PAL experience (since 2006)
Years of IPAL experience (since 2006)
Years of HOSPC experience (since 2006)

IRR
0.9592***
0.9879
1.0333***
1.0063***
1.0108***
0.9879***

SE
0.0082
0.0073
0.0091
0.0022
0.0025
0.0023

Note. HOSPC=Hospice program. IPAL=Inpatient palliative care unit. IRR=Incidence rate ratio. PAL=Inpatient
palliative care consultation service. SE=Standard error.
* p < .1 ** p < .05 *** p < .01.

The 1-year effect of PAL resulted in 3.47% (i.e., 𝑒 −0.0416+0.0063 − 1 = −0.0347, p <
.01) shorter lengths of stay for patients who were transferred to hospice after hospital discharge,
whereas the 1-year effect of HOSPC was associated with 2.09% (i.e., 𝑒 0.0328−0.0122 − 1 =
0.0209, p < .01) longer lengths of stay for patients who were transferred to hospice after hospital
discharge. The 1-year effect of hospital-based IPAL was not significantly associated with length
of stay. Furthermore, one additional year of PAL and IPAL was associated with 0.63% and
1.08% longer lengths of stay, respectively, whereas one additional year of HOSPC resulted in
1.21% shorter lengths of stay for patients who were transferred to hospice following discharge.
In-hospital mortality.
Results of main analysis.
Table 21 presents the results generated from the three-level HGLM with in-hospital
mortality as the dependent variable. According to the ICC, the vast majority of the total variance
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Table 21
Results of 3-Level Model for In-Hospital Mortality, 2007-2011
Table 21 (continued)
Variable
Research Questions Two and Three
PAL
IPAL
HOSPC
Years of PAL experience (since 2006)
Years of IPAL experience (since 2006)
Years of HOSPC experience (since 2006)
Patient Control Variables
Patient Age
50-64
65-74
75-84
85+
Patient Gender
Female
Patient Ethnicity/Race
Black
Hispanic
Other
Median HH Income (level: ZIP)
2nd lowest quartile
2nd highest quartile
Highest quartile
Patient Location
Metro
Micro/Rural
Health Insurance
Medicaid
Private
Self-pay
Other
Admission Source
Another hospital
Another HCF
Court/Law enforcement
Routine
21
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Odds Ratio

SE

0.9732**
0.9282***
0.9750*
0.9822***
1.0336***
0.9885***

0.0127
0.0135
0.0139
0.0040
0.0050
0.0043

1.2414***
1.8080***
2.4890***
3.5884***

0.0143
0.0234
0.0324
0.0486

0.9488***

0.0052

0.8709***
0.8708***
1.0246**

0.0085
0.0086
0.0109

0.9944
0.9661***
1.0018

0.0080
0.0082
0.0093

0.9516***
0.9098***

0.0113
0.0169

1.2162***
1.2103***
1.5481***
1.3531***

0.0145
0.0108
0.0252
0.0228

1.2164***
1.2870***
0.8973
0.6516***

0.0141
0.0187
0.1081
0.0050

Table 21 (continued)
Variable

Odds Ratio

Primary Diagnosis
HIV
AMI
ACD
CHF
COPD
Pneumonia
Dementia
Charlson-Comorbidity Index
Number of surgical procedures
Palliative care encounter
Hospital Control Variables
Number of set-up and staffed beds (in 10s)
Operating margin (lagged)
Presence of PC services in health system/network/JV
Share of Medicare patients (%)
Teaching hospital
Public
For-profit
Magnet Hospital
Ratio RN to total nurses
Hospital all-patient DRG case-mix
Patients with 1 of 8 primary DX (%)
Hospital patients Hispanic (%)
Hospital patients Black (%)
Hospital patients aged ≥ 65 (%)
Average length of stay (log)
County Control Characteristics
1 - Herfindahl-Hirschman Index
Area Wage Index
PPO penetration rate (%)
HMO penetration rate (%)
Per Capita Income (in 1,000 US$)
Population size (in 10,000 residents) (log)
Unemployment rate (log)
Rate of uninsured aged 18 through 64 (%)
Year
2008
2009
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SE

1.7896***
1.0525***
3.1308***
0.9458***
0.6625***
1.3795***
0.4200***
1.1419***
1.1990***
20.8885***

0.0416
0.0113
0.0306
0.0095
0.0098
0.0141
0.0144
0.0016
0.0010
0.1705

1.0002
1.0658*
1.0170**
0.9953***
0.8953***
0.9122***
1.0833***
0.9759*
0.9343*
0.6508***
0.9786***
1.0034***
1.0000
1.0040***
1.9967***

0.0002
0.0385
0.0085
0.0005
0.0123
0.0126
0.0169
0.0139
0.0338
0.0150
0.0019
0.0003
0.0004
0.0008
0.0693

0.9817
0.8762***
0.9947***
0.9951***
1.0010**
0.9075***
0.9454**
1.0082***

0.0274
0.0365
0.0008
0.0008
0.0004
0.0078
0.0244
0.0014

0.8851***
0.8137***

0.0107
0.0181

Table 21 (continued)
Variable
2010
2011

Odds Ratio
0.7433***
0.7532***

SE
0.0181
0.0186

0.6731***
0.7539***
1.1247***
0.9725
1.0718**
0.0192***

0.0192
0.0194
0.0367
0.0250
0.0290
0.0020

State
Arizona
Florida
Maryland
New Jersey
New York
Intercept

Note. ACD=Acute cerebrovascular disease. AMI=Acute myocardial infarction. CHF=Congestive heart failure.
COPD=Chronic obstructive pulmonary disease. DRG=Diagnosis-related group. DX=Diagnosis. HCF=Healthcare
facility. HH=Household. HIV=Human immunodeficiency virus. HMO=Health maintenance organization.
HOSPC=Hospice program. IPAL=Inpatient palliative care unit. PAL=Inpatient palliative care consultation service.
PC=Palliative care. PPO=Preferred provider organization. RN=Registered nurse. SE=Standard error. ZIP=Zone
improvement plan.
* p < .1 ** p < .05 *** p < .01.

in the probability of in-hospital mortality was at the patient level (99.25%), whereas the
remaining variance was between at the hospital (0.39%) and county level (0.36%).
The point estimates for a 1-year effect of PAL, IPAL, and HOSPC were associated with
4.4% (i.e., 𝑒 −0.02713−0.01793 − 1 = −0.0441, p < .01), 4.06% (i.e., 𝑒 −0.07449+0.03307 − 1 =
−0.0406, p < .01), and 3.63% (i.e., 𝑒 −0.02534−0.01159 = −0.0363, p < .01) lower odds of inhospital mortality, controlling for other variables in the model. Furthermore, one additional year
of experience with PAL and HOSPC was associated with 1.78% and 1.15% lower odds of inhospital mortality, respectively. However, one additional year of IPAL experience yielded 3.36%
higher odds of in-hospital mortality. Specifically, the point estimate for a 2-year effect of IPAL
was not significantly associated with the odds of in-hospital mortality, whereas the effects of the
following years yielded between 2.5% and 9.51% higher odds of in-hospital mortality (p < .05).
Thus, PAL and HOSPC were generally associated with lower odds of in-hospital mortality,
while IPAL was not.
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While the results of three of the outcomes were robust to the addition of the palliative
care encounter control variable, results with respect to in-hospital mortality were fairly sensitive.
Hence, this paragraph summarizes the empirical results of the model estimating in-hospital
mortality without the palliative care encounter control variable. Specifically, when estimating the
model without the palliative care encounter control variable, only the point estimate for a 1-year
effect of PAL was associated with a 2.6% (i.e., 𝑒 −0.03417+0.0077 − 1 = −0.026, p < .05)
reduction in the odds of in-hospital mortality, ceteris paribus. One additional year of experience
with PAL and IPAL was associated with 0.77% and 2.4% higher odds of in-hospital mortality,
respectively.
Several patient control variables are significant predictors of in-hospital mortality.
Specifically, patient age is a significant risk factor of in-hospital mortality. Compared with
patients aged 18-49, the odds of in-hospital mortality were 24%, 81%, 249%, and 359% higher
for patients aged 50-64, 65-74, 75-84, and 85 and older, respectively. In addition, the odds of inhospital mortality was 5.12% lower for female patients compared with male patients. Compared
with white patients, the odds of in-hospital mortality were 11.9% lower for black and Hispanic
patients, respectively. Conversely, the odds of in-hospital mortality was 2.46% higher for
patients of other ethnicities/races compared with white patients. Compared with patients in the
lowest income quartile, the odds of in-hospital mortality was 3.39% lower for patients in the
second highest quartile. The odds of in-hospital mortality for patients who lived in metro and
micro/rural areas were 4.84% and 9.02% lower, respectively, compared with patients who
resided in central/fringe areas. Compared with Medicare patients, patients with other types of
health insurance had higher odds of in-hospital mortality, with odds ratios ranging between 1.21
for patients covered by private insurance and 1.55 for patients covered by self-pay. In addition,
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the odds of in-hospital mortality were 21.64% and 28.7% higher for patients transferred from
another hospital and health care facility, respectively, compared with patients who were admitted
through the emergency room. On the contrary, the odds of in-hospital mortality was 34.84%
lower for patients who were admitted routinely compared with patients in the reference group.
The odds of in-hospital mortality were 5.42%, 33.75%, and 58% lower for patients with CHF,
COPD, and dementia, respectively, compared with cancer patients. Conversely, the odds of inhospital mortality were 78.96%, 313.08%, and 37.95% higher for patients with HIV, ACD, and
pneumonia, respectively, compared with cancer patients. Patient severity measures were also
associated with higher odds of in-hospital mortality. Specifically, one additional surgical
procedure was associated with 19.9% higher odds of in-hospital mortality. Similarly, an increase
in Charlson-Comorbidity Index by one standard deviation (SD = 2.22) resulted in 34.25% higher
odds of in-hospital mortality. Finally, patients with a documented palliative care encounter had a
2089% higher odds of in-hospital mortality compared with patients who did not have a palliative
care encounter recorded in their medical records.
Several hospital control variables exhibited statistical significance in predicting inhospital mortality, ceteris paribus. Specifically, patients treated in teaching, public, and Magnet
hospitals had lower odds of in-hospital mortality. In addition, a higher share of Medicare
patients, ratio of registered nurses to total nurses, number of patients with one of the study’s
eight primary diagnoses, and hospital all-patient DRG case-mix were associated with lower odds
of in-hospital mortality. Conversely, higher lagged operating margin, percentages of Hispanic
patients, patients aged 65 and older, and average length of stay were associated with a higher
odds of in-hospital mortality. Finally, patients treated in hospitals with access to palliative care
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services through a health system, network, or joint venture had higher odds of in-hospital
mortality.
Some market control variables were significantly associated with the odds of in-hospital
mortality, keeping other variables constant. Higher area wage index, PPO and HMO penetration
rates, population size, and unemployment rate were associated with lower odds of in-hospital
mortality. Higher rates of uninsured and per capita income were associated with somewhat
higher odds of in-hospital mortality.
Results of sensitivity analysis.
Table 22 presents the results of the sensitivity analyses for in-hospital mortality. Separate
analyses for patients with each of the study’s primary diagnoses were estimated.
In regard to research question two, the 1-year effects of PAL had a consistently negative
association with the odds of in-hospital mortality for patients with cancer, CHF, COPD,
dementia, and pneumonia, with odds ratios ranging between 5.64% for cancer patients and
48.28% for dementia patients. In addition, the 1-year effects of IPAL were associated with
4.38%, 4.87%, and 9.71% lower odds of in-hospital mortality for patients with ACD, cancer, and
COPD, respectively. The 1-year effects of HOSPC was associated with 6.46% and 6.11% lower
odds of in-hospital mortality for patients with ACD and AMI, respectively. But the 1-year effect
of HOSPC was associated with 11.07% higher odds of in-hospital mortality for COPD patients.
In regard to research question three, one additional year of PAL experience resulted in
lower in-hospital mortality for patients with AMI, cancer, and HIV, whereas one additional year
of PAL experience resulted in somewhat higher odds of in-hospital mortality for patients with
dementia and pneumonia. One additional year of IPAL experience was consistently associated
with higher in-hospital mortality for ACD, AMI, cancer, and dementia patients. Finally, one
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Table 22
Sensitivity Analyses for In-hospital Mortality by Primary Diagnosis, 2007-2011

22

Variable
Research Questions Two and Three
PAL
IPAL
HOSPC
Years of PAL experience (since 2006)
Years of IPAL experience (since 2006)
Years of HOSPC experience (since 2006)
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Variable

ACD
Odds
SE
Ratio
1.0394
0.9319**
0.9394*
0.9900
1.0261**
0.9958

0.0313
0.0303
0.0309
0.0090
0.0109
0.0097

COPD
Odds
SE
Ratio

AMI

Cancer

CHF

Odds Ratio

SE

Odds Ratio

SE

1.0127
0.9436
0.9538
0.9726***
1.0300**
0.9844

0.0323
0.0341
0.0331
0.0098
0.0126
0.0109

0.9739
0.9082***
0.9889
0.9688***
1.0475***
0.9979

0.0232
0.0230
0.0242
0.0073
0.0088
0.0076

Dementia

HIV

Odds Ratio

SE

0.4678***
0.7581
0.9568
1.1055*
1.2188***
0.9847

0.0811
0.1505
0.1889
0.0618
0.0728
0.0574

Odds
Ratio

Odds Ratio
0.9322**
0.9521
1.0304
1.0053
1.0186
0.9853

SE
0.0313
0.0367
0.0382
0.0108
0.0134
0.0117

Pneumonia
SE

Odds Ratio

SE

0.1046
0.0976
0.1097
0.0331
0.0459
0.0402

0.8254***
0.9565
1.0385
1.0306***
0.9983
0.9825

0.0288
0.0396
0.0407
0.0114
0.0141
0.0123

Research Questions Two and Three
PAL
IPAL
HOSPC
Years of PAL experience (since 2006)
Years of IPAL experience (since 2006)
Years of HOSPC experience (since 2006)

0.8390*** 0.0510
0.8952
0.0665
1.1096
0.0769
1.0068
0.0195
1.0086
0.0258
1.0010
0.0222

1.0254
0.8460
0.9981
0.9440*
1.0416
1.0058

Note. ACD=Acute cerebrovascular disease. AMI=Acute myocardial infarction. CHF=Congestive heart failure. COPD=Chronic obstructive pulmonary disease.
HIV=Human immunodeficiency virus. HOSPC=Hospice program. IPAL=Inpatient palliative care unit. PAL=Inpatient palliative care consultation service.
SE=Standard error.
* p < .1 ** p < .05 *** p < .01.

additional year of HOSPC was not associated with the odds of in-hospital mortality for any of
the eight patient groups.
Transfer to hospice.
Results of main analysis.
Table 23 presents the results generated from the three-level HGLM with transfer to
hospice as the dependent variable. Note that the ICC suggested that statistically significant
proportions of the variation in the probability of transfer to hospice were at the patient (70.96%),
hospital (16.48%), and county level (12.55%).
Table 23
Results of 3-Level Model for Transfer to Hospice, 2007-2011
Table 23 (continued)
Variable
Research Questions Two and Three
PAL
IPAL
HOSPC
Years PAL in place (since 2006)
Years IPAL in place (since 2006)
Years HOSPC in place (since 2006)
Patient Control Variables
Patient Age
50-64
65-74
75-84
85+
Patient Gender
Female
Patient Ethnicity/Race
Black
Hispanic
Other
Median HH Income (level: ZIP)
2nd lowest quartile
2nd highest quartile
23
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Odds Ratio

SE

1.1500***
0.9586***
0.8843*
0.9081***
0.9965
1.0401***

0.6130
0.0249
0.0198
0.0058
0.0077
0.0074

1.5264***
2.0263***
3.2082***
5.8944

0.0281
0.0416
0.0655
0.1232

1.1366***

0.0086

0.7555***
0.8807***
0.8510***

0.0105
0.0133
0.0178

1.0221*
1.0177

0.0119
0.0121

Table 23 (continued)
Variable
Highest quartile
Patient Location
Metro
Micro/Rural
Health Insurance
Medicaid
Private
Self-pay
Other
Admission Source
Another hospital
Another HCF
Court/Law enforcement
Routine
Primary Diagnosis
HIV
AMI
ACD
CHF
COPD
Pneumonia
Dementia
Charlson-Comorbidity Index
Number of surgical procedures
Palliative care encounter
Hospital Control Variables
Number of set-up and staffed beds (in 10s)
Operating margin (lagged)
Presence of PC services in health system/network/JV
Share of Medicare patients (%)
Teaching hospital
Public
For-profit
Magnet Hospital
Ratio RN to total nurses
Hospital all-patient DRG case-mix
Patients with 1 of 8 primary DX (%)
Hospital patients Hispanic (%)
Hospital patients Black (%)
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Odds Ratio
1.0383***

SE
0.0135

0.9126***
0.8291***

0.0189
0.0216

1.3115***
0.8708***
0.9683
1.3956***

0.0240
0.0120
0.0270
0.0296

0.6286***
0.8791***
0.0901***
0.4194***

0.0139
0.0191
0.0347
0.0044

0.4475***
0.4129***
0.7821***
0.3681***
0.2679***
0.3759***
0.4940***
1.2815***
0.9281***
15.1091***

0.0151
0.0071
0.0109
0.0047
0.0047
0.0054
0.0137
0.0023
0.0017
0.1809

1.0005
0.9652
1.0272
1.0059***
1.0949**
0.8317***
0.8386*
1.0139
1.1587**
1.0469
0.9691***
1.0014*
1.0117***

0.0010
0.0801
0.0198
0.0010
0.0448
0.0528
0.0767
0.0199
0.0693
0.0804
0.0066
0.0007
0.0037

Table 23 (continued)
Variable
Hospital patients aged ≥ 65 (%)
Average length of stay (log)
County Control Characteristics
1 - Herfindahl-Hirschman Index
Area Wage Index
PPO penetration rate (%)
HMO penetration rate (%)
Per Capita Income (in 1,000 US$)
Population size (in 10,000 residents) (log)
Unemployment rate (log)
Rate of uninsured aged 18 through 64 (%)
Year
2008
2009
2010
2011
State
Arizona
Florida
New Jersey
Intercept

Odds Ratio
0.9959
0.6028***

SE
0.0034
0.0755

0.8256***
0.4958***
1.0003
0.9899**
0.9960*
0.8867
1.2984***
1.0018

0.0498
0.0930
0.0015
0.0040
0.0024
0.0869
0.0942
0.0032

0.9492*
0.8090***
1.0061
1.5086***

0.0295
0.0520
0.0695
0.1000

3.3555***
2.5531***
1.5675*
0.0384***

1.2244
0.6084
0.3911
0.0205

ACD=Acute cerebrovascular disease. AMI=Acute myocardial infarction. CHF=Congestive heart failure.
COPD=Chronic obstructive pulmonary disease. DRG=Diagnosis-related group. DX=Diagnosis. HCF=Healthcare
facility. HH=Household. HIV=Human immunodeficiency virus. HMO=Health maintenance organization.
HOSPC=Hospice program. IPAL=Inpatient palliative care unit. PAL=Inpatient palliative care consultation service.
PC=Palliative care. PPO=Preferred provider organization. RN=Registered nurse. SE=Standard error. ZIP=Zone
improvement plan.
* p < .1 ** p < .05 *** p < .01.

The following results are interpreted controlling for other variables in the model. The
point estimate of a 1-year effect of IPAL resulted in 4.47% (i.e., 𝑒 −0.0422−0.0035 − 1 = −0.0447,
p < .05) lower odds of hospice transfer. Although one additional year of IPAL experience was
not significantly associated with the odds of hospice transfer, all year effects of IPAL were
associated with lower odds of hospice transfer, averaging around 5% lower odds of hospice
transfer (p < .1). Moreover, the point estimate of a 1-year effect of HOSPC was associated with
8.02% (i.e., 𝑒 −0.123+0.0394 − 1 = −0.0802, p < .01) lower odds of hospice transfer, while one
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additional year of HOSPC experience was associated with 4.01% higher odds of hospice
transfer. Specifically, the point estimate of a 2-year effect of HOSPC resulted in 4.3% lower
odds of hospice transfer (p < .05), whereas the point estimate of a 5-year effect of HOSPC was
associated with 7.67% higher odds of hospice transfer (p < .05). In addition, the point estimate of
a 1-year effect of PAL was associated with 4.43% (i.e., 𝑒 0.1398−0.0964 − 1 = 0.0443, p < .1)
higher odds of hospice transfer. However, one additional year of having a PAL in place was
associated with a 9.19% lower odds of transfer to hospice. In summary, IPAL were generally
associated with lower odds of hospice transfer, but PAL and HOSPC did not yield consistent
effects on hospice transfer. Specifically, while the 1-year effect of PAL was associated with
higher odds of transfer to hospice, the remaining year effects yielded lower odds of transfer to
hospice. Finally, although the first two year effects of HOSPC were negatively associated with
hospice transfer, the fifth year effect was associated with higher odds of transfer to hospice.
Several patient characteristics were significantly associated with the odds of transfer to
hospice. Specifically, the odds of transfer to hospice was increasingly higher for patients in
higher age groups. Compared with patients aged between 18 and 49, the odds of transfer to
hospice were 53%, 203%, 321%, and 589% higher for patients in age groups 50-64, 65-74, 7584, and 85 and older, respectively. In addition, the odds of transfer to hospice was 13.66% higher
for female patients compared with male patients. Compared with white patients, black, Hispanic,
and patients of other races/ethnicities had 24.45%, 11.93%, and 14.9% lower odds of transfer to
hospice. Patients in higher income quartiles had higher odds of transfer to hospice compared
with patients in the lowest income quartile. Patients in metro and micro/rural areas had 8.74%
and 17.09% lower odds of transfer to hospice compared with patients in central/fringe areas.
Compared with Medicare patients, patients covered by Medicaid and other types of insurance

149

had 31.15% and 39.56% higher odds of transfer to hospice, whereas patients covered by private
insurance had 12.92% lower odds of transfer to hospice.
Moreover, patients admitted to the hospitals through the emergency room had a higher
odds of transfer to hospice compared to patients not admitted through the emergency room. For
example, patients who were admitted routinely had a 58.06% lower odds of transfer to hospice
compared with patients admitted through the emergency room. Non-cancer patients had a lower
odds of transfer to hospice compared with cancer patients, with odds ratios ranging between
0.7821 for patients with ACD and 0.2679 for COPD patients. Furthermore, an increase in
Charlson-Comorbidity Index by one standard deviation (SD=2.22) resulted in 73.42% higher
odds of transfer to hospice. Conversely, one additional surgical procedure yielded a 10.21%
lower odds of transfer to hospice. Patients with a documented palliative care encounter had a
1511% higher odds of transfer to hospice compared with patients without a documented
palliative care encounter.
Several hospital characteristics were associated with transfer to hospice, ceteris paribus.
A higher share of Medicare patients, Black, and Hispanic patients, and ratio of registered nurses
to total nurses were associated with higher odds of transfer to hospice. Patients treated in public
and for-profit had lower odds of transfer to hospice, whereas patients treated in teaching
hospitals were more likely to be transferred to hospice. In addition, a higher average length of
stay and percentage of patients with the study’s primary diagnoses were associated with a lower
odds of transfer to hospice.
Some market control variables were significantly associated with transfer to hospice,
keeping other variables constant in the model. Specifically, patients treated in hospitals located
in counties with a higher market competition, area wage index, HMO penetration rates, and per
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capita income had lower odds of transfer to hospice. On the other hand, patients treated in
hospitals in counties with higher unemployment rates had higher odds of transfer to hospice.
Results of sensitivity analysis.
Table 24 presents the results of the sensitivity analyses for transfer to hospice. Separate
analyses for patients transferred to hospice compared to patients transferred to skilled nursing
facilities (SNF) or home-health care (HHC).
Table 24
Sensitivity Analyses for Transfer to Hospice vs. Skilled Nursing Facilities/Home-Health Care

24

Transfer to Hospice
vs. SNF/HHC
Odds Ratio
SE

Variable
Research Questions Two and Three
PAL
IPAL
HOSPC
Years of PAL experience (since 2006)
Years of IPAL experience (since 2006)
Years of HOSPC in place (since 2006)

1.1412***
0.9792
0.8525***
0.9069***
0.9940
1.0406***

0.0323
0.0242
0.0252
0.0064
0.0085
0.0081

Note. HHC=Home-health care. HOSPC=Hospice program. IPAL=Inpatient palliative care unit. PAL=Inpatient
palliative care consultation service. SE=Standard error. SNF=Skilled nursing facility.
* p < .1 ** p < .05 *** p < .01.

Among patients discharged to skilled nursing facilities or home/self-care, the 1-year
effect of HOSPC was associated with 11.29% (i.e., 𝑒 −0.1596+0.0398 − 1 = −0.1129, p < .01)
lower odds of hospice transfer. One additional year of PAL in place was associated with 9.31%
lower odds of transfer to hospice, whereas one additional year of HOSPC was associated with
4.06% higher odds of transfer to hospice.
Note that the results from a supplemental analytical model for transfer to hospice, which
excluded decedents from the study sample to allow for a comparison of patients who were
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transferred to hospice and patients who were discharged alive and transferred to other settings,
were similar to the results from the main analysis.
Summary
This chapter summarized the results of descriptive, main, and sensitivity analyses to
address the study’s three research questions. Regarding research question one, the study findings
indicated that hospital size was significantly associated with a higher probability of hospitalbased palliative care provision (Hypothesis 1). In addition, the presence of palliative care
services through a hospital’s health system, network, or joint venture was associated with a lower
probability of hospital-based palliative care provision (Hypothesis 3). Hospital market
competition (Hypothesis 2), a hospital’s share of Medicare patients (Hypothesis 4) and teaching
status (Hypothesis 5) were not significantly associated with the probability of hospital-based
palliative care provision.
The study findings also suggested that the 1-year effects of IPAL and HOSPC were
associated with lower hospital costs; the 1-year effect of PAL was not significantly associated
with hospital costs (Hypothesis 6a). One additional year of experience in providing IPAL or PAL
was associated with higher hospital costs, while one additional year of experience in providing
HOSPC was associated with lower hospital costs (Hypothesis 7a).
Among survivors and decedents, the 1-year effect of IPAL was associated with shorter
lengths of stay. Among decedents, the 1-year effect of PAL was associated with longer lengths
of stay. In addition, the 1-year effect of HOSPC was associated with longer lengths of stay
among survivors. Among decedents, the 1-year effect of HOSPC was not significantly associated
with length of stay (Hypothesis 6b). One additional year of PAL was associated with shorter
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lengths of stay, while one additional year of IPAL or HOSPC was associated with longer lengths
of stay for decedents and survivors (Hypothesis 7b).
The 1-year effects of PAL, IPAL, and HOSPC were associated with reduced odds of inhospital mortality (Hypothesis 6c). The alternative model specification without the patient
control variable palliative care encounter yielded significantly lower odds of in-hospital
mortality for a 1-year effect of PAL only. One additional year of providing PAL or HOSPC was
associated with lower odds of in-hospital mortality but one additional year of IPAL resulted in
higher odds of in-hospital mortality (Hypothesis 7c). The alternative model specification
produced higher odds of in-hospital mortality for one additional year of PAL and IPAL.
The 1-year effect of PAL was associated with higher odds of hospice transfer, whereas
the 1-year effects of IPAL and HOSPC were associated with lower odds of hospice transfer
(Hypothesis 6d). One additional year of providing PAL resulted in a lower probability of being
transferred to hospice; one additional year of HOSPC resulted in a higher probability of transfer
to hospice (Hypothesis 7d).
The next chapter summarizes and interprets the research findings and closes with a
review of the study’s limitations, a discussion of the theoretical, practical, and policy
implications of the empirical results, and suggestions for future research.
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Chapter 6: Discussion

Palliative care promises to improve organizational and patient outcomes in the hospital
setting. Specifically, a hospital’s decision to integrate palliative care models into its service mix
may influence both hospital performance and quality of patient care, as captured in such
important metrics as hospital length of stay, hospital costs, in-hospital mortality, and patient
disposition (e.g., transfer to hospice). Chapter 2 provided a comprehensive overview and
examination of prior research supporting this notion.
The study’s three research questions were stated in the first chapter: 1) Which
organizational and environmental forces are associated with the provision of hospital-based
palliative care services? 2) Do hospitals that provide palliative care services have improved
organizational and patient outcomes compared to those not providing such services? and 3) Is a
hospital’s experience in providing palliative care services associated with improved
organizational and patient outcomes? Chapter 3 continued with a presentation and discussion of
the study’s theoretical framework used to develop propositions and hypotheses to answer the
study’s research questions. To explore the association between key independent variables and
palliative care provision and hospital performance measures, analytical models were employed
controlling for additional patient, hospital, and market characteristics.
The study’s methodology, including research design, data sources, study sample, variable
measurement, and analytical strategy, was developed in Chapter 4. Detailed results from these
models were presented in Chapter 5. Chapter 6 starts with a summary and interpretation of the
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research findings, followed by a review of the study’s limitations and a discussion of the
theoretical, practical, and policy implications of the empirical results. The chapter closes with
suggestions for future research.
Summary of Study Findings
Hospital adoption of palliative care.
This study used Institutional Theory and Resource Dependence Theory to examine the
association between hospital and market characteristics and the provision of palliative care
services. The study tested five hypotheses for research question one using a two-level
hierarchical generalized linear model with a binomial sampling model and a logit link function to
describe under which circumstances hospitals tend to provide palliative care services. Table 25
summarizes the five hypotheses and specifies whether they were supported based on the results
of the main analytical models, as reported in Chapter 5.
Regarding Hypothesis 1, the findings suggested that hospital size is positively associated
with the odds of providing one or more of the three palliative care services under study (i.e.,
PAL, IPAL, and/or HOSPC). This notion was further supported when exploring the relationship
between hospital size and each of the three palliative care services individually. As hospital size
increases, a hospital may decide that providing services in-house is necessary to meet the needs
of its patient population in an efficient and timely manner.
The findings did not support the proposition that hospitals located in more competitive
hospital markets were more likely to provide palliative care services in order to secure revenue
flow and patient referrals, as proposed in Hypothesis 2. The study’s sensitivity analyses also
failed to produce significant results regarding this hypothesis. It is possible that hospitals are
unable to react to higher levels of market competition due to workforce shortages. Since the
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Table 25
Summary of Study Findings, Research Question One

25

Hypothesis
Supported
Research Question One: Which organizational and environmental forces are associated with
the provision of hospital-based palliative care services?
Hypothesis 1:
Hospitals with more staffed and set-up beds are more likely to provide palliative
Yes
care services compared to hospitals with fewer staffed and set-up beds.
Hypothesis 2:
Hospitals in more competitive markets are more likely to provide palliative care
services compared to hospitals in less competitive markets.

No

Hypothesis 3:
Hospitals that have access to palliative care services through a health system,
network, and/or joint venture in their local community are less likely to provide
palliative care services in-house.

Yes

Hypothesis 4:
Hospitals with a greater Medicare share of inpatient days are more likely to
provide palliative care services compared to hospitals with a smaller Medicare
share of inpatient days.

No

Hypothesis 5:
Hospitals that are members of the COTH are more likely to provide palliative
care services compared to hospitals that are non-COTH members.

No

Note. COTH=Council of Teaching Hospitals.

American Board of Medical Specialties (ABMS) and the American Osteopathic Association
(AOA) recognized Hospice and Palliative Medicine (HPM) as a subspecialty in 2008, 7,351
physicians achieved subspecialty certification in HPM as of 2015 (American Academy of
Hospice and Palliative Medicine, n.d.). Lupu and the American Academy of Hospice and
Palliative Medicine Workforce Task Force (2010) estimated that between 6,000 and 18,000
additional hospice and palliative care physicians were needed to close the gap between the
physician supply and national demand for hospice and palliative care. However, the current
board certification process does not facilitate the increase in hospice palliative care physicians to
meet the supply shortage. Specifically, while physicians with clinical experience and competence
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in hospice and palliative care were eligible to take the certification exam without completing a
12-month, accredited HPM fellowship until 2013, subsequent physicians are required to
complete an HPM fellowship (American Academy of Hospice and Palliative Medicine, n.d.).
Hospitals that are interested in providing specialty palliative care may be unable to create such
services because of a lack of HPM-certified physicians. Instead, hospitals in counties with a
higher level of market competition may resort to focusing on educating clinicians to provide
primary palliative care to their patients. As this study focused on specialty palliative care
provision, this relationship may need to be explored in future research studies.
The results supported the proposition presented in Hypothesis 3 that the presence of
palliative care services through a hospital’s health system, network, or joint venture was
negatively associated with the provision of hospital-based palliative care services. Sensitivity
analyses further indicated hospitals with access to palliative care services outside the hospital
were less likely to offer hospital-based IPAL and HOSPC. Although hospitals in highly
interconnected environments may be more likely to abide by the environmental pressures to
integrate medical services linked to high-quality care (Zinn et al., 2010), the study findings
suggested that the availability of such services through other means regulated the need to comply
with such pressures. Future research may consider including interaction terms of hospital-based
palliative care services and their not-hospital-based counterparts.
The results related to Hypothesis 4 provided no evidence that hospitals with a higher
percentage of Medicare patients were more likely to provide palliative care services. A possible
explanation for this finding may be that hospitals with higher percentages of Medicare patients
incorporate primary palliative care into existing clinical procedures without establishing
specialty palliative care delivery models. Further research is required to investigate whether
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having a high percentage of Medicare patients affected the prevalence of primary palliative care.
It is also probable that CMS’s commitment to high-quality, patient-centered care for seriously ill
and medically complex patients, including allowing separate billing for advance care planning
effective in early 2016, did not provide adequate motivation for a hospital to provide palliative
care services during the study period. Additional research is needed to examine the relationship
between a hospital’s patient population covered by Medicare and the provision of hospital-based
palliative care services in the years following the study period. Sensitivity analyses produced
mixed findings in regard to Hypothesis 4. Supporting the hypothesis’ notion, a hospital’s share of
Medicare patients was positively associated with the probability of providing IPAL. Conversely,
hospitals with higher shares of Medicare patients were less likely to offer hospital-based
HOSPC. One explanation for this negative relationship may be the emergence of hospital
partnerships with local hospices to provide hospice care to hospital patients with end-of-life care
needs. In addition, hospital-based hospice programs are expensive and hospitals amy struggle to
cover the costs associated with caring for hospice patients who are covered by the Medicare
Hospice Benefit.
Regarding Hypothesis 5, the study found that teaching hospitals were not significantly
more likely to provide palliative care services compared to non-teaching hospitals. The
sensitivity analyses, however, demonstrated that teaching hospitals were more likely to provide
inpatient palliative care consultation services (PAL) compared to non-teaching hospitals, which
is consistent with the proposition presented in Hypothesis 5. This finding is similar to those from
prior research examining hospital adoption of PAL (Stover, 2005). Conversely, teaching
hospitals were less likely to provide inpatient palliative care units (IPAL) compared to nonteaching hospitals. It is possible that teaching hospitals prefer inpatient palliative care
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consultation services, as these services have a more flexible and versatile scope of application
within the hospital and may therefore be viewed as more useful in a teaching environment than
IPAL or HOSPC. Specifically, teaching hospitals are likely to focus on maintaining continuity of
care to optimize learning, which is easier to accomplish with inpatient palliative care
consultation services compared to inpatient palliative care units or hospice programs as patients’
palliative care needs can be addressed without transferring them to a different unit.
Several hospital and market control variables used in the analytical model to address
research question one were significantly associated with the provision of palliative care services,
including hospital ownership, the ratio of registered nurses to total nurses, hospital all-patient
DRG case-mix index, and percentage of Hispanic patients. Note that a hospital’s lagged
operating margin, although not statistically significant, may be influenced by prior palliative care
provision such that palliative care might result in lower hospital costs. Finally, the rate of
uninsured in a county was the only market control variable that reached statistical significance.
Not-for-profit hospitals were more likely to provide palliative care services than forprofit and public hospitals. This finding is consistent with prior research (Dumanovsky et al.,
2015; Morrison et al. 2011; Morrison et al., 2005; Stover, 2005, White et al., 2002). The mission
of not-for-profit hospitals tends to focus on serving the greater good and prioritizing community
health needs as required to be granted tax exempt status (Proenca et al., 2000). Among not-forprofit hospitals, providing access to a variety of palliative care services may be viewed as an
essential component of high-quality care for patients with serious and terminal illnesses, even if
these services are potentially not economically viable. Catholic hospitals, in particular, are
considered early adopters of palliative care, as it aligns with Catholic theology, philosophy and
mission of care (White, Cochran, & Patel, 2002).
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In addition, hospitals with a higher proportion of registered nurses to total nurses were
more likely to provide palliative care services. Nursing capacity defined by a higher proportion
of highly skilled nurses, such as registered nurses, may influence a hospital’s decision to provide
palliative care services. As the nursing profession traditionally focuses on caregiving instead of
curing, including the care of seriously ill and terminal patients, hospitals that employ more
registered nurses may also be more likely to integrate services into the service mix that are not
aimed to cure diseases. Conversely, it is also possible that hospitals with palliative care services
have a higher demand for higher skill mix of nurses and are therefore more likely to hire highly
skilled nurses. Furthermore, hospitals with a higher hospital all-patient DRG case-mix were more
likely to provide palliative care services. These findings are consistent with the proposition that
hospitals with a sicker patient population are more likely to see the need to provide services
aimed to manage complex patient needs. Conversely, hospitals with higher percentages of
Hispanic patients were less likely to provide palliative care services. This finding is in
accordance with prior research suggesting that barriers to palliative care exist among ethnic
minorities due to cultural differences in attitudes toward and perceptions of terminal illnesses
(Johnson, 2013; Johnstone & Kanitsaki, 2009; Kwak & Haley, 2005).
Finally, hospitals located in counties with higher rates of uninsured aged 18-64 were
more likely to provide palliative care services. Kazley and Ozcan (2007) suggested that hospitals
in wealthier counties, a proxy for resource availability in the environment (i.e., munificence),
may be more inclined to attract patients who can afford to pay for high-quality services.
Specifically, a low rate of uninsured in a market may be viewed as a measure of munificence.
But this study found that hospitals located in markets with a higher rate of uninsured were more
likely to provide palliative care services. It could be speculated that the predominant focus on
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curative treatment within the U.S. healthcare system encouraging the provision of (typically
expensive) life-prolonging treatment implicitly incentivizes hospitals to transition patients to
palliative care, especially hospice care, when patients are not insured or underinsured. Additional
research is needed to investigate this relationship.
Performance effects of palliative care.
This study applied Donabedian’s (1980) Structure-Process-Outcome model to examine
the relation between hospital-based palliative care services and hospital costs, in-hospital
mortality, transfer to hospice, and length of stay. The study tested eight hypotheses to address
research questions two and three. The following three-level hierarchical models were employed:
a Bernoulli sampling model and a logit link function to examine in-hospital mortality and
transfer to hospice, a normal sampling model and an identity link function to evaluate hospital
costs, and a Poisson sampling model and log link function to assess hospital length of stay.
Tables 26 and 27 present the hypotheses related to research questions two and three,
respectively, and indicate whether they were supported based on the findings of the main
analytical models, as reported in the previous chapter. Note that it is difficult to distinguish
between research questions two and three due to the nature of the palliative care experience
variables, as discussed in Chapter 4. Consequently, to address research question two, the point
estimates of a 1-year effect of the three palliative care services were used to approximate the
effects of such services on the study outcomes. The coefficients of the three palliative care
experience variables were examined to address research question three.
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Table 26
Summary of Study Findings, Research Question Two

26
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Hypothesis Supported
(by Patient Disposition)
Hypothesis
Survivors
Decedents
Total
Research Question Two: Do hospitals that provide palliative care services have improved organizational and patient outcomes
compared to those not providing such services?
Hypothesis 6a: Patients treated in hospitals that provide palliative care services have lower
hospital costs than patients treated in hospitals that do not provide such services.
PAL
No
IPAL
Yes
HOSPC
No
Hypothesis 6b: Patients treated in hospitals that provide palliative care services have shorter
hospital LOS than patients treated in hospitals that do not provide such services.
PAL
No
No
IPAL
Yes
Yes
HOSPC
No
No
Hypothesis 6c: Patients treated in hospitals that provide palliative care services are less
likely to die during hospitalization than patients treated in hospitals that do not provide such
services.
PAL
Yes
IPAL
Yes
HOSPC
Yes
Hypothesis 6d: Patients treated in hospitals that provide palliative care services are more
likely to be transferred to hospice than patients treated in hospitals that do not provide such
services.
PAL
Yes
IPAL
No
HOSPC
No
Note. HOSPC=Hospice program. IPAL=Inpatient palliative care unit. LOS=Length of stay. PAL=Inpatient palliative care consultation service.

Table 27
Summary of Study Findings, Research Question Three

27

Hypothesis Supported
(by Patient Disposition)
Hypothesis
Survivors
Decedents
Total
Research Question Three: Is a hospital’s experience in providing palliative care services associated with improved organizational
and patient outcomes?
Hypothesis 7a: Patients treated in hospitals that are more experienced in providing
palliative care services have lower hospital costs than patients treated in hospitals that are
less experienced.
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Years of PAL experience (since 2006)
Years of IPAL experience (since 2006)
Years of HOSPC experience (since 2006)
Hypothesis 7b: Patients treated in hospitals that are more experienced in providing
palliative care services have shorter hospital LOS than patients treated in hospitals that are
less experienced.
Years of PAL experience (since 2006)
Years of IPAL experience (since 2006)
Years of HOSPC experience (since 2006)
Hypothesis 7c: Patients treated in hospitals that are more experienced in providing
palliative care services are less likely to die during hospitalization than patients treated in
hospitals that are less experienced.
Years of PAL experience (since 2006)
Years of IPAL experience (since 2006)
Years of HOSPC experience (since 2006)
Hypothesis 7d: Patients treated in hospitals that are more experienced in providing
palliative care services are more likely to be transferred to hospice than patients treated in
hospitals that are less experienced.
Years of PAL experience (since 2006)
Years of IPAL experience (since 2006)
Years of HOSPC experience (since 2006)

-

-

No
No
Yes

Yes
No
No

Yes
No
No

-

-

-

Yes
No
Yes

-

-

No
No
Yes

Note. HOSPC=Hospice program. IPAL=Inpatient palliative care unit. LOS=Length of stay. PAL=Inpatient palliative care consultation service.

Hospital costs.
The results suggested that the relationship between palliative care services and lower
hospital costs was partially supported. The 1-year-effect of an inpatient palliative care unit
(IPAL) was associated with lower hospital costs (Hypothesis 6a). The point estimates for year
effects after the first year were also consistently associated with lower hospital costs, although
the financial benefits of having an IPAL diminished over time (Hypothesis 7a). Conversely, the
1-year effect of HOSPC was not significantly associated with hospital costs (Hypothesis 6a), but
one additional year of experience in providing HOSPC was significantly associated with lower
hospital costs (Hypothesis 7a). The year effects of HOSPC ranged between 0.65% for the second
year and 1.67% for the fifth year. Finally, the 1-year effect of an inpatient palliative care
consultation service (PAL) was not significantly associated with hospital costs (Hypothesis 6a),
and one additional year of experience in providing PAL was significantly associated with
incrementally higher hospital costs (Hypothesis 7a). That is, the year effects of PAL ranged
between 1.45% for the second year and 5.02% for the fifth year. In sum, IPAL and HOSPC were
associated with lower hospital costs, whereas PAL was associated with higher hospital costs.
A possible explanation for these mixed findings is that PAL, IPAL, and HOSPC
potentially have different effects on hospital costs, unlike what has been proposed in this study.
In future analyses, one may need to address how each of the study’s three types of palliative care
services individually affect hospital costs. Further research is needed to explain above-mentioned
differences in effects on hospital costs. It is possible that PAL are focused on providing palliative
care services to patients in conjunction with curative treatments and thus potentially increase
hospital costs. On the other hand, HOSPC and IPAL may aim toward transitioning patients from
curative treatment plans to comfort care only, which potentially reduces hospital costs.
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Moreover, analyzing the effects of PAL, IPAL, and HOSPC on different subsets of hospital
costs, such as pharmacy, laboratory, ICU, cardiology, emergency room, or physical therapy costs
may also provide additional information on the financial impact of palliative care services.
The study found several significant associations between patient control variables and
hospital costs. Compared to patients aged 18-49, patients in the older age groups incurred
significantly lower hospital costs. While this finding contradicts national findings concerning
hospital costs for all hospital patients, it is possible that younger age groups incur higher hospital
costs if they have one of the study’s eight primary diagnoses. It is possible that younger patients
with these primary diagnoses are more likely to receive curative than palliative treatment.
Female patients incurred lower hospital costs than male patients. Furthermore, white patients
incurred higher costs than patients of other ethnicities. Medicare patients incurred higher hospital
costs than patients covered by Medicaid, private insurance, self-pay, and other means. The study
findings on patient gender and primary payer are largely consistent with national findings
concerning hospital costs for all hospital patients (Weiss & Elixhauser, 2014). In addition,
patients admitted through the emergency room incurred higher hospital costs than patients
transferred from another hospital, admitted by court or law enforcement or admitted routinely.
Patients with HIV, ACD, CHF, and pneumonia were among the most expensive patients.
Furthermore, the number of surgical procedures was associated with higher hospital costs, which
is consistent with findings from a prior study (Stover, 2005). Furthermore, a higher CharlsonComorbidity Index, as a proxy for patient severity, was associated with higher hospital costs,
consistent with findings from prior studies (e.g., Charlson et al., 2008). Finally, patients with a
documented palliative care encounter incurred lower hospital costs than patients without a
documented palliative care encounter.

165

All hospital control variables were significantly associated with hospital costs. On
average, higher lagged operating margin, number of beds, and average length of stay were
associated with higher hospital costs. The findings for hospital costs and number of hospital beds
are similar to those reported by Jiang et al. (2013). Regarding lagged operating margin, reverse
causality may exist, because reduced hospital costs influence a hospital’s operating margin.
Conversely, the presence of palliative care services through a hospital’s health system, network,
or joint venture, higher share of Medicare patients, higher ratio of registered nurses to total
nurses, higher hospital all-patient DRG case-mix, higher percentage of Hispanic patients, Black
patients, and patients aged 65 and older were, on average, associated with lower hospital costs.
Nurse staffing measures have been found to reduce hospital costs (e.g., Weiss, Yakusheva, &
Bobay, 2011). White et al. (2005) found a positive association of hospital all-patient DRG casemix with hospital costs, although it did not reach statistical significance. In addition, public and
for-profit hospitals incurred higher hospital costs than not-for-profit hospitals. Teaching hospitals
incurred higher hospital costs than non-teaching hospitals, which is consistent with prior studies
(e.g., Jiang et al., 2013; Stover, 2005). Magnet hospitals incurred lower hospital costs than nonMagnet hospitals. A study published in 2014 found a positive relationship between Magnet status
and hospital costs (Jayawardhana, Welton, & Lindrooth, 2014).
All market control variables were significantly associated with hospital costs. On
average, higher area wage index, PPO penetration rate, log-transformed population size, and logtransformed unemployment rate were associated with higher hospital costs. On the contrary,
higher market competition, HMO penetration rate, per capita income, and rate of uninsured were
associated with lower hospital costs. The findings for the relationship between HMO penetration,
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per capita income, and area wage index were similar to those reported by Jiang et al. (2013) and
Stover (2005).
Length of stay.
The 1-year effect of IPAL was associated with shorter lengths of stay for survivors and
decedents, supporting Hypothesis 6b. However, one additional year of IPAL experience resulted
in longer lengths of stay for both patient groups (Hypothesis 7b). Specifically, among decedents,
the year effects of the third through fifth year ranged between 0.91% longer lengths of stay for
the third year and 3.12% longer lengths of stay for the fifth year. Among survivors, the year
effects were between 0.41% longer lengths of stay for the third year and 1.54% longer lengths of
stay for the fifth year.
The 1-year effect of HOSPC was significantly associated with longer lengths of stay
among survivors, whereas the 1-year effect of HOSPC was not significantly associated with
length of stay among decedents (Hypothesis 6b). The results of Hypothesis 7b suggested that one
additional year of HOSPC was associated with longer lengths of stay for both patient groups.
However, among decedents, the individual year effects were not significantly associated with
length of stay. Among survivors, all year effects were positively associated with length of stay,
but with relatively small magnitudes.
The 1-year effect of PAL was positively associated with length of stay among decedents,
but not significantly associated with length of stay among survivors (Hypothesis 6b). One
additional year of PAL experience was associated with shorter lengths of stay for both patient
groups (Hypothesis 7b). Among decedents, the fifth year was associated with a 1.66% shorter
length of stay. Among survivors, all year effects after the first year were statistically significant
and ranged between 0.7% shorter lengths of stay for the second year and 2.88% shorter lengths
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of stay for the fifth year. Findings from prior research were also mixed (Cassel et al., 2010b). A
potential explanation for these inconsistent findings may be that palliative care services have
different effects at different stages during a patient’s hospitalization. For example, palliative care
services may reduce LOS in the ICU by earlier transfers to other hospital wards, but may not
necessarily reduce a patient’s hospital LOS. In addition, patients with a documented palliative
care encounter stayed significantly longer in the hospital than patients without such an encounter.
While this finding may suggest that palliative care is associated with longer hospital LOS, it may
also indicate that palliative care encounters, identified by the billable ICD-9-CM code V66.7,
were merely assigned to patients with a high likelihood of mortality and patients with prolonged
LOS. Specifically, endogeneity in terms of reverse causality may be a threat to causal inference
when examining the effects of palliative care services on hospital LOS, because clinical
guidelines used regularly include extended hospital LOS as a trigger to initiate palliative care
consultations (Norton et al., 2007). Moreover, the three-level hierarchical model used to examine
hospital LOS produced very small hospital-level and market-level ICC (< 1%), which indicates
that the majority of variation in hospital LOS lies between patients. Hierarchical models with
very small ICC at the higher levels may increase the potential of Type I errors (Barcikowski,
1981). Small ICCs also indicate that the assumption of independence may hold, which means
that traditional statistical approaches potentially suffice to examine hospital LOS. The sensitivity
analysis demonstrated that, among patients who were transferred to hospice, patients treated in
hospitals with PAL had shorter in-hospital stays than patients treated in hospitals without PAL.
This findings suggests that PAL may facilitate hospice transfers for patients at the end of life,
and is consistent with palliative care teams actively trying to transfer patients out of the hospital
to their homes or community hospices.
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Several patient control variables were significantly associated with length of stay. For
both survivors and decedents, patient age was positively associated with length of stay. Prior
studies found similar results for the relationship between length of stay and patient age (e.g., Shi,
1996; van de Vijsel, Heijink, & Schipper, 2015). On average, female survivors stayed in the
hospital longer than male survivors. Among decedents, patient gender was not significantly
associated with length of stay. Compared with white patients, black patients stayed in the
hospital longer, regardless of patient disposition. Among survivors, Hispanic patients had longer
lengths of stay than white patients. Conversely, expired patients of other ethnicities had shorter
lengths of stay.
Patient health insurance had similar effects across patient disposition. Compared to
Medicare patients, patients covered by Medicaid had longer lengths of stay. Patients covered by
private insurance, self-pay, or other types had shorter lengths of stay than Medicare patients.
Among survivors, patients with HIV, ACD, CHF, COPD, pneumonia, and dementia had longer
lengths of stay than cancer patients, whereas AMI patients had significantly shorter lengths of
stay. The results regarding primary diagnosis were similar for decedents. Among decedents,
patients with ACD and CHF as a primary diagnoses had a shorter lengths of stay than cancer
patients. More surgical procedures and a higher Charlson-Comorbidity Index were associated
with longer hospital stays for both patient groups, which is consistent with prior studies (e.g., van
de Vijsel et al., 2015). Finally, patients with a documented palliative care encounter had, on
average, longer hospital stays than patients without such a documented encounter, regardless of
patient disposition. Again, it is possible that this variable is endogenous, as patients with longer
lengths of stay are more likely to have a palliative care encounter compared to patients with
shorter lengths of stay.
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Several hospital control variables were significantly associated with length of stay. The
relationships were similar for survivors and decedents. Specifically, a higher number of hospital
beds and lagged operating margin were associated with longer lengths of stay. The findings for
length of stay and number of hospital beds contradicted those reached by White and et al. (2005).
Conversely, having a higher hospital all-patient DRG case-mix, higher percentage of Hispanic
and black patients were associated with shorter lengths of stay. A higher ratio of registered
nurses to total nurses was associated with shorter lengths of stay among survivors, but associated
with longer lengths of stay among decedents. The findings for length of stay and hospital allpatient DRG case-mix contradict those reached by White and et al. (2005). Nursing capacity
measures have been associated with shorter length of stay in prior studies (e.g., Voepel-Lewis,
Pechlavanidis, Burke, & Talsma, 2013). Compared with non-teaching hospitals, teaching
hospitals had on average longer lengths of stay. This may indicate that teaching hospitals spend
more time treating patients than non-teaching hospitals. The findings for length of stay and
teaching status are similar to those reached by White et al. (2005) and Lin et al. (2006).
Furthermore, for-profit hospitals had longer lengths of stay than not-for-profit hospitals, whereas
public hospitals had shorter hospital stays than not-for-profit hospitals among survivors.
Seven market control variables were found to be significantly associated with length of
stay. Higher PPO penetration rate, log-transformed population size, and log-transformed
unemployment rate were associated with longer lengths of stay. A higher HMO penetration rate
was associated with longer lengths of stay among survivors, whereas a higher HMO penetration
rate was associated with shorter lengths of stay. Higher market competition, area wage index,
and rate of uninsured were associated with shorter lengths of stay. The findings for length of stay
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and population size and area wage index were consistent with findings reached by White et al.
(2005).
In-hospital mortality.
Regarding Hypotheses 6c and 7c, the results consistently supported the hypothesis that
palliative care services reduce the odds of in-hospital mortality. The 1-year effects of PAL,
IPAL, and HOSPC were associated with reduced odds of in-hospital mortality (Hypothesis 6c).
One additional year of PAL experience resulted in reduced odds of in-hospital mortality, ranging
between 4.41% lower odds of in-hospital mortality in the first year and 11% lower odds of inhospital mortality in the fifth year. Similarly, one additional year of HOSPC experience was
associated with lower odds of in-hospital mortality, ranging between 3.63% and 7.99% lower
odds of in-hospital mortality for the effect of a given year. However, one additional year of IPAL
resulted in higher odds of in-hospital mortality. That is, the year effects of the third through fifth
year were associated with incrementally higher odds of in-hospital mortality, ranging between
2.5% higher odds of in-hospital mortality for the third year and 9.51% higher odds of in-hospital
mortality for the fifth year. The point estimate of the 2-year effect was negative but statistically
not significant. It is possible that hospitals with more experience in providing IPAL are more
likely to provide palliative care to terminally-ill patients rather than transferring them to hospice
or other health care settings. Transfers out of the hospital are often too time-intensive and painful
for terminally-ill patients who are imminently dying, so that remaining in the IPAL is often
preferred over a transfer to hospice. Furthermore, IPAL patients and their families often decide
against transfers out of the unit because of the bonds made between them and the IPAL staff
(K.R. White, personal communication, July 5, 2016).
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When estimating the model without the palliative care encounter control variable, only
the 1-year effect of PAL resulted in reduced in-hospital mortality. Similarly, the effects of one
additional year of providing PAL or IPAL was associated with a higher risk of dying during
hospitalization.
The sensitivity analyses conducted regarding in-hospital mortality were largely consistent
with the findings of the main analyses. Specifically, separate analyses were estimated for patients
with the study’s eight primary diagnoses, and the majority of analyses revealed either
significantly lower in-hospital mortality or no effect on in-hospital mortality for patients treated
in hospitals with PAL, IPAL, or HOSPC. Similar to the analytical model for length of stay, the
three-level hierarchical model used to examine in-hospital mortality produced very small
hospital-level and market-level ICC (< 1%), which indicates that the majority of variation in inhospital mortality lies between patients. Hierarchical models with very small ICC at the higher
levels may increase the potential of Type I errors (Barcikowski, 1981). Small ICCs provide
evidence that the assumption of independence of hospitals may hold. Therefore, conventional
single-level approaches may be adequate to evaluate in-hospital mortality.
The majority of patient control variables were significant predictors of in-hospital
mortality. Higher patient age was associated with higher odds for in-hospital mortality. Female
patients were less likely to die during hospitalization than male patients. Black and Hispanic
patients had lower odds of in-hospital mortality than white patients. Patients of other ethnicities
were more likely to die during hospitalization than white patients. These findings are consistent
with those reported by Stover (2005) and Lackan et al. (2009). Research has shown that
minorities may have limited resources and access to end-of-life services in their communities,
such as home hospice services or nursing homes (Kirby & Kaneda, 2005). In addition, Johnson
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(2013) discussed the factors contributing to racial and ethnic disparities in palliative care,
including knowledge gaps about palliative care, religious beliefs not in line with palliative care
delivery models, general distrust in the medical system, and greater preference for curative
treatment among minority patients. These patients may therefore be more likely to die in the
hospital than opting for alternative sites of death outside of the hospital. Compared with
Medicare patients, patients covered by Medicaid, private health insurance, self-pay, and other
payer types had, on average, higher odds of in-hospital mortality. Patients transferred from other
hospitals or healthcare facilities had on average higher odds of in-hospital mortality compared
with patients admitted through the emergency room. Patients admitted routinely were on average
less likely to die during hospitalization than patients in the reference group. Compared with
cancer patients, patients with HIV, AMI, ACD, and pneumonia had higher odds of in-hospital
mortality, whereas patients with CHF, COPD, and dementia had lower odds of in-hospital
mortality. In addition, a higher Charlson-Comorbidity Index and more surgical procedures were
associated with higher odds of in-hospital mortality. The findings for in-hospital mortality and
surgical procedures are similar to those attained by Stover (2005) and for in-hospital mortality
and the Charlson-Comorbidity Index similar to those reported by Ladha et al. (2015). Finally,
patients who had a documented palliative care encounter had a higher odds of in-hospital
mortality than patients without such a documented encounter.
Among hospital control variables, lagged operating margin, log-transformed average
length of stay, percentage of Hispanic patients and patients aged 65 and older were associated
with higher odds of in-hospital mortality. Conversely, a higher share of Medicare patients, ratio
of registered nurses to total nurses, hospital all-patient DRG case-mix, and percentage of patients
with the study’s primary diagnoses were associated with lower odds of in-hospital mortality.
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Teaching hospitals had lower odds of in-hospital mortality than non-teaching hospitals. The
findings for teaching status and in-hospital mortality are similar to those reported by Allison et
al. (2000), who examined the association between teaching status and hospital mortality between
thirty days and two years after hospital admission for patients with AMI. Shahian et al. (2014)
also found significantly lower 30-day risk-standardized mortality rates for patients with AMI,
heart failure, and pneumonia treated in teaching hospitals. Magnet hospitals had lower odds of
in-hospital mortality than non-Magnet hospitals, which is consistent with prior studies (McHugh
et al., 2013). While public hospitals had lower odds of in-hospital mortality than not-for-profit
hospitals, for-profit hospitals had higher odds of in-hospital mortality.
Among market control variables, higher area wage index, PPO and HMO penetration
rates, log-transformed population size, and log-transformed unemployment rate were associated
with lower odds of in-hospital mortality. The findings for in-hospital mortality, PPO and HMO
penetration, and area wage index are consistent with those reported in prior studies (e.g., Stover,
2005). Per capita income and rate of uninsured were associated with higher odds of in-hospital
mortality.
Transfer to hospice.
The study results generally contradicted the effects of palliative care services on hospice
transfers depicted in Hypotheses 6d and 7d. The 1-year effect of PAL was associated with higher
odds of hospice transfer (Hypothesis 6d), whereas one additional year of PAL experience was
negatively associated with odds of hospice transfer (Hypothesis 7d). Specifically, the year effects
of PAL after the first year were significantly associated with incrementally lower odds of hospice
transfer, ranging between 5.17% lower odds of hospice transfer for the second year and 28.99%
lower odds of hospice transfer for the fifth year. Furthermore, the year effects of IPAL were
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consistently associated with lower odds of hospice transfer, although one additional year of IPAL
was not significantly associated with odds of hospice transfer (Hypothesis 7d). In other words,
the year effects of IPAL remained relatively constant with 4.47% lower odds of hospice transfer
in the first year and 5.8% lower odds of hospice transfer in the fifth year. The year effects of the
first two years of HOSPC were associated with 8% and 4.33% lower odds of hospice transfer
respectively (Hypothesis 6d), whereas the fifth year was associated with 7.67% higher odds of
hospice transfer. The year effects of the third and fourth year of HOSPC were not statistically
significant. The findings largely contradicted Hypotheses 6d and 7d and further research is
needed to understand this relationship. It is possible that hospitals with IPAL and PAL are more
likely to treat patients at the end of life and therefore view these services as a suitable alternative
to transferring patients to hospice. A lack of community-based alternatives, such as home
hospice services, home health services, or nursing homes, may also contribute to fewer hospice
transfers. Future research studies may need to account for market characteristics that capture the
availability of alternative resources outside of the hospital setting.
All patient control variables significantly predicted the odds of transfer to hospice. On
average, older patient age were associated with higher odds of transfer to hospice. In addition,
female patients had a higher odds of transfer to hospice than male patients. Compared to white
patients, black, Hispanic, and patients of other ethnicities had lower odds of transfer to hospice.
Compared with any other primary diagnosis, cancer patients had a higher odds of transfer to
hospice. The findings for hospice transfer, patient age, ethnicity/race, gender, and primary
diagnosis are consistent with reports on characteristics of the U.S. hospice patient population
(National Hospice and Palliative Care Organization, 2014). Compared to Medicare patients,
Medicaid patients and patients covered by other payer types had higher odds of transfer to
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hospice. Conversely, patients covered by private insurance were less likely to be transferred to
hospice. Furthermore, patients admitted through the emergency room had higher odds of transfer
to hospice than patients transferred from another hospital or healthcare facility, admitted by court
or law enforcement, and admitted routinely. A higher Charlson-Comorbidity Index was
associated with higher odds of transfer to hospice, whereas a higher number of surgical
procedures was associated with lower odds of transfer to hospice. Patients with a documented
palliative care encounter had a higher odds of transfer to hospice than patients who did not have
such an encounter.
Several hospital control variables significantly predicted the odds of transfer to hospice.
Teaching hospitals had higher odds of transfer to hospice than non-teaching hospitals. Public and
for-profit hospitals had lower odds of transfer to hospice than not-for-profit hospitals. A higher
ratio of registered nurses to total nurses, percentage of Hispanic and Black patients, and share of
Medicare patients were associated with higher odds of transfer to hospice. Conversely, a higher
percentage of patients with one of eight primary diagnoses and log-transformed average length
of stay were associated with lower odds of transfer to hospice.
Among market control variables, higher market competition, area wage index, HMO
penetration rate, and per capita income were associated with lower odds of transfer to hospice,
whereas a higher log-transformed unemployment rate was associated with higher odds of transfer
to hospice. This study is among the first to examine the relationship between hospice transfers
and hospital and market characteristics, which limits the ability to compare the study findings
with those attained by prior studies.
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Study Limitations
This study has six noteworthy limitations. These limitations relate to the use of
administrative data, the construction and representativeness of key variables, the type of analysis,
the generalizability of the study findings, and the scope of outcome measures.
First, this study relied on administrative data, primarily information from the AHA
Annual Survey of Hospitals for the key variables related to palliative care provision and from the
HCUP SID for the study’s dependent variables to examine research questions two and three. The
use of these administrative databases has several caveats. First, HCUP SID data are based on
patient discharge files. This study relies on the fact that patient information is recorded in a
correct and complete manner. Specifically, discharge coding for patients transferred to hospice
may be prone to coding errors. Although hospitals should code a patient as discharged to hospice
regardless of whether that patient is transferred to a hospital-based or on outside hospice facility,
it is possible that in some instances patients transferred to a hospital-based facility are not coded
in this manner, which may affect the measurement of hospice transfers and lengths of stay for
these patients. Second, the AHA Survey of Hospitals was used to determine whether hospitals
had PAL, IPAL, and/or HOSPC in place in a given year. Approximately 23% of urban, nonfederal, acute care hospitals across the study states had missing information for PAL, IPAL,
and/or HOSPC in one or more study years and about 30% of hospitals with non-missing
information showed inconsistent palliative care implementation patterns prior to and during the
study period, which may be an indication of inaccurate coding. The AHA Survey of Hospitals is
completed on a voluntary basis by hospital administrative staff. The information provided in the
survey is not externally checked for accuracy. Third, a definitional issue may arise when
identifying the source of palliative care services. That is, the AHA Survey of Hospitals
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distinguishes between palliative care services provided by the health system, network, and joint
venture. It is unclear whether this distinction is understood and interpreted uniformly across
participating hospitals. It is also possible that the distinction between hospital-based and nothospital-based palliative care services is not fully understood by those completing the survey.
Thus, these data points may be prone to misinterpretation, which may lead to data inaccuracy.
Second, the key independent variable to examine research question three is limited in its
capability to represent the overall construct of a hospital’s experience providing palliative care
services. First, due to data inconsistencies, information on the presence of palliative care services
prior to the study period could not be taken into account to determine each service’s
implementation year. In other words, hospitals with a service in place in 2007 were assigned a
“1” in that year; that is, these hospitals were considered to have one year of experience in
providing a palliative care service in 2007. However, these hospitals may have had these services
in place longer than one year. The palliative care experience variable also assumes that time has
a linear effect. Given the possibility that the palliative care programs have been in existence for
several years prior to 2007, this specification may be an imprecise presentation of the underlying
construct of palliative care experience. It is also possible that there is a selection effect such that
hospitals that adopted palliative care services early are inherently different from hospitals that
adopted such services later. Therefore, estimating whether or not a hospital had a palliative care
service may not be sufficient to explain the true nature of hospital adoption of palliative care
services. In addition, due to a high rate of inconsistent implementation patterns within the study
period (~30%), it is also possible that the measurement of palliative care experience for all
hospital cases suffers from inaccuracy. In addition, this study did not take non-linear effects of
palliative care services on patient and organizational outcomes into account. For example, it is
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possible that hospital costs and length of stay increase during the first year of implementation of
a palliative care service and decrease in the years after due to learning effects. Such non-linear
effects need to be considered carefully in future study development, data collection, and analysis.
Similarly, the measurement of market competition corresponding to Hypothesis 5 may not be
able to accurately define the notion that hospitals are more likely to provide hospital-based
palliative care services if they are located in a highly competitive market. This study used the
Herfindahl-Hirschman Index to represent market competition, which was calculated using
information on total hospital admissions in the county. However, it may be more appropriate to
focus on hospital admissions of patients with primary diagnoses most likely to benefit and utilize
palliative care services instead, as hospitals are likely to assess this patient population as a
potential source of revenue when deciding for or against providing hospital-based palliative care
services.
Third, it is likely that not only the presence of palliative care services, but also other
structural characteristics, such as utilization, organization, or staffing, influence the effectiveness
of palliative care provision. Integrating procedural attributes (e.g., work processes, care
protocols) may also help to identify how hospitals deliver palliative care services, which can in
turn influence hospital costs, length of stay, in-hospital mortality, and transfer to hospice. This
also raises the question of how experience in providing a palliative care service can influence the
study’s empirical results, as hospitals potentially need time to identify procedures that are most
effective in addressing specific patients’ palliative care needs. Similarly, due to limited data
availability, this study was unable to control for all relevant factors influencing hospital adoption
of palliative care services and patient outcome measures. Specifically, the prevalence of hospices
and home health services in the county, as a measure of market supply of palliative care services,
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may influence a hospital’s decision to provide hospital-based palliative care services. Similarly, a
large number of hospices and home health services may also affect a hospital’s discharge pattern
and, in turn, affect the odds of hospice transfers, in-hospital mortality, and length of stay.
Fourth, the effect of palliative care services on patient and organizational outcomes
would ideally be evaluated by focusing on patients who actually utilized palliative care services
(and to what extent). Although the distinction between patients with and without primary
diagnoses most likely to benefit from and use palliative care services attempts to resolve this
issue, it is merely an approximation of actual palliative care utilization. For example, it might be
possible that patients categorized as most likely to benefit from and utilize palliative care
services in this study did not receive any palliative care. Even in hospitals with established
specialty palliative care, many patients with palliative care needs do not have access to such care.
While, on average, 3.4% of hospital admissions receive palliative care, more than twice as many
hospital patients are estimated to have palliative care needs (Morrison & Meier, 2015). Nonreferrals or late referrals are attributable to uncertainty about disease progression; misconception
and lack of knowledge about palliative care among medical professionals, families, and patients;
poor communication skills; and inadequate capacity of specialty palliative care programs to serve
all hospital patients with palliative care needs (Melvin & Oldham, 2009). Conversely, patients
who were not categorized as most likely to benefit from and utilize palliative care services may
have received palliative care services during their hospital stays. A fundamental problem with
this type of analysis would be related to the identification of a control group; that is, patients who
did not receive palliative care services. A suitable control group may include hospital patients
who qualify for palliative care but do not receive such care. Palliative care assessment criteria
have been introduced to screen patients and assure that unmet palliative care needs are identified
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and met efficiently, such as repeated hospital admissions, comprehensive care needs, advanced
and incurable cancer, or inadequate social support (Weissman & Meier, 2011). Given such
information is available for all patients admitted to a hospital, a control group could be
constructed from patients who meet these and other criteria. However, due to limited patient
information available through the HCUP SID, this type of study cannot be conducted on a large
scale and may need to be limited to patients admitted to one or a few hospitals for which
additional relevant patient data can be obtained.
Fifth, the generalizability of this study may be limited. Specifically, although this study
aims for geographic diversity in terms of state selection by choosing states from three of the four
U.S. census regions, the results may not be reproducible in other states.
Finally, this study evaluated a limited set of outcome measures due to restricted data
availability and thus other important quality indicators of palliative care could not be examined.
Comprehensive assessments of patient-centered health care services, such as palliative care,
should include a broader set of outcome measures, including patient and family satisfaction,
symptom and pain management, and alignment of goals of care with patient preferences.
Implications of the Findings
Theoretical implications.
Regarding research question one, this study used two widely-used organizational
theories, namely Institutional Theory (IT) and Resource Dependence Theory (RDT), to study
hospital adoption of palliative care services and derive five propositions and hypotheses. While
two hypotheses were supported, the remaining three were not. In future analysis, it may therefore
be necessary to identify additional theories to reconsider the study’s conceptual framework in an
attempt to assess the hypotheses that were not supported in this study or to establish new
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hypotheses to provide a more complete perspective on a hospital’s adoption behavior. The
application of institutional economics, such as transaction cost economics (TCE), may shed
further light on a hospital’s decision to provide palliative care services. This theory provides a
rational perspective on organizational decision-making, whereas IT and RDT tend to emphasize
the role of external constituents to explain organizational behavior (Shortell, 1997). Specifically,
TCE may be used to explain why hospitals decide to invest in hospital-based palliative care
services rather than to rely on palliative care services available through the health system,
network, or joint venture. This theory is often used in the context of make-or-buy decisions, and
its basic premise is that it is more efficient to produce transactions (or services) in-house if they
are frequently occurring, uncertain, and asset-specific (Williamson, 1975). Finally, it may also be
useful to utilize qualitative research methods to gain a more comprehensive understanding about
the drivers of hospital-based palliative care adoption. It is essential to note that palliative care
adoption is likely driven by a variety of factors and may be more fully understood when
additional or alternative theoretical perspectives are utilized.
The study also drew from Donabedian’s Structure-Process-Outcome (SPO) model to
address research questions two and three. However, the SPO model largely failed to explain how
palliative care services are associated with hospital performance measures and explain
associations clearly, which may be due to the limited depth of the model. While a framework
based on structures, processes, and outcomes may be useful to describe and quantify the main
dimensions of health care quality, it may not be able to sufficiently explain how organizational
structures, such as the presence of PAL, IPAL, and HOSPC, influence hospital performance
measures.
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In addition, this study does not take procedural dimensions regarding the provision of
palliative care into account due to data limitations, but instead focuses on the presence of
hospital-based palliative care services and their impact on hospital performance. In the context of
palliative care, however, it may be more appropriate to quantify a hospital’s processes of how,
when, and where palliative care services are delivered. While the presence of palliative care
services is an essential structural component, the procedural characteristics of care delivery and
management promise more predictive power in terms of hospital performance. Additional data
and research are required to establish causal relationships between palliative care services and
hospital performance by focusing on processes related to care delivery and other structural
components of such services that go beyond the provision of access to palliative care in the
hospital setting. In order to test these relationships empirically, primary data collection may need
to be conducted because administrative data on procedural characteristics of health care service
delivery are currently not collected on a large scale.
Health care policy implications.
Since the publication of the SUPPORT study in 1995, policy makers and leaders in the
healthcare industry have focused on improving care for patients with serious, complex, lifelimiting and potentially life-threatening illnesses (Cassel, 2014). Given the rising demand for
palliative care due to an aging population with chronic life-limiting diseases, the results of this
study provide valuable insight for policy makers in regard to potential barriers or drivers of
palliative care provision.
Increased presence of PAL in the hospital setting has been viewed as a trend toward
improvement of care for this patient population (Dumanovsky et al., 2015; Morrison et al.,
2005). From a policy perspective, a better understanding of the drivers behind hospital adoption
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of palliative care may help to accomplish two goals: (1) to ensure full access to palliative care to
patients with palliative care needs, and (2) to create incentives that motivate hospitals to integrate
these services in a way that improves both hospital performance and care provision for patients
with palliative care needs. These goals may be accomplished by overcoming persistent barriers
to palliative care provision, including payment models (Cassel, 2014; Center to Advance
Palliative Care, 2016). For example, linking hospital performance with financial incentive
programs, such as value-based purchasing, is an important step toward rewarding quality rather
than quantity of care. It is questionable, however, whether the presence of such services is
synonymous with adequate delivery. Merely encouraging hospitals to provide palliative care may
not suffice to ensure that patients with palliative care needs are effectively identified and
managed. In other words, providing palliative care does not necessarily equate with quality of
palliative care. Consequently, policy makers could structure incentive programs based on
outcome-related quality measures that can be addressed effectively by palliative care, such as the
alignment of goals of care with patient preferences, provider-patient and provider-family
communication and interaction, bereavement support, and symptom management. In addition to
outcome-related quality measures, incentives should also reward the structural and procedural
components of palliative care services, such as those promoted in NCP’s clinical practice
guidelines for quality palliative care (National Consensus Project for Quality Palliative Care,
2013). For example, the NCP encourages “a comprehensive and timely interdisciplinary
assessment of patient and family” (p. 14) to identify patient and family needs early in the disease
trajectory, typically within 24-72 hours of hospital admission. Processes and structures that
ensure early identification of patients with palliative care needs may be a better indication of
quality palliative care than the mere presence of palliative care services.
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Practice implications.
Healthcare administrators, in cooperation with clinical staff, need to decide whether and
how palliative care services fit into their service mix. A variety of factors drive the decisionmaking process, including available resources and demand. Although clinical guidelines
proposed by the National Quality Forum and NCP provide general guidance on how optimal
palliative care should be structured and delivered, clearer direction is needed for hospitals to
decide which type of palliative care service is most appropriate to meet the palliative care needs
of their patient population.
This study has shed some light on the association of three types of hospital-based
specialty palliative care services with hospital costs, in-hospital mortality, length of stay, and
transfer to hospice. However, the study findings are in part inconclusive and may not provide
clear guidance in regard to the benefits of specialty palliative care in the hospital setting.
Therefore, healthcare administrators may also investigate the use of primary palliative care,
although not examined in this study, as a means to improve care for patients with serious and
potentially life-limiting illnesses. Relying on palliative care competencies of clinical staff to
provide basic palliative care to patients on a day-to-day basis may provide hospitals with an
opportunity to reserve palliative care specialists for managing the most complex patients
(Weissman & Meier, 2011). While prior research has shown that primary palliative care services,
such as integrative care models, are associated with hospital performance, further research is
needed to determine to what extent both primary and specialty palliative care fit into a hospital’s
service mix. In this context, it is also important to assess how hospitals educate clinical staff to
provide primary palliative care. Primary palliative care education often lacks an interdisciplinary
team approach, where clinical staff are trained within their respective professions (K. White,
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personal communication, July 7, 2016). A hospital may be better equipped to meet patients’
basic palliative care needs if its clinical staff trains in a collaborative environment, in which the
roles of each profession or discipline are taught and applied.
In addition, health care administrators may be advised to evaluate a variety of outcome
measures, not just the outcome measures evaluated in this study. Prior research, as summarized
in Chapter 2, and this study have provided evidence of palliative care’s benefits with respect to
cost savings, efficient delivery of patient-centered care and health care utilization, and patient
discharge patterns. Research findings consistently support the notion that palliative care reduces
hospital costs, whereas the empirical evidence on how hospital LOS and in-hospital mortality are
influenced is mixed. Thus, health care administrators may be advised to avoid hospital LOS and
in-hospital mortality as measures to evaluate quality of care in the context of palliative care and
instead “focus on other validated and highly valued outcomes that their work produces, such as
reductions in hospital costs and improved clinical outcomes.” (Cassel et al., 2010b, p. 766)
Suggestions for Future Research
This study provides several suggestions for future research based on the limitations
identified in the previous section. First, future studies could optimize the measurement accuracy
of palliative care variables and reduce missing information. The use of additional data sources
may be able to validate the presence of palliative care services as indicated in the AHA Annual
Survey of Hospitals. Furthermore, the construction of palliative care experience could be
optimized by using information from years prior to the study period to determine the year of
service inception. This study treated hospitals with palliative care services in place at the
beginning of the study period as hospitals with one year of experience. In particular, information
from prior years were not used due to missing values and inconsistent implementation patterns.
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Additional data sources to confirm palliative care presence may be used to reach a more accurate
presentation of palliative care diffusion and experience. Alternatively, future studies may include
a dummy variable to identify programs that were already in place in 2007 to capture the effect of
having a program in place for more than five years; that is, the average effect of palliative care
experience prior to 2006. Ideally, however, future studies focus on tracing the origins of
palliative care services to measure the exact length of time they have been in effect. Also, as
hospitals may not adopt palliative care services randomly (i.e., possible selection effects), it may
be useful to consider modeling the effects of hospital and environmental factors on the timing of
palliative care service adoption. In addition, future research may consider constructing the
Herfindahl-Hirschman Index using only information on hospital admissions for patients with
primary diagnoses most likely to benefit and use palliative care services in a county to measure
market competition, as a hospital’s decision to provide hospital-based palliative care provision is
likely influenced by a perceived competitive advantage in securing revenue from a patient
population that may benefit from palliative care.
Second, this study evaluated the impact of palliative care on four outcome measures,
namely hospital LOS, in-hospital mortality, transfer to hospice, and hospital costs. Future
research should evaluate the effects of palliative care services on additional outcome measures,
including pain and symptom management, patient and family satisfaction, ICU LOS, ICU
mortality, alignment of goals of care with patient preferences, and hospital readmissions. In
regard to hospital costs, it is also important to examine hospital costs pertaining to specific costs
centers, such as ICU, emergency room, pharmacy, laboratory, subacute care, or oncology. More
specific data collection is needed as these measures are all dependent on the availability of welldefined data. With regard to estimating the effects of palliative care services on length of stay,
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future research may also consider modeling length of stay as a duration model with competing
hazards, where death and discharge to other settings are distinct outcomes.
Third, this study was limited to evaluating the association of the presence of specialty
palliative care, namely inpatient palliative care consultation services, hospice programs, and
inpatient palliative care units on certain dependent variables. The AHA Survey of Hospitals does
not collect detailed information on structural or procedural attributes of hospital services, such as
palliative care services. Researchers could therefore gather primary data on processes of care
(e.g., timing of services, care protocols) and structural components (e.g., staffing, resources) and
examine their impact on patient and organizational outcomes. Future research could also
examine the nature and diffusion of primary palliative care in different hospital units, such as
ICUs or emergency rooms. Primary palliative care is essential in treating patients’ basic
palliative care needs and can be provided by the attending physician, whereas specialty palliative
care typically focuses on patients with complex illnesses and symptoms that are difficult to
manage and require medical attention of palliative care specialists. Studies that focus on the use
and attributes of primary palliative care may provide valuable insights for health care
administrators about the relative performance of primary and specialty palliative care.
Fourth, this study evaluated how the presence of palliative care services was associated
with care received by patients most likely to benefit from these services. It was unclear whether
or to what extend the patients in the sample received palliative care services. Future research
could focus on comparing differences in outcomes for patients who actually received palliative
care services and those who did not. However, this patient information is currently not collected
and available on a larger scale. Alternatively, future research could apply a different method for
identifying patients who are most likely to use and benefit from palliative care. For example, the
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diagnosis-related groups (DRG) or all-patient refined DRGs (APR-DRG), developed by 3M
Health Information Systems, are patient classification approaches with groups of patients who
are similar in terms of resource usage and clinical attributes. These classification schemes may
be valuable alternatives to select appropriate patient populations in the context of palliative care.
Another possibility to approximate actual palliative care utilization without available data on
which patients received palliative care services during hospitalization is to compare the effects of
hospital-based palliative care services on outcomes between patients with primary diagnoses
most likely to benefit from palliative care services (e.g., COPD patients) and patients with
primary diagnoses not likely to utilize palliative care during hospitalization (e.g., patients
admitted for normal pregnancies). Considering the former patient group the intervention group
and the latter the control group, it may be expected that hospital-based palliative care services
affect the outcomes of the former patient group only. This approach may be used to gauge
whether the presence of hospital-based palliative care services is synonymous with palliative
care utilization among patients who are most likely to use and benefit from palliative care
services. Future research may also evaluate the impact of two advance care planning CPT
(Current Procedural Terminology) billing codes introduced by CMS in early 2016 (Centers for
Medicare and Medicaid Services, 2015a). This change in reimbursement may incentivize
palliative care adoption among hospitals, as palliative care consultations become more profitable.
At the patient level, designated billing codes to reimburse advance care planning may also
provide an opportunity to identify patients who received advance care planning and evaluate the
impact of such services on patient outcomes more accurately using large databases, such as the
SID files. The systematic documentation of patients who received palliative care services is
currently not possible, as no billable CPT codes exist. Common, billable ICD-9-CM and ICD-10-
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CM codes used by palliative care physicians are related to the symptoms they treat, such as
delirium, depression, shortness of breath, weight loss, and pain (EPEC Project, 1999). Although
these codes are available through the HCUP SID, they are not unique to palliative care services
and are thus not meaningful in identifying palliative care patients. Note that one ICD-9-CM
code, V66.7, indicates whether a patient had a palliative care encounter during hospitalization
and is used as a patient control variable in the analytical models to address research questions
two and three. It was introduced in 1996 and belongs to a supplementary list of ICD-9-CM
codes, which may be used to further describe health care services provided to a hospital patient.
However, research has demonstrated infrequent use of this code among palliative care patients in
the hospital setting (Kroch, Johnson, Martin, & Duan, 2010). It is also likely that palliative care
encounters under this code occur when death is imminent. Cassel et al. (2010a) noted that V66.7
“appears to be geared toward end-of-life care (only) and not concurrent management of pain and
symptoms.” (p. 921) Some palliative care providers primarily use the V66.7 code to flag patients
to be excluded from a hospital’s mortality rate calculation (L. Blackhall, personal
communication, January 6, 2015). Hence, this code was deemed unsuitable for use as a key
explanatory variable to evaluate the effects of palliative care services on the study’s outcomes as
proposed under research questions two and three and, instead, was used as a control variable.
Finally, this study limited its sample to hospitals located in six states, namely Arizona,
California, Florida, Maryland, New Jersey, and New York and which were in operation from
2007 until 2011. Additional future studies could be conducted with hospitals located in different
states and evaluate different time periods to explore whether the study findings are generalizable
to other health care markets and time periods.
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Conclusion
This study used organizational theories to explore three research questions. First, research
question one employed a two-level hierarchical generalized linear model to examine the
organizational and environmental factors associated with the provision of hospital-based
palliative care services. This study found that hospital size was significantly associated with a
higher probability of hospital-based palliative care provision, whereas the presence of palliative
care services through a hospital’s health system, network, or joint venture was associated with a
lower probability of hospital-based palliative care provision.
Research questions two and three investigated whether hospitals that provide palliative
care services have improved organizational and patient outcomes compared to those not
providing such services; and whether a hospital’s experience in providing palliative care services
is associated with improved organizational and patient outcomes. This study found that hospitals
with an IPAL or HOSPC incurred lower hospital costs than hospitals that do not provide such
services; hospitals with PAL incurred higher hospital costs than hospitals without such services.
Among survivors and decedents, the 1-year effects of IPAL were associated with shorter
lengths of stay, whereas the remaining year effects of IPAL were associated with longer lengths
of stay. Among decedents, while the 1-year effect of PAL was associated with longer lengths of
stay, the fifth year effect was associated with shorter lengths of stay. In addition, the 1-year
effect of PAL was not significantly associated with length of stay among survivors but the
remaining year effects were associated with shorter lengths of stay. Finally, survivors treated in
hospitals with HOSPC had longer lengths of stay. The presence of HOSPC was not significantly
associated with length of stay among decedents.
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All year effects of PAL and HOSPC were associated with lower odds of in-hospital
mortality. The 1-year effect of IPAL was associated with lower odds of in-hospital mortality but
the effects of the third through fifth year indicated higher odds of in-hospital mortality.
While the 1-year effect of PAL was associated with higher odds of hospice transfer, the
annual effects of the second through fifth year indicated incrementally lower odds of transfer to
hospice. In addition, all year effects of IPAL suggested lower odds of hospice transfer. Finally,
the first two year effects of HOSPC were associated with lower odds of hospice transfer, whereas
the fifth year effect of HOSPC was associated with higher odds of hospice transfer.
Several sensitivity analyses were conducted to examine the robustness of these
associations. In general, findings corresponding to research questions two and three were robust
across model specifications. Further research is necessary to fully understand the association
between hospital and environmental factors and the presence of individual palliative care
services.
Although this study has several limitations, the study findings are relevant to hospital
administrators and policy makers. Hospital administrators who plan to provide or expand
hospital-based palliative care services may use the study findings to assist them in deciding
which palliative care services are most appropriate for their patient population. Similarly, policy
makers can use the study findings as a guidance for structuring incentive programs aiming to
promote outcome-related quality measures that can be addressed effectively by palliative care.
As the prevalence of hospital-based palliative care has been growing steadily since the beginning
of the 21st century, an understanding of drivers of hospital provision of palliative care services
and subsequent care outcomes offers valuable guidance for future efforts to assure access to
palliative care and high quality of such services for patients with palliative care needs.
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